image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
74079524d50956cdc7bd70f70607916a82fb2e0783a1bdde68ee3c7ae1ecb7a7.png | simple | <table><tr><td>Norm Method</td><td>% Correct</td><td>Sensitivity</td><td>Specificity</td><td>Between-mean array correlation (after normalization)</td><td>Between array coefficient of variation (after normalization)</td><td>Confounding index (after normalization)</td></tr><tr><td>SGM-Log2</td><td>0.709</td><td>0.411</td><td>0.782</td><td>0.931</td><td>0.105</td><td>0.985</td></tr><tr><td>Quantile 75</td><td>0.511</td><td>0.647</td><td>0.478</td><td>0.996</td><td>0.807</td><td>0.989</td></tr><tr><td>Mean</td><td>0.488</td><td>0.705</td><td>0.434</td><td>0.993</td><td>0</td><td>0.989</td></tr><tr><td>Minimum Mean</td><td>0.488</td><td>0.705</td><td>0.434</td><td>0.993</td><td>0</td><td>0.989</td></tr><tr><td>Sum</td><td>0.488</td><td>0.705</td><td>0.434</td><td>0.993</td><td>0</td><td>0.989</td></tr><tr><td>Z Trans</td><td>0.476</td><td>0.647</td><td>0.434</td><td>0.992</td><td>−30.447</td><td>0.989</td></tr><tr><td>5%–95% Adjust</td><td>0.465</td><td>0.882</td><td>0.362</td><td>0.991</td><td>0.252</td><td>0.989</td></tr><tr><td>Global Mean Adjust</td><td>0.465</td><td>0.705</td><td>0.405</td><td>0.902</td><td>0</td><td>0.989</td></tr><tr><td>Max1, Min0</td><td>0.465</td><td>0.882</td><td>0.362</td><td>0.991</td><td>0.258</td><td>0.989</td></tr><tr><td>Quantile 90</td><td>0.465</td><td>0.647</td><td>0.42</td><td>0.991</td><td>0.265</td><td>0.989</td></tr><tr><td>Quantile 95</td><td>0.465</td><td>0.647</td><td>0.42</td><td>0.991</td><td>0.265</td><td>0.989</td></tr><tr><td>Quantile 99</td><td>0.465</td><td>0.647</td><td>0.42</td><td>0.991</td><td>0.265</td><td>0.989</td></tr><tr><td>SGM-Square Root Trans</td><td>0.441</td><td>0.941</td><td>0.318</td><td>0.961</td><td>0.372</td><td>0.988</td></tr><tr><td>No Norm</td><td>0.43</td><td>1</td><td>0.289</td><td>0.902</td><td>0.862</td><td>0.989</td></tr><tr><td>Trimmed Mean 10–90</td><td>0.418</td><td>0.764</td><td>0.333</td><td>0.987</td><td>0.767</td><td>0.989</td></tr><tr><td>Trimmed Mean 1–99</td><td>0.418</td><td>0.764</td><td>0.333</td><td>0.987</td><td>0.767</td><td>0.989</td></tr><tr><td>Trimmed Mean 5–95</td><td>0.418</td><td>0.764</td><td>0.333</td><td>0.987</td><td>0.767</td><td>0.989</td></tr><tr><td>Median Mean</td><td>0.406</td><td>1</td><td>0.26</td><td>0.557</td><td>2.067</td><td>0.989</td></tr><tr><td>Quantile 25</td><td>0.406</td><td>1</td><td>0.26</td><td>−0.721</td><td>−10.2</td><td>1.018</td></tr><tr><td>SGM-Cond Log Trans</td><td>0.36</td><td>1</td><td>0.202</td><td>0.966</td><td>0.886</td><td>1.026</td></tr><tr><td>Quantile 50</td><td>0.36</td><td>0.941</td><td>0.217</td><td>0.622</td><td>2.417</td><td>0.989</td></tr><tr><td>Trimmed Mean 25–75</td><td>0.36</td><td>0.941</td><td>0.217</td><td>0.768</td><td>1.915</td><td>0.989</td></tr><tr><td>Median</td><td>0.348</td><td>0.941</td><td>0.202</td><td>0.694</td><td>2.2</td><td>0.989</td></tr></table> |
612b20fac8112cdc74e0e4b9f7b801475479d6973800ee72226e83497fc744be.png | simple | <table><tr><td></td><td>Cases</td><td>Deaths</td></tr><tr><td>Cervical cancer</td><td>1344</td><td>492</td></tr><tr><td>CIN2+</td><td>4528</td><td>–</td></tr><tr><td>CIN1</td><td>2532</td><td>–</td></tr><tr><td>Vaginal cancer</td><td>14</td><td>4</td></tr><tr><td>Vulvar cancer</td><td>20</td><td>6</td></tr><tr><td>Anal cancer females</td><td>242</td><td>75</td></tr><tr><td>Anal cancer males</td><td>79</td><td>34</td></tr><tr><td>Genital warts females</td><td>33,091</td><td>–</td></tr><tr><td>Genital warts males</td><td>24,258</td><td>–</td></tr><tr><td>Total</td><td>66,108</td><td>611</td></tr></table> |
a16508fba94fcd291285896604bb41179ae0bdcf2f8c835293bcc176c7bf9f47.png | complex | <table><tr><td rowspan="3" colspan="2">Herd-level performance indicators</td><td colspan="7">Semesters</td></tr><tr><td>Jan-Jun 2009</td><td>Jul-Dec 2009</td><td>Jan-Jun 2010</td><td>Jul-Dec 2010</td><td>Jan-Jun 2011</td><td>Jul-Dec 2011</td><td>Jan-Jun 2012</td></tr><tr><td>(<i>n</i> = 710)</td><td>(<i>n</i> = 620)</td><td>(<i>n</i> = 726)</td><td>(<i>n</i> = 636)</td><td>(<i>n</i> = 747)</td><td>(<i>n</i> = 632)</td><td>(<i>n</i> = 591)</td></tr><tr><td>1</td><td>Average daily milk production per cow (L/day/cow)</td><td>29.08 (±5.46)</td><td>27.44 (±4.54)</td><td>29.23 (±4.52)</td><td>27.05 (±4.57)</td><td>29.16 (±4.69)</td><td>27.33 (±4.60)</td><td>29.32 (±4.69)</td></tr><tr><td>2</td><td>Average milk protein content (%)</td><td>3.43 (±0.19)</td><td>3.43 (±0.16)</td><td>3.39 (±0.14)</td><td>3.4 (±0.28)</td><td>3.36 (±0.14)</td><td>3.43 (±0.18)</td><td>3.42 (±0.15)</td></tr><tr><td>3</td><td>Average milk fat content (%)</td><td>3.65 (±0.33)</td><td>3.73 (±0.32)</td><td>3.67 (±0.31)</td><td>3.71 (±0.43)</td><td>3.61 (±0.32)</td><td>3.68 (±0.32)</td><td>3.72 (±0.30)</td></tr><tr><td>4</td><td>Average number of lactations per cow (no.)</td><td>2.37 (±0.30)</td><td>2.36 (±0.30)</td><td>2.34 (±0.28)</td><td>2.34 (±0.27)</td><td>2.33 (±0.27)</td><td>2.33 (±0.28)</td><td>2.33 (±0.28)</td></tr><tr><td>5</td><td>Average lactation length (days)</td><td>200.75 (±34.37)</td><td>203.41 (±37.20)</td><td>203.42 (±38.30)</td><td>203.83 (±38.73)</td><td>198.8 (±33.28)</td><td>195.03 (±32.89)</td><td>198.89 (±31.81)</td></tr><tr><td>6</td><td>Average calving-to-conception interval (days)</td><td>163.65 (±34.65)</td><td>167.28 (±38.08)</td><td>164.03 (±38.36)</td><td>166.25 (±38.95)</td><td>159.34 (±34.71)</td><td>158.44 (±34.60)</td><td>157.5 (±34.46)</td></tr><tr><td>7</td><td>Average number of inseminations per pregnancy (no.)</td><td>2.38 (±0.63)</td><td>2.36 (±0.66)</td><td>2.43 (±0.74)</td><td>2.47 (±0.76)</td><td>2.39 (±0.78)</td><td>2.34 (±0.71)</td><td>2.36 (±0.69)</td></tr><tr><td>8</td><td>Average number of inseminations per pregnancy in primiparous cows (no.)</td><td>2.36 (±0.83)</td><td>2.36 (±0.89)</td><td>2.44 (±0.88)</td><td>2.48 (±0.98)</td><td>2.42 (±0.95)</td><td>2.32 (±0.87)</td><td>2.39 (±0.84)</td></tr><tr><td>9</td><td>Average number of inseminations per pregnancy in multiparous cows (no.)</td><td>2.39 (±0.71)</td><td>2.35 (±0.67)</td><td>2.42 (±0.81)</td><td>2.48 (±0.84)</td><td>2.37 (±0.86)</td><td>2.35 (±0.77)</td><td>2.33 (±0.77)</td></tr><tr><td>10</td><td>Average number of inseminations per pregnancy leading to a registered newborn (no.)<sup>a</sup></td><td>0.66 (±0.58)</td><td>0.81 (±0.73)</td><td>0.67 (±0.64)</td><td>0.79 (±0.75)</td><td>0.67 (±0.63)</td><td>0.76 (±0.74)</td><td>0.65 (±0.61)</td></tr><tr><td>11</td><td>Total number of registered newborns (no.)<sup>b</sup></td><td>5.04 (±4.18)</td><td>4.47 (±3.69)</td><td>5.34(±4.37)</td><td>4.74 (±3.80)</td><td>5.34 (±4.38)</td><td>4.71 (±4.22)</td><td>4.98 (±3.69)</td></tr><tr><td>12</td><td>Number of cows per farm (no.)</td><td>70.27 (±45.49)</td><td>70.54 (±48.23)</td><td>70.67 (±48.17)</td><td>71.52 (±50.00)</td><td>72.72 (±49.51)</td><td>73.73 (±52.68)</td><td>64.65 (±22.36)</td></tr><tr><td>13</td><td>Cows’ average age (months)</td><td>46.19 (±5.98)</td><td>46.66 (±6.67)</td><td>46.61 (±6.38)</td><td>46.73 (±5.98)</td><td>46.69 (±5.16)</td><td>46.77 (±5.18)</td><td>46.85 (±5.85)</td></tr><tr><td>14</td><td>Average length of dry period (days)</td><td>76.78 (±59.67)</td><td>76.03 (±66.95)</td><td>74.16 (±41.76)</td><td>74.15 (±38.01)</td><td>70.1 (±20.19)</td><td>67.96 (±13.57)</td><td>67.09 (±14.23)</td></tr><tr><td>15</td><td>Proportion of pregnant primiparous cows (%)</td><td>44.63 (±14.18)</td><td>45.74 (±15.34)</td><td>43.79 (±15.59)</td><td>45.96 (±15.99)</td><td>46.53 (±15.82)</td><td>46.48 (±16.22)</td><td>44.84 (±16.07)</td></tr><tr><td>16</td><td>Proportion of pregnant multiparous cows (%)</td><td>41.66 (±13.53)</td><td>42.21 (±14.07)</td><td>40.4 (±14.93)</td><td>43.13 (±14.41)</td><td>42.62 (±13.76)</td><td>42.42 (±14.75)</td><td>40.72 (±14.92)</td></tr><tr><td>17</td><td>Proportion of artificial inseminations (%)</td><td>91.67 (±20.39)</td><td>91.48 (±21.35)</td><td>91.61 (±22.42)</td><td>89.95 (±25.04)</td><td>89.02 (±26.32)</td><td>89.62 (±25.56)</td><td>89.65 (±25.39)</td></tr><tr><td>18</td><td>Proportion of culled cows (%)</td><td>2.54 (±3.09)</td><td>3.04 (±3.18)</td><td>2.27 (±2.29)</td><td>2.83 (±2.55)</td><td>2.37 (±2.40)</td><td>2.85 (±2.74)</td><td>2.31 (±2.35)</td></tr><tr><td>19</td><td>Cows’ average age at first delivery (months)</td><td>27.15 (±4.04)</td><td>27.87 (±6.67)</td><td>28.17 (±6.71)</td><td>31.32 (±39.57)</td><td>21.07 (±12.97)</td><td>20.9 (±12.00)</td><td>19.25 (±12.88)</td></tr></table> |
f9b69f57bd7749d3d020fa1775a688a53c7acd642d1ecb9db5babbae5821246f.png | complex | <table><tr><td rowspan="2">Drink tea</td><td rowspan="2">Term (<i>n</i>)</td><td colspan="2">Preterm (<i>n</i> = 1019)</td><td colspan="2">Moderate preterm (<i>n</i> = 833)</td><td colspan="2">Very preterm (<i>n</i> = 186)</td><td colspan="2">Medically indicated (<i>n</i> = 338)</td><td colspan="2">Spontaneous (<i>n</i> = 681)</td></tr><tr><td>No.</td><td>OR(95 % CI)</td><td>No.</td><td>OR(95 % CI)</td><td>No.</td><td>OR(95 % CI)</td><td>No.</td><td>OR(95 % CI)</td><td>No.</td><td>OR(95 % CI)</td></tr><tr><td>Never</td><td>8403</td><td>900</td><td>1</td><td>733</td><td>1</td><td>167</td><td>1</td><td>295</td><td>1</td><td>605</td><td>1</td></tr><tr><td>Ever</td><td>757</td><td>119</td><td>1.36(1.09–1.69)</td><td>100</td><td>1.41(1.12–1.79)</td><td>19</td><td>1.05(0.64–1.72)</td><td>43</td><td>1.24(0.85–1.83)</td><td>76</td><td>1.41(1.09–1.83)</td></tr><tr><td> Before pregnancy</td><td>680</td><td>107</td><td>1.39(1.10–1.75)</td><td>91</td><td>1.47(1.15–1.87)</td><td>16</td><td>1.01(0.59–1.73)</td><td>36</td><td>1.24(0.82–1.88)</td><td>71</td><td>1.49(1.14–1.94)</td></tr><tr><td> During pregnancy ever</td><td>377</td><td>69</td><td>1.38(1.04–1.83)</td><td>55</td><td>1.37(1.00–1.87)</td><td>14</td><td>1.34(0.75–2.39)</td><td>33</td><td>1.76(1.13–2.76)</td><td>36</td><td>1.19(0.83–1.72)</td></tr><tr><td> Before pregnancy only</td><td>380</td><td>50</td><td>1.33(0.97–1.83)</td><td>45</td><td>1.47(1.05–2.05)</td><td>5</td><td>0.66(0.27–1.65)</td><td>10</td><td>0.62(0.30–1.28)</td><td>40</td><td>1.67(1.18–2.36)</td></tr><tr><td> Before and during pregnancy</td><td>300</td><td>57</td><td>1.45(1.06–1.98)</td><td>46</td><td>1.47(1.05–2.06)</td><td>11</td><td>1.35(0.71–2.58)</td><td>26</td><td>1.92(1.17–3.15)</td><td>31</td><td>1.29(0.87–1.92)</td></tr><tr><td> During pregnancy only</td><td>77</td><td>12</td><td>1.10(0.57–2.14)</td><td>9</td><td>1.01(0.48–2.13)</td><td>3</td><td>1.30(0.38–4.42)</td><td>7</td><td>1.25(0.48–3.28)</td><td>5</td><td>0.78(0.30–2.03)</td></tr></table> |
d93774a34da71f92e26f9061552e6f05e62e70e25cba2a477bf0abd86b1b90b4.png | simple | <table><tr><td>Antimicrobial agents</td><td>Breakpoint for resistance (mg/L)</td><td>% Resistant</td><td>Range (mg/L)</td><td>MIC<sub>50</sub> (mg/L)</td><td>MIC<sub>90</sub> (mg/L)</td></tr><tr><td>Imipenem</td><td>≥8</td><td>100</td><td>8–128</td><td>32</td><td>64</td></tr><tr><td>Meropenem</td><td>≥8</td><td>99</td><td>4–128</td><td>32</td><td>64</td></tr><tr><td>Amikacin</td><td>≥64</td><td>87</td><td>0.5 – > 512</td><td>>512</td><td>>512</td></tr><tr><td>Ciprofloxacin</td><td>≥4</td><td>100</td><td>32 – > 512</td><td>>512</td><td>>512</td></tr><tr><td>Colistin</td><td>≥4</td><td>5</td><td>0.125–16</td><td>0.5</td><td>1</td></tr><tr><td>Tigecycline</td><td>-</td><td>-</td><td>≤0.125–16</td><td>1</td><td>8</td></tr></table> |
1932c6847d8f94842bdd9e6bf8bf72050ce8d49daa6a895289dd9243439342e9.png | simple | <table><tr><td>Year</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td></tr><tr><td>Export</td><td>9,762</td><td>9,975</td><td>9,630</td><td>9,496</td></tr><tr><td>Import</td><td>7,288</td><td>6,956</td><td>5,763</td><td>4,683</td></tr><tr><td>Net export</td><td>2,474</td><td>3,019</td><td>3,867</td><td>4,813</td></tr></table> |
7580aba22c626899f1258b13edaff941910fae57792ba6df8f2d09334348fe7c.png | complex | <table><tr><td></td><td colspan="3">Cohort<sup>a</sup></td><td colspan="3">Claimants<sup>b</sup></td></tr><tr><td></td><td>Odd Ratio<sup>*</sup></td><td colspan="2">95 % Confidence Interval</td><td>Odd Ratio<sup>*</sup></td><td colspan="2">95 % Confidence Interval</td></tr><tr><td colspan="7">Top cost percentile during 2010</td></tr><tr><td> Top 1 Percentile</td><td>0.99</td><td>0.84</td><td>1.15</td><td>1.66<sup>c</sup></td><td>1.42</td><td>1.94</td></tr><tr><td> Top 5 Percentile</td><td>0.8<sup>c</sup></td><td>0.74</td><td>0.85</td><td>1.34<sup>c</sup></td><td>1.25</td><td>1.43</td></tr><tr><td> Incremental Effect on PMPY</td><td>-$323.08</td><td>-$345.54</td><td>-$278.07</td><td>$494.72</td><td>$461.63</td><td>$526.01</td></tr><tr><td colspan="7">Top cost percentile during 2011</td></tr><tr><td> Top 1 Percentile</td><td>1.17<sup>c</sup></td><td>1.01</td><td>1.37</td><td>1.80<sup>c</sup></td><td>1.55</td><td>2.10</td></tr><tr><td> Top 5 Percentile</td><td>0.96</td><td>0.89</td><td>1.02</td><td>1.47<sup>c</sup></td><td>1.37</td><td>1.57</td></tr><tr><td> Incremental Effect on PMPY</td><td>-$88.22</td><td>-$133.59</td><td>-$42.84</td><td>$831.80</td><td>$763.38</td><td>$879.21</td></tr><tr><td colspan="7">Top cost percentile during 2010 and 2011 combined</td></tr><tr><td> Top 1 Percentile</td><td>1.11</td><td>0.97</td><td>1.27</td><td>1.60<sup>c</sup></td><td>1.40</td><td>1.84</td></tr><tr><td> Top 5 Percentile</td><td>0.89<sup>c</sup></td><td>0.84</td><td>0.95</td><td>1.29<sup>c</sup></td><td>1.25</td><td>1.41</td></tr><tr><td> Incremental Effect on PMPY</td><td>-$411.44</td><td>-$491.53</td><td>-$348.55</td><td>$647.10</td><td>$570.87</td><td>$703.56</td></tr></table> |
cf10eafb2b090d0ecdc1995aaf21a577d76e34b3179baf42be4125a83d6f021c.png | simple | <table><tr><td>Mean of self-monitored FPG values from preceding 3 days</td><td>Adjust of nocturnal basal insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−1</td></tr><tr><td>90-130 mg/dL (5.0-7.2 mmol/L)</td><td>No adjustment</td></tr><tr><td>>130 mg/dL (7.2 mmol/L)</td><td>+2</td></tr><tr><td>Mean of self-monitored pre-dinner values from preceding 3 days</td><td>Adjust of diurnal basal insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−2</td></tr><tr><td>90-130 mg/dL (5.0-7.2 mmol/L)</td><td>No adjustment</td></tr><tr><td>>130 mg/dL (7.2 mmol/L)</td><td>+2</td></tr><tr><td>Mean of self-monitored postprandial values from preceding 3 days</td><td>Adjust of prandial insulin dosage (IU/day)</td></tr><tr><td><90 mg/dL (5.0 mmol/L)</td><td>−1</td></tr><tr><td>90-180 mg/dL (5.0-10.0 mmol/L)</td><td>No adjustment</td></tr><tr><td>>180 mg/dL (10.0 mmol/L)</td><td>+1</td></tr></table> |
3e278de93289701e86be7dd6ae3027cf7bf8bb30ac82a81ad0b248e31bf70eb0.png | complex | <table><tr><td rowspan="2">EV71 vaccine candidates </td><td rowspan="2">Adjuvant formulated </td><td colspan="2">Total IgG titers </td><td colspan="3">Western blot </td><td colspan="2">Virus neutralization titer </td></tr><tr><td>VP1-43</td><td>VP2-28</td><td>rVP1</td><td>rVP2</td><td>rVP3</td><td>EV71 (B4 E59)</td><td>CVA16 (N5079)</td></tr><tr><td>VP1-43</td><td>Alum </td><td>1/3200 </td><td> </td><td>++</td><td> </td><td> </td><td><1/8</td><td><1/8 </td></tr><tr><td> VP1-43</td><td>CFA/IFA </td><td>1/6400</td><td> </td><td>+++</td><td> </td><td> </td><td> 1/32</td><td><1/8 </td></tr><tr><td> VP2-28</td><td>Alum </td><td> </td><td>1/200 </td><td> </td><td>−</td><td> </td><td> <1/8 </td><td><1/8 </td></tr><tr><td> VP2-28</td><td>CFA/IFA </td><td> </td><td>1/1600 </td><td> </td><td>+</td><td> </td><td><1/8</td><td><1/8 </td></tr><tr><td> VP1-43/VP2-28 </td><td>CFA/IFA </td><td> 1/6400 </td><td>1/800</td><td>+++ </td><td> + </td><td> </td><td> 1/32 </td><td><1/8 </td></tr><tr><td>rVP1</td><td>Alum </td><td>1/6400 </td><td> </td><td>+++ </td><td> </td><td> </td><td><1/8 </td><td><1/8 </td></tr><tr><td> rVP1</td><td>CFA/IFA </td><td>1/12800 </td><td> </td><td>+++ </td><td> </td><td> </td><td>1/128</td><td><1/8 </td></tr><tr><td> rVP2</td><td>Alum </td><td> </td><td><1/100 </td><td> </td><td>+++ </td><td> </td><td> <1/8 </td><td><1/8 </td></tr><tr><td> rVP2 </td><td>CFA/IFA </td><td> </td><td>1/200 </td><td> </td><td>+++ </td><td> </td><td>1/8 </td><td><1/8</td></tr><tr><td>rVP3 </td><td>Alum </td><td> </td><td> </td><td> </td><td> </td><td>++</td><td><1/8 </td><td> <1/8 </td></tr><tr><td>rVP3 </td><td>CFA/IFA </td><td> </td><td> </td><td> </td><td> </td><td> +++ </td><td>1/8 </td><td><1/8 </td></tr><tr><td>EV71-VLP</td><td>PBS </td><td>1/1600 </td><td><1/100 </td><td>++ </td><td>++</td><td>++ </td><td>1/64 </td><td><1/8 </td></tr><tr><td> EV71-VLP </td><td>Alum</td><td>1/6400 </td><td><1/100 </td><td>++ </td><td> ++ </td><td>++ </td><td>1/128 </td><td><1/8</td></tr><tr><td>EV71-VLP </td><td>CFA/IFA</td><td>1/12800 </td><td><1/100 </td><td>+++ </td><td>+++ </td><td>++ </td><td>1/160 </td><td> <1/8 </td></tr><tr><td>2 <i>μ</i>g of inactivated </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> EV71 virion </td><td>PBS </td><td>1/6400 </td><td><1/100 </td><td>+++</td><td>+++ </td><td>++ </td><td>1/64 </td><td><1/8 </td></tr><tr><td> EV71 virion </td><td>Alum </td><td>1/12800 </td><td><1/100 </td><td> +++ </td><td>+++ </td><td>++ </td><td>1/640 </td><td><1/8 </td></tr><tr><td>5 <i>μ</i>g of inactivated</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> EV71 virion </td><td>Alum </td><td>1/12800 </td><td><1/100 </td><td> +++ </td><td>+++ </td><td>+++</td><td>1/2560 </td><td><1/8 </td></tr></table> |
d1ada4924a073bf06337993c2af9279de57c684f7d12e4f1598911c61994ec9a.png | complex | <table><tr><td rowspan="2">System</td><td colspan="2">Prosthetic crown</td></tr><tr><td>8 mm</td><td>13 mm</td></tr><tr><td>Neodent</td><td>31.43 ±15.44Aa</td><td>28.13 ± 12.66Aa</td></tr><tr><td>Bicon</td><td>26.18 ± 13.00Ba</td><td>30.92 ± 14.89Aa</td></tr></table> |
c6ef6855f7ecf430cc22156b65cfbde20e05187b250e6ac9e364fbdddf22eb99.png | complex | <table><tr><td></td><td>Number of patients (percentage of sample in parentheses)</td></tr><tr><td colspan="2">Age</td></tr><tr><td><=60 years</td><td>1743 (65.1%)</td></tr><tr><td>>60 years</td><td>936 (34.9%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>Female</td><td>1439 (53.7%)</td></tr><tr><td>Male</td><td>1240 (46.3%)</td></tr><tr><td colspan="2">Body mass index</td></tr><tr><td><=25 kg/m2</td><td>309 (11.5%)</td></tr><tr><td>>25 to < =30 kg/m2</td><td>1003 (37.4%)</td></tr><tr><td>= > 30 kg/m2</td><td>1367 (51.0%)</td></tr><tr><td colspan="2">Smoking status</td></tr><tr><td>Current smoker</td><td>464 (17.3%)</td></tr><tr><td>Ex-smoker</td><td>301 (11.2%)</td></tr><tr><td>Non-smoker</td><td>1914 (71.4%)</td></tr><tr><td colspan="2">Country</td></tr><tr><td>Eastern European countries</td><td>1763 (65.8%)</td></tr><tr><td>Western-central European countries</td><td>916 (34.2%)</td></tr></table> |
fc060b841b31eafeb330043db70d8efc75ae4f0fb855a57d8c0ae5f25e346760.png | complex | <table><tr><td></td><td>miR-155 copy no.</td><td>Age</td><td>DD</td><td>ESR</td><td>CRP</td><td>TJS</td><td>SJS</td></tr><tr><td rowspan="3">Age</td><td>−0.239</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(−0.58, 0.18)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0.260</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3">DD</td><td>−0.064</td><td>0.464</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(−0.45, 0.34)</td><td>(0.07, 0.73)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0.766</td><td>0.022</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3">ESR</td><td>0.546</td><td>−0.136</td><td>−0.108</td><td></td><td></td><td></td><td></td></tr><tr><td>(0.18, 0.77)</td><td>(−0.51, 0.28)</td><td>(−0.49, 0.30)</td><td></td><td></td><td></td><td></td></tr><tr><td>0.006</td><td>0.526</td><td>0.615</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="3">CRP</td><td>0.186</td><td>−0.169</td><td>−0.095</td><td>0.672</td><td></td><td></td><td></td></tr><tr><td>(−0.23, 0.54)</td><td>(−0.53, 0.25)</td><td>(−0.48, 0.32)</td><td>(0.36, 0.84)</td><td></td><td></td><td></td></tr><tr><td>0.384</td><td>0.429</td><td>0.659</td><td>0.000</td><td></td><td></td><td></td></tr><tr><td rowspan="3">TJS</td><td>0.631</td><td>−0.035</td><td>0.127</td><td>0.261</td><td>0.197</td><td></td><td></td></tr><tr><td>(0.30, 0.82)</td><td>(−0.43, 0.37)</td><td>(−0.29, 0.50)</td><td>(−0.15, 0.60)</td><td>(−0.22, 0.55)</td><td></td><td></td></tr><tr><td>0.001</td><td>0.872</td><td>0.555</td><td>0.218</td><td>0.356</td><td></td><td></td></tr><tr><td rowspan="3">SJS</td><td>0.503</td><td>−0.232</td><td>−0.301</td><td>0.565</td><td>0.472</td><td>0.529</td><td></td></tr><tr><td>(0.12, 0.75)</td><td>(−0.58, 0.18)</td><td>(−0.62, 0.11)</td><td>(0.21, 0.78)</td><td>(0.08, 0.73)</td><td>(0.16, 0.76)</td><td></td></tr><tr><td>0.012</td><td>0.276</td><td>0.152</td><td>0.004</td><td>0.020</td><td></td><td></td></tr><tr><td rowspan="3">DAS28</td><td>0.728</td><td>−0.193</td><td>−0.055</td><td>0.759</td><td>0.600</td><td>0.781</td><td>0.803</td></tr><tr><td>(0.46, 0.87)</td><td>(−0.55, 0.22)</td><td>(−0.44, 0.35)</td><td>(0.51, 0.88)</td><td>(0.26, 0.80)</td><td>(0.55, 0.90)</td><td>(0.59, 0.93)</td></tr><tr><td>0.000</td><td>0.366</td><td>0.797</td><td>0.000</td><td>0.002</td><td>0.000</td><td>0.000</td></tr></table> |
bd82304d3f88fab4b3d74c2464d42d3de5b0eecb27943c48ffca68e1feb25d74.png | simple | <table><tr><td></td><td>Intrathecal morphine (<i>n</i> = 50)</td><td>Epidural analgesia (<i>n</i> = 50)</td><td><i>P</i></td></tr><tr><td>Patients with complications</td><td>8 (16%)</td><td>11 (22%)</td><td>.59</td></tr><tr><td> Biloma</td><td>1 (2%)</td><td>1 (2%)</td><td>.89</td></tr><tr><td> Hepatic insufficiency</td><td>2 (4%)</td><td>3 (6%)</td><td>.88</td></tr><tr><td> Wound infection</td><td>3 (6%)</td><td>4 (8%)</td><td>.73</td></tr><tr><td> Pleural effusion</td><td>1 (2%)</td><td>2 (4%)</td><td>.78</td></tr><tr><td> Pneumonia</td><td>—</td><td>1 (2%)</td><td>—</td></tr><tr><td> Urinary tract infection</td><td>1 (2%)</td><td>—</td><td>—</td></tr></table> |
655ef9ad5ea76958499cc59f1a75bf4275b59d7917f14bdb2c752a01879ffa60.png | simple | <table><tr><td></td><td>Positive likelihood ratio (95% CI)</td><td>Negative likelihood ratio (95% CI)</td></tr><tr><td>Serial ECG & ST monitoring N = 690</td><td>5.4 (3.0 to 9.8)</td><td>0.801 (0.696 to 0.922)</td></tr><tr><td>Initial CK-MB(mass) N = 687</td><td>20.9 (11.3 to 38.5)</td><td>0.579 (0.464 to 0.722)</td></tr><tr><td>Delayed CK-MB(mass) N = 601</td><td>31.7 (17.0 to 58.9)</td><td>0.373 (0.261 to 0.534)</td></tr><tr><td>Delta CK-MB(mass) N = 601</td><td>153.1 (37.6 to 623.5)</td><td>0.444 (0.327 to 0.602)</td></tr><tr><td>Any positive CK-MB(mass) N = 601</td><td>28.1 (16.9 to 46.7)</td><td>0.291 (0.194 to 0.435)</td></tr><tr><td>Troponin T > = 0.1 ng/ml N = 686</td><td>~25*</td><td>~0*</td></tr><tr><td>Troponin T > = 0.03 ng/ml N = 686</td><td>281.5 (70.4 to 1126)</td><td>0.104 (0.049 to 0.221)</td></tr></table> |
691cc4c699f6b69163df8cc574ad891e6bef4e57f0ab59a8e3c3b4483b0ee630.png | simple | <table><tr><td>Molar ratio</td><td>Vitamin K recovery (%)</td><td>Lipid recovery (%)</td><td>Loading capacity (w %)</td><td>Size (nm)</td></tr><tr><td>0.22</td><td>98.4 ± 2.8</td><td>96.3 ± 0.4</td><td>5.0 ± 0.2</td><td>11.0 ± 1.4</td></tr><tr><td>0.44</td><td>91.3 ± 2.0</td><td>89.5 ± 4.1</td><td>9.9 ± 0.2</td><td>19 ± 6</td></tr><tr><td>0.88</td><td>42.6 ± 1.5</td><td>41.1 ± 3.9</td><td>18.4 ± 0.5</td><td>44 ± 5</td></tr></table> |
d3fea483e6f1c47fa318ff13b8977b42592863de13606049f493ae1e143f0ce8.png | complex | <table><tr><td></td><td></td><td colspan="2">TGC</td><td colspan="2">CGC</td><td rowspan="2">Overall event rates (%)</td><td colspan="2">M-H pooled RR</td><td colspan="2">Heterogeneity</td></tr><tr><td>Events</td><td>Studies</td><td>N+(%)</td><td>Total</td><td>N+(%)</td><td>Total</td><td>RR/ SMD (95%CI)</td><td><i>p</i></td><td><i>I</i><sup>2</sup>(%)</td><td><i>p</i></td></tr><tr><td>Infection</td><td>[1, 15–27]</td><td>231(9.4%)</td><td>2464</td><td>392(15.8%)</td><td>2488</td><td>12.6%</td><td>0.586(0.504, 0.680)</td><td><0.001</td><td>3.9</td><td>0.407</td></tr><tr><td>Sepsis</td><td>[1, 19, 20, 23, 25, 26]</td><td>48(2.7%)</td><td>1753</td><td>82(4.7%)</td><td>1763</td><td>3.7%</td><td>0.594(0.418, 0.842)</td><td>0.003</td><td><0.001</td><td>0.945</td></tr><tr><td>Pneumonia</td><td>[19, 20, 23–26]</td><td>22(2.0%)</td><td>1079</td><td>31(2.9%)</td><td>1078</td><td>2.5%</td><td>0.692(0.400, 1.196)</td><td>0.187</td><td><0.001</td><td>0.511</td></tr><tr><td>Urinary tract infection</td><td>[19, 20, 23, 25, 30]</td><td>36(3.6%)</td><td>988</td><td>43(4.4%)</td><td>980</td><td>4.0%</td><td>0.843(0.548, 1.297)</td><td>0.437</td><td><0.001</td><td>0.682</td></tr><tr><td>Wound infection</td><td>[19, 20, 22–27]</td><td>54(4.6%)</td><td>1186</td><td>86(7.2%)</td><td>1188</td><td>6.1%</td><td>0.620(0.422, 0.910)</td><td>0.015</td><td>18.8</td><td>0.287</td></tr><tr><td>Short-term mortality</td><td>[1, 14–22, 24, 27]</td><td>85(3.8%)</td><td>2233</td><td>122(5.4%)</td><td>2259</td><td>4.6%</td><td>0.692(0.527, 0.909)</td><td>0.008</td><td><0.001</td><td>0.769</td></tr><tr><td>Any mortality</td><td>[1, 14–27]</td><td>159(6.3%)</td><td>2514</td><td>204(8.0%)</td><td>2539</td><td>7.2%</td><td>0.792(0.653, 0.960)</td><td>0.018</td><td><0.001</td><td>0.738</td></tr><tr><td>Neurological dysfunction</td><td>[14, 18, 22, 24, 26]</td><td>8(1.1%)</td><td>752</td><td>18(2.4%)</td><td>761</td><td>1.7%</td><td>0.499(0.219, 1.137)</td><td>0.098</td><td><0.001</td><td>0.651</td></tr><tr><td>Acute renal failure</td><td>[1, 22, 24, 26]</td><td>46(3.3%)</td><td>1413</td><td>78(5.4%)</td><td>1439</td><td>4.3%</td><td>0.610(0.359, 1.038)</td><td>0.068</td><td>16.0</td><td>0.312</td></tr><tr><td>Hypoglycemia</td><td>[1, 16–20, 22–24, 27]</td><td>467(22.3%)</td><td>2097</td><td>233(11.0%)</td><td>2118</td><td>16.6%</td><td>3.145(1.928, 5.131)</td><td><0.001</td><td>81.4</td><td><0.001</td></tr><tr><td>Severe hypoglycemia</td><td>[15, 16, 19–21, 24, 26]</td><td>34(2.8%)</td><td>1207</td><td>8(0.7%)</td><td>1210</td><td>1.7%</td><td>3.821(1.796, 8.127)</td><td><0.001</td><td><0.001</td><td>0.894</td></tr><tr><td>ICU stay</td><td>[1, 15, 16, 18, 23, 26, 27]</td><td></td><td></td><td></td><td></td><td></td><td>−0.428(−0.833, −0.022)</td><td>0.039</td><td>96.6</td><td><0.001</td></tr><tr><td>Mechanical ventilation</td><td>[1, 15, 16, 18, 23, 26, 27]</td><td></td><td></td><td></td><td></td><td></td><td>−0.275(−0.695,0.146)</td><td>0.201</td><td>96.9</td><td><0.001</td></tr><tr><td>LOS</td><td>[15, 16, 18–20, 26, 27]</td><td></td><td></td><td></td><td></td><td></td><td>−0.233(−0.496,0.030)</td><td>0.082</td><td>85.4</td><td><0.001</td></tr></table> |
a9cf66c7ab90d6b42fca49b9ef34271b5cf84c83a195f7fc54417f99e96b578d.png | complex | <table><tr><td rowspan="2">Results of TST</td><td colspan="3">Results of T.SPOT.TB</td><td> </td></tr><tr><td>Negative</td><td>Positive</td><td>Indeterminate</td><td>Total</td></tr><tr><td>Negative</td><td>79</td><td>3</td><td>4</td><td>86</td></tr><tr><td>Positive</td><td>4</td><td>2</td><td>0</td><td>6</td></tr><tr><td>Total</td><td>83</td><td>5</td><td>4</td><td>92</td></tr></table> |
a0d5a49fd6f11c8c839b63122a05b422afb4a1713103501eb477bb60673b9ed5.png | complex | <table><tr><td></td><td colspan="2">Controls</td><td colspan="2">Offspring</td></tr><tr><td></td><td>Beta ± SE †</td><td><i>P</i>-value*</td><td>Beta ± SE†</td><td><i>P</i>-value*</td></tr><tr><td>PC (O-34:3)</td><td>0.037 ± 0.322</td><td>0.909</td><td>0.034 ± 0.369</td><td>0.927</td></tr><tr><td>PC (O-34:1)</td><td>−0.384 ± 0.303</td><td>0.206</td><td>−0.124 ± 0.236</td><td>0.600</td></tr><tr><td>PC (O-36:3)</td><td>0.015 ± 0.372</td><td>0.969</td><td>−0.352 ± 0.372</td><td>0.345</td></tr><tr><td>PC (O-36:2)</td><td>0.029 ± 0.386</td><td>0.940</td><td>−0.718 ± 0.428</td><td>0.094</td></tr><tr><td>PE (38:6)</td><td>−0.900 ± 0.680</td><td>0.186</td><td>0.602 ± 0.652</td><td>0.356</td></tr><tr><td>SM (d18:1/14:0)</td><td>−0.051 ± 0.278</td><td>0.854</td><td>0.524 ± 0.288</td><td>0.069</td></tr><tr><td>SM (d18:1/15:0)</td><td>−0.368 ± 0.296</td><td>0.215</td><td>0.408 ± 0.274</td><td>0.136</td></tr><tr><td>SM (d18:1/16:0)</td><td>−0.049 ± 0.221</td><td>0.825</td><td>0.344 ± 0.185</td><td>0.064</td></tr><tr><td>SM (d18:1/17:0)</td><td>−0.118 ± 0.329</td><td>0.719</td><td>−0.002 ± 0.448</td><td>0.996</td></tr><tr><td>SM (d18:1/18:2)</td><td>−0.589 ± 0.404</td><td>0.146</td><td>0.093 ± 0.341</td><td>0.786</td></tr><tr><td>SM (d18:1/21:0)</td><td>−0.058 ± 0.319</td><td>0.855</td><td>0.418 ± 0.315</td><td>0.186</td></tr><tr><td>SM (d18:1/23:1)</td><td>−0.169 ± 0.283</td><td>0.550</td><td>0.682 ± 0.226</td><td>0.003</td></tr><tr><td>SM (d18:1/23:0)</td><td>0.197 ± 0.255</td><td>0.440</td><td>0.630 ± 0.238</td><td>0.008</td></tr><tr><td>TG (52:1)</td><td>−0.050 ± 0.691</td><td>0.942</td><td>1.40 ± 0.632</td><td>0.027</td></tr><tr><td>TG (54:7)</td><td>−0.672 ± 0.786</td><td>0.393</td><td>1.24 ± 0.637</td><td>0.052</td></tr><tr><td>TG (54:6)</td><td>−0.360 ± 0.793</td><td>0.650</td><td>1.86 ± 0.690</td><td>0.005</td></tr><tr><td>TG (56:7)</td><td>−0.686 ± 0.727</td><td>0.346</td><td>1.10 ± 0.656</td><td>0.094</td></tr><tr><td>TG (56:6)</td><td>−0.699 ± 0.609</td><td>0.252</td><td>1.18 ± 0.537</td><td>0.028</td></tr><tr><td>TG (57:2)</td><td>−0.779 ± 0.633</td><td>0.219</td><td>0.828 ± 0.544</td><td>0.129</td></tr></table> |
0df99866a6d94a4b04577d09fee04ef835b6b1577db81df51489f1620c095865.png | complex | <table><tr><td>Criteria/Quantitative description</td><td>Score</td></tr><tr><td colspan="2">Background blood/clot</td></tr><tr><td>Large amount; great compromise in diagnosis</td><td>0</td></tr><tr><td>Moderate amount; diagnosis possible</td><td>1</td></tr><tr><td>Minimal; diagnosis</td><td>2</td></tr><tr><td colspan="2">Amount of cellular material</td></tr><tr><td>Minimal to absent; diagnosis not possible</td><td>0</td></tr><tr><td>Sufficient for diagnosis</td><td>1</td></tr><tr><td>Abundant; diagnosis possible</td><td>2</td></tr><tr><td colspan="2">Degree of cellular degeneration</td></tr><tr><td>Degeneration marked; diagnosis impossible</td><td>0</td></tr><tr><td>Degeneration moderate; diagnosis possible</td><td>1</td></tr><tr><td>Degeneration minimal; diagnosis obvious</td><td>2</td></tr><tr><td colspan="2">Degree of cellular trauma</td></tr><tr><td>Marked; diagnosis impossible</td><td>0</td></tr><tr><td>Moderate; diagnosis possible</td><td>1</td></tr><tr><td>Minimal; diagnosis obvious</td><td>2</td></tr><tr><td colspan="2">Retention of appropriate architecture</td></tr><tr><td>Minimal to absent; non-diagnostic</td><td>0</td></tr><tr><td>Moderate; some preservation of, e.g., follicle, papillae, acini, etc.</td><td>1</td></tr><tr><td>Excellent architectural display closely reflecting histology; diagnosis obvious</td><td>2</td></tr></table> |
4cbcc40629aa724635e56a40553869cf1f5d8af8853ce856fe388ca9f11f8d9f.png | complex | <table><tr><td></td><td colspan="6">Strains with Stable ST</td></tr><tr><td>Patient</td><td>ST of the first CoS strain isolated</td><td>Sample type</td><td>Sample type of first clinical CoS</td><td>ST of CoR strain isolated</td><td>Sample type</td><td>Time to switch from CoR to CoS (days)</td></tr><tr><td>1</td><td>554</td><td>SRS</td><td>Arterial catheter</td><td>-</td><td>bronchial aspirate</td><td>36</td></tr><tr><td>2</td><td>512</td><td>SRS</td><td>skin swab</td><td>-</td><td>urine</td><td>26</td></tr><tr><td>3</td><td>307</td><td>SRS</td><td>skin swab</td><td>-</td><td>skin swab</td><td>42</td></tr><tr><td>4</td><td>512</td><td>SRS</td><td>skin swab</td><td>-</td><td>SRS</td><td>123</td></tr><tr><td>5</td><td>512</td><td>SRS</td><td>drainage fluid</td><td>-</td><td>drainage fluid</td><td>28</td></tr><tr><td>6</td><td>512</td><td>urine</td><td>urine</td><td>-</td><td>urine</td><td>17</td></tr><tr><td>7</td><td>512</td><td>SRS</td><td>bronchial aspirate</td><td>-</td><td>SRS</td><td>74</td></tr><tr><td>8</td><td>1543</td><td>SRS</td><td>-</td><td>-</td><td>SRS</td><td>50</td></tr><tr><td>9</td><td>512</td><td>SRS</td><td>bronchial aspirate</td><td>-</td><td>bronchial aspirate</td><td>31</td></tr><tr><td>10</td><td>512</td><td>SRS</td><td>bronchial aspirate</td><td>-</td><td>bronchial aspirate</td><td>6</td></tr><tr><td>11</td><td>554</td><td>SRS</td><td>-</td><td>-</td><td>bronchial aspirate</td><td>na</td></tr><tr><td>12</td><td>512</td><td>SRS</td><td>bronchial aspirate</td><td>-</td><td>blood</td><td>24</td></tr><tr><td>13</td><td>258</td><td>SRS</td><td>urine</td><td>-</td><td>urine</td><td>8</td></tr><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td>Median</td></tr><tr><td>29.5 days</td></tr><tr><td></td><td colspan="6">Switched ST</td></tr><tr><td>Patient</td><td>ST of the first CoS strain isolated</td><td>Sample type</td><td>Sample type of first clinical CoS</td><td>ST of CoR strain isolated</td><td>Sample type</td><td>Time to switch from CoR to CoS (days)</td></tr><tr><td>14</td><td>15</td><td>SRS</td><td>urine</td><td>512</td><td>SRS</td><td>167</td></tr><tr><td>15</td><td>554</td><td>urine</td><td>urine</td><td>512</td><td>SRS</td><td>67</td></tr><tr><td>16</td><td>258<sup>1</sup></td><td>SRS</td><td>skin swab</td><td>512</td><td>SRS</td><td>34</td></tr><tr><td>17</td><td>554</td><td>SRS</td><td>arterial catheter</td><td>1733 (554 SLV)</td><td>drainage fluid</td><td>54</td></tr><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td>Median:</td></tr><tr><td>60.5 days</td></tr></table> |
7c9495d3ea0482a146396e2fbcfca5f3a98bfd9b6ca339052572a1b554ac681c.png | complex | <table><tr><td rowspan="2">Variants</td><td rowspan="2">Haplotype</td><td colspan="2">Haplotype frequency</td><td rowspan="2">OR (95% CI)</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>Case (<i>n</i> = 350)</td><td>Control (<i>n</i> = 350)</td></tr><tr><td rowspan="4">eNOS 4 and eNOS 7</td><td>bG</td><td>0.5550</td><td>0.7912</td><td>0.33 (0.23–0.46)</td><td>0.000∗</td></tr><tr><td>aT</td><td>0.0650</td><td>0.0112</td><td>6.08 (1.97–20.99)</td><td>0.002∗</td></tr><tr><td>aG</td><td>0.1850</td><td>0.1288</td><td>1.55 (1.00–2.39)</td><td>0.048∗</td></tr><tr><td>bT</td><td>0.1950</td><td>0.0688</td><td>3.28 (1.95–5.52)</td><td>0.000∗</td></tr><tr><td rowspan="4">eNOS 4 and eNOS T786C</td><td>bT</td><td>0.5775</td><td>0.6794</td><td>0.64 (0.47–0.89)</td><td>0.006∗</td></tr><tr><td>bC</td><td>0.1725</td><td>0.1806</td><td>0.94 (0.63–1.42)</td><td>0.843</td></tr><tr><td>aT</td><td>0.1925</td><td>0.1106</td><td>1.89 (1.21–2.96)</td><td>0.004∗</td></tr><tr><td>aC</td><td>0.0575</td><td>0.0294</td><td>2.17 (0.96–5.02)</td><td>0.07</td></tr><tr><td rowspan="4">eNOS 7 and eNOS T786C</td><td>GT</td><td>0.5698</td><td>0.7268</td><td>0.50 (0.36–0.69)</td><td>0.000∗</td></tr><tr><td>GC</td><td>0.1702</td><td>0.1932</td><td>0.86 (0.57–1.28)</td><td>0.47</td></tr><tr><td>TT</td><td>0.2002</td><td>0.0632</td><td>3.73 (2.19–6.38)</td><td>0.000∗</td></tr><tr><td>TC</td><td>0.0598</td><td>0.0168</td><td>3.66 (1.38–10.26)</td><td>0.006∗</td></tr></table> |
c0772a5f9fc49b52496281c362f29dd455134bfa515d6622b2eab02e5241d3d8.png | simple | <table><tr><td>Classifier</td><td>PSGO-TRN</td><td>PSGO-TST</td><td>ORI-TRN</td><td>ORI-TST</td><td>ORIRW-TRN</td><td>ORIRW-TST</td><td>Mean</td></tr><tr><td>SCMPSP</td><td>83.82</td><td>71.54</td><td>77.78</td><td>62.60</td><td>81.8</td><td>64.38</td><td>66.17</td></tr><tr><td>SVM-AAC</td><td>85.45</td><td>78.85</td><td>71.36</td><td>50.61</td><td>71.20</td><td>57.30</td><td>62.25</td></tr><tr><td>SVM-DPC</td><td>83.33</td><td>72.31</td><td>68.94</td><td>69.11</td><td>67.30</td><td>61.37</td><td>67.60</td></tr><tr><td>SVM-AAindex</td><td>79.19</td><td>75.38</td><td>71.40</td><td>71.03</td><td>71.36</td><td>71.14</td><td>72.52</td></tr><tr><td>J48-AAC</td><td>68.50</td><td>73.84</td><td>64.24</td><td>63.41</td><td>68.21</td><td>49.79</td><td>62.35</td></tr><tr><td>J48-DPC</td><td>63.20</td><td>61.92</td><td>55.25</td><td>51.22</td><td>55.70</td><td>59.44</td><td>57.53</td></tr><tr><td>J48-AAindex</td><td>65.03</td><td>70.38</td><td>62.50</td><td>62.02</td><td>61.46</td><td>68.09</td><td>66.83</td></tr><tr><td>Bayers-AAC</td><td>67.92</td><td>69.20</td><td>64.65</td><td>63.00</td><td>65.00</td><td>65.02</td><td>65.74</td></tr><tr><td>Bayers-DPC</td><td>65.41</td><td>67.31</td><td>58.28</td><td>57.32</td><td>58.80</td><td>60.73</td><td>61.79</td></tr><tr><td>Bayes-AAindex</td><td>66.09</td><td>64.62</td><td>62.70</td><td>60.30</td><td>62.73</td><td>57.11</td><td>60.68</td></tr><tr><td>Mean</td><td>72.79</td><td>70.54</td><td>65.71</td><td>61.06</td><td>66.37</td><td>61.44</td><td></td></tr></table> |
ee7311b4fc06224443850343ba2210cf74d14ccf4d2827db60df586e2b4e2573.png | complex | <table><tr><td rowspan="2">Factor</td><td colspan="2">IRR (95% CI)</td></tr><tr><td>Unadjusted</td><td>Adjusted</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td>Female</td><td>1.00</td><td>1.00</td></tr><tr><td>Male</td><td>0.53 (0.45-0.61)</td><td>0.53 (0.45-0.61)</td></tr><tr><td>Age (years)</td><td> </td><td> </td></tr><tr><td>0-40</td><td>0.90 (0.71-1.12)</td><td>0.87 (0.69-1.09)</td></tr><tr><td>40-55</td><td>1.00</td><td>1.00</td></tr><tr><td>55-70</td><td>0.80 (0.67-0.96)</td><td>0.78 (0.65-0.94)</td></tr><tr><td>> 70</td><td>0.27 (0.21-0.34)</td><td>0.25 (0.19-0.32)</td></tr><tr><td>Region</td><td> </td><td> </td></tr><tr><td>Stockholm</td><td>1.00</td><td>1.00</td></tr><tr><td>North</td><td>0.57 (0.40-0.83)</td><td>0.66 (0.46-0.94)</td></tr><tr><td>South-east</td><td>1.04 (0.78-1.39)</td><td>1.13 (0.84-1.51)</td></tr><tr><td>South</td><td>1.23 (0.97-1.58)</td><td>1.38 (1.08-1.77)</td></tr><tr><td>Uppsala/Örebro</td><td>1.00 (0.78-1.27)</td><td>1.19 (0.93-1.52)</td></tr><tr><td>West</td><td>1.37 (1.07-1.74)</td><td>1.49 (1.17-1.89)</td></tr><tr><td>Abroad</td><td>0.78 (0.25-2.47)</td><td>0.46 (0.15-1.44)</td></tr><tr><td>Cause of renal disease</td><td> </td><td> </td></tr><tr><td>Diabetes</td><td>1.00</td><td>1.00</td></tr><tr><td>Nephrosclerosis</td><td>1.02 (0.75-1.39)</td><td>1.56 (1.14-2.13)</td></tr><tr><td>Glomerulonephritis</td><td>2.22 (1.75-2.80)</td><td>2.30 (1.80-2.94)</td></tr><tr><td>Adult polycystic kidney disease</td><td>2.17 (1.65-2.87)</td><td>1.88 (1.42-2.50)</td></tr><tr><td>Pyelonephritis</td><td>2.60 (1.90-3.56)</td><td>2.54 (1.85-3.48)</td></tr><tr><td>Other</td><td>1.22 (0.98-1.60)</td><td>1.30 (1.00-1.68)</td></tr><tr><td>Years with functioning transplant</td><td> </td><td> </td></tr><tr><td>0</td><td>1.00</td><td>1.00</td></tr><tr><td>0 > and < 1</td><td>1.32 (1.03-1.68)</td><td>1.59 (1.23-2.04)</td></tr><tr><td>≥ 1 and < 3</td><td>3.22 (2.56-4.06)</td><td>0.71 (0.56-0.89)</td></tr><tr><td>≥ 3</td><td>1.00 (0.79-1.27)</td><td>0.24 (0.19-0.30)</td></tr></table> |
257780f771a5ee98928c37b95fec0d35aebb72e05b3d30f928a8e473ba737a8a.png | complex | <table><tr><td colspan="2"></td><td>Word-pairs</td><td>Sentences</td><td>Oddball</td><td>Mean per task</td></tr><tr><td>Ignore task</td><td><i>M</i></td><td>32.55</td><td>55.99</td><td>46.89</td><td>45.15</td></tr><tr><td></td><td><i>SD</i></td><td>22.08</td><td>56.99</td><td>40.52</td><td>42.66</td></tr><tr><td>Passive task</td><td><i>M</i></td><td>72.91</td><td>80.01</td><td>89.39</td><td>80.77</td></tr><tr><td></td><td><i>SD</i></td><td>47.24</td><td>58.11</td><td>55.82</td><td>53.34</td></tr><tr><td>Focused task</td><td><i>M</i></td><td>73.76</td><td>85.98</td><td>83.71</td><td>81.15</td></tr><tr><td></td><td><i>SD</i></td><td>46.09</td><td>59.84</td><td>54.37</td><td>52.98</td></tr></table> |
04df60799f8d4d0ad1929879a99219a3a82daf2b801f0772b557391d5e55af19.png | complex | <table><tr><td></td><td>liver</td><td>spleen</td><td>caecum</td></tr><tr><td></td><td colspan="3">(log CFU/g of tissue)</td></tr><tr><td>wt</td><td>4.97 ± 2.22</td><td>5.52 ± 2.47</td><td>4.19 ± 2.49</td></tr><tr><td>ΔSPI1</td><td>5.10 ± 1.12</td><td>5.79 ± 1.07</td><td>4.18 ± 1.15</td></tr><tr><td>ΔSPI2</td><td>0.25 ± 0.43*</td><td>0.56 ± 0.50*</td><td>2.05 ± 1.49</td></tr><tr><td>ΔSPI3</td><td>5.13 ± 0.19</td><td>6.19 ± 0.36</td><td>3.79 ± 0.02</td></tr><tr><td>ΔSPI4</td><td>4.83 ± 1.42</td><td>5.60 ± 1.36</td><td>2.97 ± 1.75</td></tr><tr><td>ΔSPI5</td><td>3.52 ± 1.79</td><td>4.29 ± 2.32</td><td>2.90 ± 1.40</td></tr><tr><td>SPI1o</td><td>0.33 ± 0.47*</td><td>0.33 ± 0.47*</td><td>2.20 ± 1.59</td></tr><tr><td>SPI2o</td><td>5.29 ± 0.87</td><td>5.82 ± 1.07</td><td>3.76 ± 0.77</td></tr><tr><td>SPI3o</td><td>0.00 ± 0.00*</td><td>0.00 ± 0.00*</td><td>0.33 ± 0.47*</td></tr><tr><td>SPI4o</td><td>0.00 ± 0.00*</td><td>0.00 ± 0.00*</td><td>1.68 ± 2.38</td></tr><tr><td>SPI5o</td><td>0.00 ± 0.00*</td><td>0.00 ± 0.00*</td><td>1.07 ± 1.51*</td></tr><tr><td>ΔSPI1-5</td><td>0.00 ± 0.00*</td><td>0.00 ± 0.00*</td><td>1.06 ± 1.50*</td></tr></table> |
90f91e47e62f4aba434d7ce5f1b731814bfbdcbf7ad20e6095f18e10350c3940.png | simple | <table><tr><td>Area</td><td>WT TA (o)</td><td>SOD TA (o)</td><td>WT TA (i)</td><td>SOD TA (i)</td><td>WT Soleus</td><td>SOD Soleus</td></tr><tr><td>#Dock vesicles/μm AZ</td><td>5.11 ± 0.65</td><td>4.91 ± 0.65</td><td>5.67 ± 0.97</td><td>4.62 ± 0.96</td><td>5.99 ± 0.63</td><td>4.55 ± 0.62</td></tr><tr><td>#Vesicles/μm<sup>2</sup> terminal</td><td>55.00 ± 7.60</td><td>55.83 ± 7.58</td><td>54.94 ± 7.59</td><td>53.96 ± 7.47</td><td>65.65 ± 6.80</td><td>54.77 ± 6.72</td></tr><tr><td>#Junctional folds/μm AZ</td><td>1.60 ± 0.10</td><td>1.60 ± 0.10</td><td>1.45 ± 0.14</td><td>1.27 ± 0.13</td><td>1.12 ± 0.11</td><td>0.95 ± 0.11</td></tr><tr><td>Junctional fold length (nm)</td><td>683.48 ± 22.58</td><td>598.26 ± 21.93</td><td>617.28 ± 36.08</td><td>562.52 ± 32.82</td><td>595.13 ± 32.98</td><td>553.27 ± 31.78</td></tr><tr><td>Junctional fold diameter (nm)</td><td>65.24 ± 2.90</td><td>67.60 ± 2.88</td><td>72.014 ± 4.46</td><td>65.26 ± 4.27</td><td>79.06 ± 4.43</td><td>73.02 ± 4.30</td></tr></table> |
ceb81b8842f6042d07c7c6486fccd6d3a7b3c28c8e0c75271bff974939f32950.png | complex | <table><tr><td></td><td colspan="2">General Practitioner Visits</td><td></td><td colspan="2">Specialist Visits</td><td></td></tr><tr><td>Variables</td><td>Chinese N (% of 746)</td><td>White N (% of 711)</td><td>P-Value</td><td>Chinese N (% of 485)</td><td>White N (% of 637)</td><td>P-Value</td></tr><tr><td>Satisfied with physician care</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Very Satisfied</td><td>158 (21.2)</td><td>420 (59.1)</td><td>0.0001</td><td>140 (28.9)</td><td>364 (57.1)</td><td>0.0001</td></tr><tr><td>Satisfied</td><td>392 (52.5)</td><td>240 (33.8)</td><td></td><td>226 (46.6)</td><td>181 (28.4)</td><td></td></tr><tr><td>Neither</td><td>153 (20.5)</td><td>30 (4.2)</td><td></td><td>89 (18.4)</td><td>33 (5.2)</td><td></td></tr><tr><td>Dissatisfied</td><td>33 (4.4)</td><td>17 (2.4)</td><td></td><td>20 (4.1)</td><td>25 (3.9)</td><td></td></tr><tr><td>Very Dissatisfied</td><td>5 (0.7)</td><td>2 (0.3)</td><td></td><td>7 (1.4)</td><td>23 (3.6)</td><td></td></tr><tr><td>Unsure</td><td>5 (0.7)</td><td>2 (0.3)</td><td></td><td>3 (0.6)</td><td>11 (1.7)</td><td></td></tr><tr><td>Definitely trust physician enough to always follow physician advice</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>443 (59.4)</td><td>424 (59.6)</td><td>0.606</td><td>326 (67.2)</td><td>400 (62.8)</td><td>0.003</td></tr><tr><td>Yes, to some extent</td><td>267 (35.8)</td><td>242 (34)</td><td></td><td>131 (27)</td><td>158 (24.8)</td><td></td></tr><tr><td>No</td><td>29 (3.9)</td><td>37 (5.2)</td><td></td><td>21 (4.3)</td><td>62 (9.7)</td><td></td></tr><tr><td>Unsure</td><td>7 (0.9)</td><td>8 (1.1)</td><td></td><td>7 (1.4)</td><td>17 (2.7)</td><td></td></tr><tr><td>Definitely felt physician had adequate experience</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>330 (44.2)</td><td>586 (82.4)</td><td>0.0001</td><td>285 (58.8)</td><td>538 (84.5)</td><td>0.0001</td></tr><tr><td>Yes, to some extent</td><td>361 (48.4)</td><td>103 (14.5)</td><td></td><td>153 (31.5)</td><td>67 (10.5)</td><td></td></tr><tr><td>No</td><td>41 (5.5)</td><td>12 (1.7)</td><td></td><td>28 (5.8)</td><td>19 (3)</td><td></td></tr><tr><td>Unsure</td><td>14 (1.9)</td><td>10 (1.4)</td><td></td><td>19 (3.9)</td><td>13 (2)</td><td></td></tr><tr><td>Definitely felt enough time was spent with physician</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>252 (33.8)</td><td>524 (73.7)</td><td>0.0001</td><td>212 (43.7)</td><td>404 (63.4)</td><td>0.0001</td></tr><tr><td>Yes, to some extent</td><td>335 (44.9)</td><td>132 (18.6)</td><td></td><td>187 (38.6)</td><td>155 (24.3)</td><td></td></tr><tr><td>No</td><td>149 (20)</td><td>52 (7.3)</td><td></td><td>81 (16.7)</td><td>68 (10.7)</td><td></td></tr><tr><td>Unsure</td><td>10 (1.3)</td><td>3 (0.4)</td><td></td><td>5 (1)</td><td>10 (1.6)</td><td></td></tr><tr><td>Definitely felt comfortable asking physician questons</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>549 (73.6)</td><td>637 (89.6)</td><td>0.0001</td><td>343 (70.7)</td><td>494 (77.6)</td><td>0.001</td></tr><tr><td>Yes, to some extent</td><td>173 (23.2)</td><td>61 (8.6)</td><td></td><td>108 (22.3)</td><td>85 (13.3)</td><td></td></tr><tr><td>No</td><td>19 (2.5)</td><td>13 (1.8)</td><td></td><td>26 (5.4)</td><td>49 (7.7)</td><td></td></tr><tr><td>Unsure</td><td>4 (0.7)</td><td>0 (0)</td><td></td><td>8 (1.6)</td><td>9 (1.4)</td><td></td></tr><tr><td>Definitely understood physician explanation and advice</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>567 (76)</td><td>667 (93.8)</td><td>0.0001</td><td>278 (57.3)</td><td>516 (81)</td><td>0.0001</td></tr><tr><td>Yes, to some extent</td><td>156 (20.9)</td><td>41 (5.8)</td><td></td><td>157 (32.4)</td><td>99 (15.5)</td><td></td></tr><tr><td>No</td><td>18 (2.4)</td><td>2 (0.3)</td><td></td><td>49 (10.1)</td><td>16 (2.5)</td><td></td></tr><tr><td>Unsure</td><td>5 (0.7)</td><td>1 (0.1)</td><td></td><td>1 (0.2)</td><td>6 (0.9)</td><td></td></tr><tr><td>Definitely felt physician listened carefully</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes Definitely</td><td>473 (63.4)</td><td>585 (82.3)</td><td>0.0001</td><td>289 (59.6)</td><td>456 (71.6)</td><td>0.0001</td></tr><tr><td>Yes, to some extent</td><td>238 (31.9)</td><td>112 (15.8)</td><td></td><td>167 (34.4)</td><td>121 (19)</td><td></td></tr><tr><td>No</td><td>31 (4.2)</td><td>14 (2)</td><td></td><td>21 (4.3)</td><td>50 (7.8)</td><td></td></tr><tr><td>Unsure</td><td>4 (0.5)</td><td>0 (0)</td><td></td><td>8 (1.6)</td><td>10 (1.6)</td><td></td></tr></table> |
6d155b4d3e1d9bbb16d7f360416839b84c6a6d1968298c4f6d21fc110db46c8f.png | complex | <table><tr><td colspan="2">Cost in CDN dollars Mean (SD)</td></tr><tr><td>Total Cost</td><td>$49,923 (45,773)</td></tr><tr><td>Total Indirect Cost</td><td>$13,566 (12,625)</td></tr><tr><td>Total Direct Cost</td><td>$36,358 (33,501)</td></tr><tr><td colspan="2">Direct Costs per costing Category</td></tr><tr><td> Health Professionals</td><td>$2600 (4787)</td></tr><tr><td> Imaging</td><td>$1069 (1428)</td></tr><tr><td> Lab</td><td>$1923 (1709)</td></tr><tr><td> Nursing</td><td>$16,378 (16,735)</td></tr><tr><td> Operating room</td><td>$1192 (1819)</td></tr><tr><td> Surgical Implants</td><td>$907 (2821)</td></tr><tr><td> Post anaesthesia care unit</td><td>$307 (590)</td></tr><tr><td> Pharmacy</td><td>$3273 (4157)</td></tr><tr><td> Special Care Unit</td><td>$7502 (16,929)</td></tr><tr><td> Endoscopy</td><td>$72 (223)</td></tr><tr><td> Food Services</td><td>$1134 (1247)</td></tr></table> |
56eb2fe0c4ba77a0411b6bc689a7809a63293d59cc4e20726183dcfe97cf7fcc.png | simple | <table><tr><td>Variables</td><td>Mean ± SD</td><td>Range</td></tr><tr><td>Age (yr)</td><td>21.5 ± 2.6</td><td>18.0~25.0</td></tr><tr><td>Height (cm)</td><td>175.5 ± 6.0</td><td>167.0~185.0</td></tr><tr><td>Weight (kg)</td><td>94.9 ± 12.9</td><td>79.3~117.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>30.7 ± 2.6</td><td>27.4~34.3</td></tr><tr><td>LBM (kg)</td><td>74.4 ± 8.7</td><td>62.1~90.9</td></tr><tr><td>FM (kg)</td><td>16.4 ± 5.8</td><td>9.7~27.0</td></tr><tr><td>FM (%)</td><td>17.0 ± 4.4</td><td>12.3~25.6</td></tr></table> |
38068945230b7a9dbc00ea2a778ee8eaa3a7b1ae3f7ee08fdc782610647e9c0a.png | complex | <table><tr><td>Variables</td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td><td><i>P</i> value</td></tr><tr><td colspan="6">Demographics</td></tr><tr><td>(<i>n</i> = 4,970)</td><td>(<i>n</i> = 1,347)</td><td>(<i>n</i> = 1,356)</td><td>(<i>n</i> = 1,150)</td><td>(<i>n</i> = 1,117)</td><td></td></tr><tr><td>Age, in years</td><td>56.5 (8.6)</td><td>59.7 (9.3)</td><td>63.4 (9.3)</td><td>67.8 (9.6)</td><td><0.0001</td></tr><tr><td>Male</td><td>511 (38%)</td><td>647 (48%)</td><td>621 (54%)</td><td>591 (53%)</td><td><0.0001</td></tr><tr><td>Female</td><td>836 (62%)</td><td>709 (52%)</td><td>529 (46%)</td><td>526 (47%)</td><td><0.0001</td></tr><tr><td>Caucasian</td><td>453 (33%)</td><td>505 (37%)</td><td>484 (42%)</td><td>501 (45%)</td><td><0.0001</td></tr><tr><td>Chinese</td><td>234 (17%)</td><td>172 (13%)</td><td>129 (11%)</td><td>116 (10%)</td><td><0.0001</td></tr><tr><td>African</td><td>384 (29%)</td><td>359 (26%)</td><td>257 (22%)</td><td>274 (25%)</td><td><0.003</td></tr><tr><td>Hispanic</td><td>276 (20%)</td><td>320 (24%)</td><td>280 (24%)</td><td>226 (20%)</td><td><0.024</td></tr><tr><td colspan="6">Medical history</td></tr><tr><td>HTN</td><td>425 (32%)</td><td>491 (36%)</td><td>524 (46%)</td><td>669 (60%)</td><td><0.0001</td></tr><tr><td>Diabetes</td><td>142 (11%)</td><td>120 (9%)</td><td>95 (8%)</td><td>155 (14%)</td><td><0.0001</td></tr><tr><td>Current smokers</td><td>158 (12%)</td><td>165 (12%)</td><td>151 (13%)</td><td>157 (14%)</td><td><0.31</td></tr><tr><td>Renal disease (self-report)</td><td>20 (1.5%)</td><td>17 (1.3%)</td><td>31 (2.7%)</td><td>45 (4.0%)</td><td>0.0001</td></tr><tr><td colspan="6">Laboratory/clinical parameters</td></tr><tr><td>Creatinine mg/dL</td><td>0.84 (0.2)</td><td>0.91 (0.2)</td><td>0.97 (0.2)</td><td>1.13 (0.5)</td><td><0.0001</td></tr><tr><td>GFR MDRD mL/min/1.73 m<sup>2</sup></td><td>91.8 (16.0)</td><td>84.0 (14.2)</td><td>78.4 (13.5)</td><td>67.8 (16.0)</td><td><0.0001</td></tr><tr><td>Systolic BP, mm Hg</td><td>121.2 (20.2)</td><td>123.8 (20.0)</td><td>126.7 (21.0)</td><td>131.4 (22.9)</td><td><0.0001</td></tr><tr><td>Diastolic BP, mm Hg</td><td>71.5 (10.5)</td><td>72.3 (10.2)</td><td>72.0 (9.9)</td><td>71.6 (10.6)</td><td>0.19</td></tr><tr><td>Body mass index Kg/m<sup>2</sup></td><td>26.7 (4.8)</td><td>27.5 (4.7)</td><td>28.2 (4.9)</td><td>28.8 (5.2)</td><td><0.0001</td></tr><tr><td>Body surface area m<sup>2</sup></td><td>1.80 (0.2)</td><td>1.85 (0.2)</td><td>1.87 (0.2)</td><td>1.88 (0.2)</td><td><0.0001 </td></tr><tr><td colspan="6">Medications</td></tr><tr><td>Antihypertensive meds</td><td>322 (24%)</td><td>414 (31%)</td><td>421 (37%)</td><td>598 (54%)</td><td><0.0001</td></tr><tr><td>Beta-blockers</td><td>70 (5%)</td><td>86 (6%)</td><td>110 (10%)</td><td>157 (14%)</td><td><0.0001</td></tr><tr><td>ACE inhibitors</td><td>107 (8%)</td><td>113 (8%)</td><td>122 (11%)</td><td>199 (18%)</td><td><0.0001</td></tr><tr><td>ARB</td><td>23 (2%)</td><td>41 (3%)</td><td>30 (3%)</td><td>67 (6%)</td><td><0.0001</td></tr><tr><td>Calcium channel blockers</td><td>127 (9%)</td><td>146 (11%)</td><td>145 (13%)</td><td>174 (16%)</td><td><0.0001</td></tr><tr><td>Thiazide diuretics</td><td>47 (3%)</td><td>70 (5%)</td><td>79 (7%)</td><td>126 (11%)</td><td><0.0001</td></tr><tr><td>Loop diuretics</td><td>10 (1%)</td><td>11 (1%)</td><td>15 (1%)</td><td>40 (4%)</td><td><0.0001</td></tr></table> |
306c4d855d432f8d7d66b4a5f981dbbac3effab57dee4429b198bb5161a34eef.png | complex | <table><tr><td>Factor</td><td>Univariable HR</td><td><i>p</i>-value</td><td>Multivariable HR (95% CI)</td><td><i>p</i>-value</td></tr><tr><td colspan="5">Monitoring randomisation</td></tr><tr><td> LCM</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td> CDM</td><td>1.07</td><td>0.45</td><td>1.11 (0.93 - 1.35)</td><td>0.25</td></tr><tr><td colspan="5">Gender</td></tr><tr><td> Male</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td> Female</td><td>0.80</td><td>0.02</td><td>0.79 (0.65 - 0.95)</td><td>0.01</td></tr><tr><td colspan="5">Initial ART</td></tr><tr><td> TDF</td><td>1.00</td><td><0.0001</td><td>1.00</td><td><0.0001</td></tr><tr><td> NVP</td><td>0.49</td><td>-</td><td>0.48 (0.38 - 0.62)</td><td>-</td></tr><tr><td> ABC</td><td>1.18</td><td>-</td><td>1.27 (1.02 - 1.59) </td><td>-</td></tr><tr><td>TB in 12 months prior to enrolment</td><td>1.13</td><td>0.26</td><td>1.07 (0.86 - 1.33)</td><td>0.52</td></tr><tr><td>Age (per 10 years older)</td><td>0.73</td><td><0.0001</td><td>0.73 (0.64 - 0.84)</td><td><0.0001</td></tr><tr><td>Baseline CD4 (per 100 cells/mm<sup>3</sup> higher)</td><td>0.60</td><td><0.0001</td><td>0.64 (0.54 - 0.75)</td><td><0.0001</td></tr><tr><td>Baseline viral load (log<sub>10</sub> copies/mL)</td><td>1.02</td><td>0.84</td><td>1.01 (0.84 - 1.22) </td><td>0.89</td></tr><tr><td>Adherence in previous 48 weeks<sup>a</sup> (per 10% higher)</td><td>0.89</td><td><0.0001</td><td>0.89 (0.84 - 0.94)</td><td><0.0001</td></tr></table> |
cf4e56613021fe95f39b5b3b46cbdef806cc50bc88650d57c6c2860c1ccdb7ea.png | simple | <table><tr><td>Method</td><td>Planar objects</td><td>Real feet</td><td>Main disadvantages</td></tr><tr><td> </td><td>Accuracy/Repeatibility</td><td>Static/Dynamic</td><td> </td></tr><tr><td>Coudert <i>et al.</i>[13]</td><td>NA/NA</td><td>NA/NA</td><td>Technique requires spraying foot with paint or adding sock</td></tr><tr><td>Jezersek & Mazina [14]</td><td>0.2 mm/NA</td><td>0.4 mm/NA</td><td>The system requires several specialized camera-projector-mirror systems</td></tr><tr><td>Jezersek <i>et al.</i>[16]</td><td>0.5 mm/NA</td><td>NA/NA</td><td>Similar to Jezersek & Mazina, the system requires expensive specialized equipment</td></tr><tr><td>Kouchi <i>et al.</i>[17]</td><td>0.5 mm/NA</td><td>2.0 mm/NA</td><td>System only measures 4 cross-section areas of the foot, which need to be manually marked on the foot surface</td></tr><tr><td>Schmeltzpfenning <i>et al.</i>[18]</td><td>NA/NA</td><td>NA/NA</td><td>Camera-projector systems work sequentially thus reducing the acquisition frequency</td></tr><tr><td>Mochimaru <i>et al.</i>[20]</td><td>NA/NA</td><td>NA/NA</td><td>Matching random pattern is computationally expensive and can create unpredictable errors</td></tr><tr><td>Yoshida & Kouchi [21]</td><td>NA/NA</td><td>4.0 mm/NA</td><td>System uses one generic model for all foot reconstructions; shape deformations during walking cannot be fully accounted by the generic model</td></tr><tr><td>Liu <i>et al.</i>[22]</td><td>0.25 mm/NA</td><td>NA/NA</td><td>System provides good visual results, but lacks proper experiments with real feet</td></tr><tr><td>Blenkinsopp <i>et al.</i>[25]</td><td>NA/NA</td><td>NA/NA</td><td>Reconstruction is based on painted artifacts on the foot surface</td></tr></table> |
cb604686ec2ab9529f30bb181c7fdebe00d5966b15eeb93b7aab93e2afd30ec6.png | simple | <table><tr><td></td><td>CFS</td><td>Healthy</td></tr><tr><td></td><td>(n = 55)</td><td>(n = 30)</td></tr><tr><td>Age (y)</td><td>35.4 ± 1.1</td><td>36.1 ± 1.6</td></tr><tr><td>Male</td><td>20</td><td>11</td></tr><tr><td>Female</td><td>35</td><td>19</td></tr><tr><td>α-MSH (pg/mL)</td><td>17.9 ± 1.0</td><td>14.5 ± 1.0*</td></tr></table> |
3615f4b380631ae8ee09a2574346c86c351270105eca535496870eaf78274bfe.png | complex | <table><tr><td>Response to endotoxin administration</td><td>Clinical</td><td>Autonomic</td><td colspan="4">Immune</td></tr><tr><td>Outcome expectancies</td><td>Flu-like symptoms (T90)</td><td>Epinephrine (T0)</td><td>IL-10 (T60)</td><td>TNF-α (T90)</td><td>IL-6 (T120)</td><td>IL-8 (T120)</td></tr><tr><td colspan="7">Generalized outcome expectancies</td></tr><tr><td>Optimism (LOT-R)</td><td>−.38</td><td>.76**</td><td>.60*</td><td>−.32</td><td>−.26</td><td>−.32</td></tr><tr><td>Neuroticism (BFI)</td><td>.10</td><td>−.32</td><td>−.09</td><td>.27</td><td>.22</td><td>.11</td></tr><tr><td>Specific outcome expectancies</td><td>−.71**</td><td>.28</td><td>.33</td><td>.00</td><td>.16</td><td>−.15</td></tr></table> |
10ed6dc043f222f86f8c5921871ff6def4c57edfa6dda79c55304dba121158bc.png | complex | <table><tr><td>Surfactant</td><td>Drug loaded</td><td>Comments</td><td>References</td></tr><tr><td>Brij 35, 78, 98, and 700</td><td>Atenolol, timolol, betaxololcyclosporine A</td><td>Significantly increased the corneal permeability.Significantly increased bioavailability of ophthalmic drugs by using contact lenses.</td><td>[52, 76]</td></tr><tr><td>Polysorbate 80, polyoxyl 40 stearate, and polyoxyl 60 hydrogenated castor oil</td><td>Cyclosporine A</td><td>Improve ocular CsA penetration and are clinically useful in the treatment of immune-mediated ophthalmic diseases.</td><td>[71]</td></tr><tr><td>Pluronic F127</td><td>Pilocarpine</td><td>Enhanced miotic response to a single instillation of pilocarpine eye drops compared to an aqueous solution of the drug.</td><td>[68]</td></tr><tr><td>Polysorbates 60 and 80 and Brij 35</td><td>Gentamicin sulphate</td><td>Effective in the prolongation of drug release from the ocular delivery and observed no irritancy on albino rabbits.</td><td>[72] </td></tr><tr><td>Polysorbate 20</td><td>Cyclopentolate</td><td>Promoted ocular absorption.</td><td>[23, 25]</td></tr><tr><td>Solulan C-24 and span 60</td><td>Timolol maleate</td><td>Treatment of ocular hypotensive activity. Exhibited sustained controlled ocular drug delivery.</td><td>[45, 46]</td></tr><tr><td rowspan="8">Spans 20, 40, 60, and 80</td><td>Acyclovir</td><td>Effective for the treatment of herpes simplex keratitis.</td><td>[67]</td></tr><tr><td>Acetazolamide</td><td>Effective in enhancing the bioavailability of drug and lowered the intraocular pressure.</td><td>[43, 45, 73]</td></tr><tr><td>Brimonidine tartrate</td><td>Improved bioavailability and increased precorneal residence time.Decreased the intraocular pressure for a prolonged period of time and nonirritant effect</td><td>[77–80]</td></tr><tr><td>Naltrexone hydrochloride</td><td>Possessed better ocular tolerability and less ocular irritation.</td><td>[74]</td></tr><tr><td>Fluconazole</td><td>Improved permeability as compared to marketed formulation and nonirritant effect.</td><td>[25]</td></tr><tr><td>Flupirtine maleate</td><td>Improved the low corneal permeability for effective management of trigeminal neuralgia.</td><td>[75]</td></tr><tr><td>Diclofenac sodium</td><td>Nonirritant and safe vesicular system for the effective ocular drug delivery.</td><td>[68]</td></tr><tr><td>Levofloxacin.</td><td>Efficient in prolonging the drug release with reduced side effects.</td><td>[69]</td></tr></table> |
a30164d64430187532573aed060100999ce5e0f5b99aac4470f146ca18cc84b2.png | simple | <table><tr><td>Expression</td><td>Gene_Symbol</td><td>LogFC</td><td>Adjusted <i>p</i> value</td></tr><tr><td>Upregulated</td><td>Grin2c</td><td>2.272</td><td>4.27E−06</td></tr><tr><td></td><td>Ccnb3</td><td>3.243</td><td>4.27E−06</td></tr><tr><td></td><td>Usp51</td><td>1.702</td><td>4.45E−06</td></tr><tr><td></td><td>Slc1a3</td><td>1.443</td><td>6.34E−06</td></tr><tr><td></td><td>Kcnk1</td><td>2.774</td><td>6.34E−06</td></tr><tr><td></td><td>Bmp3</td><td>2.764</td><td>9.74E−06</td></tr><tr><td></td><td>Rbm44</td><td>1.846</td><td>1.14E−05</td></tr><tr><td></td><td>Plppr5</td><td>2.010</td><td>1.85E−05</td></tr><tr><td></td><td>Phex</td><td>1.977</td><td>1.85E−05</td></tr><tr><td></td><td>Nell1</td><td>2.368</td><td>2.00E−05</td></tr><tr><td></td><td>AI593442</td><td>1.477</td><td>2.00E−05</td></tr><tr><td></td><td>Ooep</td><td>0.828</td><td>2.00E−05</td></tr><tr><td></td><td>Trpc6</td><td>1.628</td><td>2.00E−05</td></tr><tr><td></td><td>Dkk1</td><td>1.730</td><td>2.00E−05</td></tr><tr><td>Downregulated</td><td>Lef1</td><td>− 1.677</td><td>2.90E−06</td></tr><tr><td></td><td>Elf1</td><td>− 1.300</td><td>4.79E−06</td></tr><tr><td></td><td>Jph1</td><td>− 1.674</td><td>5.47E−06</td></tr><tr><td></td><td>Zfhx4</td><td>− 2.183</td><td>6.34E−06</td></tr><tr><td></td><td>S1pr3</td><td>− 1.209</td><td>8.30E−06</td></tr><tr><td></td><td>Slc20a2</td><td>− 1.031</td><td>9.06E−06</td></tr><tr><td></td><td>Pdgfc</td><td>− 1.073</td><td>9.20E−06</td></tr><tr><td></td><td>Wbp4</td><td>− 1.221</td><td>9.74E−06</td></tr><tr><td></td><td>Robo1</td><td>− 1.536</td><td>1.12E−05</td></tr><tr><td></td><td>Dgkh</td><td>− 1.183</td><td>1.12E−05</td></tr><tr><td></td><td>Mpped2</td><td>− 1.873</td><td>1.14E−05</td></tr><tr><td></td><td>Dnajc15</td><td>− 1.661</td><td>1.24E−05</td></tr><tr><td></td><td>Atp10a</td><td>− 1.118</td><td>1.85E−05</td></tr><tr><td></td><td>Slc6a15</td><td>− 2.051</td><td>1.85E−05</td></tr></table> |
865ba1306ed73d847c1a26d112711cf5744b174ba5f39cfb8bccdca8887ab911.png | complex | <table><tr><td></td><td colspan="3">Intention to quit</td><td colspan="3">Quitting smoking</td></tr><tr><td></td><td>OR</td><td colspan="2">95 % CI</td><td>OR</td><td colspan="2">95 % CI</td></tr><tr><td>Province (Hanoi vs Nam Dinh)</td><td>0.47***</td><td>0.34</td><td>0.67</td><td>0.50*</td><td>0.23</td><td>1.08</td></tr><tr><td>Location (Urban vs Rural)</td><td>1.44</td><td>0.90</td><td>2.31</td><td></td><td></td><td></td></tr><tr><td>Duration of MMT (month)</td><td>1.00</td><td>0.99</td><td>1.02</td><td>0.99</td><td>0.95</td><td>1.03</td></tr><tr><td>Outpatient service use last 12 months (yes vs no)</td><td>1.98***</td><td>1.44</td><td>2.72</td><td></td><td></td><td></td></tr><tr><td># of drug rehabilitation</td><td></td><td></td><td></td><td>1.03</td><td>0.98</td><td>1.07</td></tr><tr><td>Religion (vs cult of ancestors)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Buddhism</td><td></td><td></td><td></td><td>2.72*</td><td>0.84</td><td>8.78</td></tr><tr><td>Occupation (vs unemployed)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Other jobs</td><td>1.41</td><td>0.87</td><td>2.28</td><td></td><td></td><td></td></tr><tr><td>Age (vs 18–<25)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 35–<40</td><td></td><td></td><td></td><td>2.63**</td><td>1.30</td><td>5.30</td></tr><tr><td> ≥45</td><td>0.51***</td><td>0.34</td><td>0.78</td><td></td><td></td><td></td></tr><tr><td>Marital status (vs single)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Live with spouse</td><td>1.23</td><td>0.91</td><td>1.67</td><td></td><td></td><td></td></tr><tr><td>Income quintile (vs poorest)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Rich</td><td>0.78</td><td>0.56</td><td>1.09</td><td></td><td></td><td></td></tr><tr><td>Having pain/discomfort (yes vs no)</td><td></td><td></td><td></td><td>0.41</td><td>0.12</td><td>1.43</td></tr><tr><td>HIV status (vs negative)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Positive</td><td>0.58**</td><td>0.34</td><td>0.99</td><td></td><td></td><td></td></tr><tr><td>Body mass index (vs underweight)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Normal</td><td>1.47</td><td>0.86</td><td>2.52</td><td></td><td></td><td></td></tr><tr><td>Level of nicotine dependence (vs very low)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td></td><td></td><td></td><td>0.31**</td><td>0.12</td><td>0.81</td></tr><tr><td> Moderate</td><td></td><td></td><td></td><td>0.22**</td><td>0.05</td><td>0.97</td></tr><tr><td> High</td><td></td><td></td><td></td><td>0.37**</td><td>0.13</td><td>1.04</td></tr><tr><td> Very high</td><td></td><td></td><td></td><td>0.22**</td><td>0.05</td><td>0.99</td></tr><tr><td>Year of smoking</td><td></td><td></td><td></td><td>0.95**</td><td>0.91</td><td>1.00</td></tr></table> |
4e19943723e66435374116b3924d16a138f2b8e3311b1df428249869334f7607.png | complex | <table><tr><td></td><td>Testosterone group<i>n</i> = 49</td><td>Placebo group<i>n</i> = 51</td><td>Difference between groups<sup>a</sup></td><td><i>P</i> value<sup>b</sup></td></tr><tr><td colspan="5">Fat mass, kg</td></tr><tr><td> Week 0–10</td><td>–7.9 (–9.7 to –6.1)<sup>*</sup></td><td>–7.5 (–9.4 to –5.7)<sup>*</sup></td><td>–0.4 (–3.0 to 2.2)</td><td>0.78</td></tr><tr><td> Week 0–56</td><td>–9.4 (–11.3 to –7.5)<sup>*</sup></td><td>–6.5 (–8.5 to –4.5)<sup>*</sup></td><td>–2.9 (–5.7 to –0.2)</td><td>0.04</td></tr><tr><td colspan="5">Fat mass, %</td></tr><tr><td> Week 0–10</td><td>–3.8 (–4.9 to –2.6)<sup>*</sup></td><td>–3.0 (–4.3 to –1.8)<sup>*</sup></td><td>–0.7 (–2.4 to 1.0)</td><td>0.40</td></tr><tr><td> Week 0–56</td><td>–5.7 (–6.9 to –4.5)<sup>*</sup></td><td>–2.9 (–4.3 to –1.6)<sup>*</sup></td><td>–2.8 (–4.6 to –1.0)</td><td>0.003</td></tr><tr><td colspan="5">Lean mass, kg</td></tr><tr><td> Week 0–10</td><td>–3.9 (–5.3 to –2.6)<sup>*</sup></td><td>–4.8 (–6.2 to –3.5)<sup>*</sup></td><td>0.9 (–1.0 to 2.8)</td><td>0.36</td></tr><tr><td> Week 0–56</td><td>–0.6 (–2.0 to 0.8)</td><td>–4.0 (–5.5 to –2.5)<sup>*</sup></td><td>3.4 (1.3 to 5.5)</td><td>0.002</td></tr><tr><td colspan="5">VAT area, mm<sup>2</sup></td></tr><tr><td> Week 0–10</td><td>–7688 (–9333 to –6044)<sup>*</sup></td><td>–6590 (–8267 to –4912)<sup>*</sup></td><td>–1099 (–3448 to 1251)</td><td>0.36</td></tr><tr><td> Week 0–56</td><td>–7223 (–8921 to –5526)<sup>*</sup></td><td>–4545 (–6383 to –2708)<sup>*</sup></td><td>–2678 (–5180 to –176)</td><td>0.04</td></tr><tr><td colspan="5">Body weight, kg</td></tr><tr><td> Week 0–10</td><td>–12.0 (–14.5 to –9.5)<sup>*</sup></td><td>–13.5 (–16.0 to –11.0)<sup>*</sup></td><td>1.5 (–2.0 to 5.1)</td><td>0.40</td></tr><tr><td> Week 0–56</td><td>–11.4 (–13.9 to –8.8)<sup>*</sup></td><td>–10.9 (–13.6 to –8.1)<sup>*</sup></td><td>–0.5 (–4.3 to 3.3)</td><td>0.80</td></tr></table> |
4dfa9f4753e42a969a82bae9118658f041fba90e95dbe7eb7232e4999e30ccba.png | simple | <table><tr><td>Documentation practice</td><td>Description</td><td>Number of sites</td></tr><tr><td>Paper-based documentation</td><td>Documentation on a structured paper-based template and later scanned into the EHR in pdf format. No entries of vital signs were done in the EHR.</td><td>2 Sites</td></tr><tr><td>Mixed Documentation</td><td>Done on a paper-based template and later transferred into a digital EHR template.</td><td>3 sites</td></tr><tr><td>Digital documentation</td><td>Documentation on a digital template</td><td>4 sites</td></tr></table> |
73aac7b18e3638f660fc21ebe82b9bc9593fdb6b628573da2ebec1b026ba711c.png | complex | <table><tr><td colspan="2">Variable</td><td>Number</td><td>% of total</td><td>% male</td><td>% female</td></tr><tr><td colspan="2">Patients</td><td>64,179</td><td>100.0</td><td>63.6</td><td>36.4</td></tr><tr><td>Age (year)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤21</td><td>59,928</td><td>93.4</td><td>91.7</td><td>96.3</td></tr><tr><td></td><td>22–28</td><td>3,656</td><td>5.7</td><td>7.3</td><td>2.9</td></tr><tr><td></td><td>≥29</td><td>595</td><td>0.9</td><td>1.0</td><td>0.8</td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Elementary</td><td>63</td><td>0.1</td><td>0.1</td><td>0.0</td></tr><tr><td></td><td>High school</td><td>59,578</td><td>92.8</td><td>90.5</td><td>96.9</td></tr><tr><td></td><td>Post-high school</td><td>4,415</td><td>6.9</td><td>9.1</td><td>2.9</td></tr><tr><td></td><td>Unknown</td><td>123</td><td>0.2</td><td>0.2</td><td>0.2</td></tr><tr><td>Ethnicity</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Israel</td><td>4,853</td><td>7.6</td><td>8.4</td><td>6.1</td></tr><tr><td></td><td>Asia + Africa + Ethiopia</td><td>30,215</td><td>47.1</td><td>45.2</td><td>50.3</td></tr><tr><td></td><td>West</td><td>15,329</td><td>23.9</td><td>24.6</td><td>22.7</td></tr><tr><td></td><td>Former Soviet Union</td><td>8,187</td><td>12.8</td><td>13.3</td><td>11.9</td></tr><tr><td></td><td>Unknown</td><td>5,595</td><td>8.7</td><td>8.6</td><td>9.0</td></tr><tr><td>Country of birth</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Israel</td><td>50,726</td><td>79.0</td><td>78.4</td><td>80.1</td></tr><tr><td></td><td>Asia, Africa</td><td>1,298</td><td>2.0</td><td>2.4</td><td>1.5</td></tr><tr><td></td><td>West</td><td>1,861</td><td>2.9</td><td>3.1</td><td>2.6</td></tr><tr><td></td><td>Former Soviet Union</td><td>6,776</td><td>10.6</td><td>10.8</td><td>10.1</td></tr><tr><td></td><td>Unknown</td><td>3,518</td><td>5.5</td><td>5.3</td><td>5.8</td></tr></table> |
a3c572b4674f081a54ebd99f453e06fedd17987728cdcc3ed89b86d843964ba9.png | simple | <table><tr><td>Study</td><td>Patients (#)</td><td>SRS median total dose/fx</td><td>Follow-up median, range (months)</td><td>Tumor size median, range (cc)</td><td>Prior irradiation Dose, median, range (Gy)</td><td>Toxicity</td><td>Complete Response Rate</td><td>Overall survival</td></tr><tr><td>Voynov et al. [13]</td><td>22</td><td>24/1-8</td><td>19, 11-40*</td><td>19.1, 2.5-140.3</td><td>97.8, 70.1-190.3 (BED<sub>10</sub>)</td><td>No Grade 4+</td><td>-</td><td>22% at 2-yrs</td></tr><tr><td>Heron et al. [15]</td><td>25</td><td>25-44/5</td><td>NS</td><td>44.8, 4.2-217</td><td>66-69.2</td><td>No Grade 3+</td><td>8.6%</td><td>18% at 1-yr</td></tr><tr><td>Roh et al. [14]</td><td>36</td><td>30/3-5</td><td>17.3</td><td>22.6, 0.2-114.9</td><td>70.2, 39.6-134.4</td><td>No Grade 4+ 36% Grade 3</td><td>42.9%</td><td>52.1% at 1-yr, 30.9% at 2-yrs</td></tr><tr><td>Rwigema et al. [23]</td><td>85</td><td>35/1-5</td><td>6, 1.3-39</td><td>25.1, 2.5-162</td><td>70, 32-170.7</td><td>No Grade 4+ 4.7% Grade 3</td><td>34%</td><td>48% at 1-yr, 16% at 2-yrs</td></tr><tr><td>Sulman et al. [31]</td><td>78<sup>§</sup></td><td>IMRT 60 Gy</td><td>25, 0-81</td><td>64.1, 2.9-425.4</td><td>60, 16-75</td><td>20% severe Including 1% Grade 5</td><td>-</td><td>58% at 2-yrs</td></tr><tr><td>Siddiqui et al. [25]</td><td>44<sup>§</sup>†</td><td>13-18/1 or 36-48/5-8</td><td>6.8, 1.5-48</td><td>15.5, 1.7-155‡</td><td>63.5, 50.4-74‡</td><td>6.7% Grade 3‡ 9% Grade 4‡</td><td>31%</td><td>38.1% at 1-yr 14.3% at 2-yrs</td></tr><tr><td>Unger et al. [24]</td><td>65</td><td>30/2-5</td><td>16*</td><td>75, 7-276</td><td>67, 32-120</td><td>11% Grade 4+</td><td>54%</td><td>41% at 2-yrs</td></tr><tr><td>Current Study</td><td>22 (14 N-, 8 N+)</td><td>33.7/2-5</td><td>24, 4-39</td><td>24.5, 3.4-74.4</td><td>40-65</td><td>No Grade 4+ 22.7% Grade 3</td><td>45.4% (N- 64.3%, N+ 12.5%)</td><td>N- 78.6% at 2-yrs N+ 12.5% at 2-yrs</td></tr></table> |
42a6f8101b0b70bd48be4f1f6a32743bf7f0428fb0e635dd39c00bae1f5d0a06.png | complex | <table><tr><td>Country</td><td colspan="4">Natural forest cover (1000 ha)</td><td>Loss (1000 ha)</td><td>Coverage %</td><td colspan="3">Annual deforestation rate (%)</td></tr><tr><td></td><td>1990</td><td>2000</td><td>2005</td><td>2010</td><td>1990–2010</td><td>2000</td><td>1990–2000</td><td>2000–2005</td><td>2005–2010</td></tr><tr><td>Burundi</td><td>289</td><td>112</td><td>103</td><td>103</td><td>186</td><td>3.7</td><td>−6.1</td><td>−6.12</td><td>−0.8</td></tr><tr><td>Ethiopia</td><td>14,623</td><td>13,214</td><td>12,509</td><td>11,785</td><td>2838</td><td>4.2</td><td>−1.0</td><td>−0.96</td><td>−1.08</td></tr><tr><td>Kenya</td><td>3470</td><td>3370</td><td>3320</td><td>3270</td><td>200</td><td>30.0</td><td>−0.3</td><td>−0.29</td><td>−0.30</td></tr><tr><td>Madagascar</td><td>13,461</td><td>12,850</td><td>12,548</td><td>12,138</td><td>1323</td><td>20.2</td><td>−0.5</td><td>−0.45</td><td>−0.55</td></tr><tr><td>Rwanda</td><td>70</td><td>62</td><td>62</td><td>62</td><td>8</td><td>n.a</td><td>−1.1</td><td>−1.14</td><td>0</td></tr><tr><td>Tanzania</td><td>41,345</td><td>37,262</td><td>35,215</td><td>33,188</td><td>8157</td><td>43.9</td><td>−1.0</td><td>−0.99</td><td>−1.09</td></tr><tr><td>Uganda</td><td>4717</td><td>3837</td><td>3398</td><td>2937</td><td>1780</td><td>21.0</td><td>−1.9</td><td>−1.87</td><td>−2.35</td></tr></table> |
020861e318cb3a3f74f1645a8a5eaac5087e4407f55925e49b98c64d842dc897.png | complex | <table><tr><td>HospitalVolume</td><td>No. ofhospitals inJapan</td><td>No. of beds in Japan (Ni)</td><td colspan="2">No. of beds in DPCparticipating hospitals (ni)</td><td colspan="2">No. of intussusceptionfrom July to December(Xi)</td><td colspan="2">Estimated No. of cases per year(Yi)</td></tr><tr><td></td><td></td><td></td><td>2007</td><td>2008</td><td>2007</td><td>2008</td><td>2007</td><td>2008</td></tr><tr><td>< 400 beds(i = 1)</td><td>7,001</td><td>566,658</td><td>138,979</td><td>119,853</td><td>86</td><td>97</td><td>701 (597-806)</td><td>917 (788-1046)</td></tr><tr><td>400 - < 600beds (i = 2)</td><td>466</td><td>175,715</td><td>98,050</td><td>89,627</td><td>176</td><td>169</td><td>631 (565-697)</td><td>663 (592-733)</td></tr><tr><td>600 - < 800beds (i = 3)</td><td>161</td><td>88,870</td><td>54,351</td><td>49,740</td><td>98</td><td>78</td><td>320 (276-365)</td><td>278 (235-322)</td></tr><tr><td>> 800 beds(i = 4)</td><td>95</td><td>78,995</td><td>50,245</td><td>50,245</td><td>97</td><td>71</td><td>305 (262-348)</td><td>223 (187-260)</td></tr><tr><td>Total</td><td>7,723</td><td>910,238</td><td>341,625</td><td>309,465</td><td>457</td><td>415</td><td>1,957 (1743-2216)</td><td>2,081 (1802-2361)</td></tr></table> |
31602009a94fbe6a6da192a52004c646f874b2129f6e75c9e49b82811765734f.png | simple | <table><tr><td>Markers</td><td>Afreq</td><td>Families</td><td>S</td><td>E(s)</td><td>Z</td><td><i>p</i>-values</td></tr><tr><td>rs4366301</td><td>C:0.831G:0.169</td><td>169169</td><td>213.00125.00</td><td>233.00105.00</td><td>-2.8722.872</td><td>0.0040.004</td></tr><tr><td>rs11585959</td><td>C:0.243T:0.757</td><td>216216</td><td>123.00309.00</td><td>141.00291.00</td><td>-2.1992.199</td><td>0.0280.028</td></tr><tr><td>rs1322784</td><td>G:0.369A:0.631</td><td>242242</td><td>206.00278.00</td><td>202.50281.50</td><td>-0.3920.392</td><td>0.6950.695</td></tr><tr><td>rs6668845</td><td>G:0.332A:0.668</td><td>244244</td><td>172.00316.00</td><td>193.00295.00</td><td>-2.3262.326</td><td>0.0200.020</td></tr><tr><td>rs10864698</td><td>A:0.330G:0.670</td><td>242242</td><td>175.00309.00</td><td>191.50292.50</td><td>-1.8311.831</td><td>0.0670.067</td></tr><tr><td>rs872624</td><td>G:0.345A:0.655</td><td>232232</td><td>168.00296.00</td><td>180.00284.00</td><td>-1.3721.372</td><td>0.1700.170</td></tr><tr><td>rs821616</td><td>A:0.881T:0.119</td><td>130130</td><td>186.0074.00</td><td>181.5078.50</td><td>0.728-0.728</td><td>0.4670.467</td></tr></table> |
a0b13115f57b00a3e00bea79e50c7d49c6954536c0c9cf2301795fffa5948a65.png | complex | <table><tr><td rowspan="2" colspan="2">Materials</td><td colspan="3">Melting</td><td colspan="3">Solidification</td></tr><tr><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td><td>Onset temperature (°C)</td><td>End temperature (°C)</td><td>Enthalpy (J/g)</td></tr><tr><td rowspan="3">FS TD-CA PCM</td><td>0 cycling</td><td>18.90</td><td>24.24</td><td>100.50</td><td>14.16</td><td>9.18</td><td>99.70</td></tr><tr><td>500 cycling</td><td>18.47</td><td>23.34</td><td>98.70</td><td>14.66</td><td>9.53</td><td>96.40</td></tr><tr><td>1000 cycling</td><td>18.12</td><td>22.90</td><td>96.30</td><td>15.40</td><td>10.18</td><td>94.50</td></tr><tr><td rowspan="3">FS TD-LA PCM</td><td>0 cycling</td><td>24.53</td><td>30.18</td><td>90.20</td><td>24.92</td><td>19.88</td><td>88.70</td></tr><tr><td>500 cycling</td><td>23.62</td><td>29.69</td><td>87.60.</td><td>25.93</td><td>20.67</td><td>86.40</td></tr><tr><td>1000 cycling</td><td>23.22</td><td>29.28</td><td>85.70</td><td>26.23</td><td>21.12</td><td>85.10</td></tr><tr><td rowspan="3">FS TD-MA PCM</td><td>0 cycling</td><td>33.15</td><td>37.75</td><td>128.60</td><td>30.72</td><td>27.63</td><td>125.70</td></tr><tr><td>500 cycling</td><td>32.81</td><td>37.28</td><td>125.30</td><td>31.11</td><td>28.00</td><td>123.40</td></tr><tr><td>1000 cycling</td><td>32.65</td><td>37.04</td><td>123.50</td><td>31.72</td><td>28.55</td><td>121.70</td></tr></table> |
b79bfe75e8ad323e72143070cec4596c598aaf4ddefb4ab352f1045a5aefe1d5.png | complex | <table><tr><td>Variable</td><td></td><td>Totaln (%)</td><td>Normaln (%)</td><td>Anemia<sup>1</sup>n (%)</td><td>X<sup>2</sup></td><td>P</td></tr><tr><td colspan="7">Occupation</td></tr><tr><td></td><td>Mixed farming</td><td>351 (36.2)</td><td>266 (75.8)</td><td>85 (24.2)</td><td>21.7</td><td>0.001</td></tr><tr><td></td><td>Livestock</td><td>33 (3.4)</td><td>14 (42.4)</td><td>19 (57.6)</td><td></td><td></td></tr><tr><td></td><td>Trade</td><td>125 (12.9)</td><td>85 (68.0)</td><td>40 (32.0)</td><td></td><td></td></tr><tr><td></td><td>Civil servant</td><td>154 (15.9)</td><td>108 (70.1)</td><td>46 (29.9)</td><td></td><td></td></tr><tr><td></td><td>Factory worker</td><td>26 (2.7)</td><td>15 (57.7)</td><td>11 (42.3)</td><td></td><td></td></tr><tr><td></td><td>Handicraft</td><td>40 (4.1)</td><td>29 (72.5)</td><td>11 (27.5)</td><td></td><td></td></tr><tr><td></td><td>None(housewife)</td><td>241 (24.8)</td><td>158 (65.6)</td><td>83 (34.4)</td><td></td><td></td></tr><tr><td colspan="7">Type of family planning</td></tr><tr><td></td><td>None</td><td>521 (53.7)</td><td>353 (67.8)</td><td>168 (32.2)</td><td>15.8</td><td>0.003</td></tr><tr><td></td><td>Pills</td><td>146 (15.1)</td><td>109 (74.7)</td><td>37 (25.3)</td><td></td><td></td></tr><tr><td></td><td>IUCD</td><td>7 (0.7)</td><td>5 (71.5)</td><td>2 (28.5)</td><td></td><td></td></tr><tr><td></td><td>Injection</td><td>285 (29.4)</td><td>203 (71.2)</td><td>82 (28.8)</td><td></td><td></td></tr><tr><td></td><td>Others (condom)</td><td>25 (2.6)</td><td>9 (36.0)</td><td>16 (64.0)</td><td></td><td></td></tr><tr><td colspan="7">Type of illnesses<sup>2</sup></td></tr><tr><td></td><td>Pneumonia</td><td>39 (4.0)</td><td>25 (64.1)</td><td>14 (35.9)</td><td>16.7</td><td>0.001</td></tr><tr><td></td><td>Malaria</td><td>42 (4.3)</td><td>26 (61.9)</td><td>16 (38.1)</td><td></td><td></td></tr><tr><td></td><td>Chronic illnesses<sup>3</sup></td><td>45 (4.6)</td><td>20 (44.4)</td><td>25 (55.6)</td><td></td><td></td></tr><tr><td></td><td>None</td><td>844 (87.0)</td><td>604 (71.6)</td><td>240 (28.4)</td><td></td><td></td></tr><tr><td colspan="7">Intestinal parasites</td></tr><tr><td></td><td>Present</td><td>837 (86.3)</td><td>620 (74.1)</td><td>217 (25.9)</td><td>3.07</td><td>0.07</td></tr><tr><td></td><td>Absent</td><td>163 (13.7)</td><td>123 (75.5)</td><td>40 (24.5)</td><td></td><td></td></tr><tr><td colspan="7">Vegetable consumption daily</td></tr><tr><td></td><td>Once a day or more</td><td>567 (58.5)</td><td>451 (79.5)</td><td>116 (24.5)</td><td>16.6</td><td>0.001</td></tr><tr><td></td><td>Less than once a day</td><td>403 (41.5)</td><td>274 (68.0)</td><td>129 (32.0)</td><td></td><td></td></tr><tr><td colspan="7">Meat consumption weekly</td></tr><tr><td></td><td>Once a week or more</td><td>194 (20.0)</td><td>116 (59.8)</td><td>78 (40.2)</td><td>13.6</td><td>0.001</td></tr><tr><td></td><td>Less than once a week</td><td>776 (80.0)</td><td>349 (45.0)</td><td>427 (55.0)</td><td></td><td></td></tr></table> |
dbeb82d9be4fbd1c65299092132015d62250b8222e09775c870860da27cc429c.png | simple | <table><tr><td> </td><td> Total</td><td> Woman</td><td> Man</td></tr><tr><td>Total thyroidectomy</td><td> 166</td><td> 125 (75.3)<sup><i>∗</i></sup></td><td> 41 (24.7)</td></tr><tr><td>Pyramidal lobe present</td><td> 109 (65.7)</td><td> 82 (65.6)</td><td> 27 (65.9) </td></tr><tr><td>Pyramidal lobe absent</td><td> 57 (34.3)</td><td> 43 (34.4)</td><td> 14 (34.1)</td></tr></table> |
676a831aec721d1e6d1e4c39b388fd3790787506e0f5a21d2cc3d3ae13c5ea54.png | simple | <table><tr><td>Parameters</td><td>Control group</td><td>500 mg/kg·b·wt (A)</td><td>1000 mg/kg·b·wt (B)</td><td>2000 mg/kg·b·wt (C)</td></tr><tr><td>Number of examined fetuses</td><td>15</td><td>15</td><td>15</td><td>15</td></tr><tr><td>Impairment of skull ossification</td><td>—</td><td>3 (20%)</td><td>5 (33.33%)</td><td>8 (53.33%)</td></tr><tr><td>Absence or dislocation of sternebrae</td><td>—</td><td>2 (13.33%)</td><td>3 (20%)</td><td>5 (33.33%)</td></tr><tr><td>Reduction or absence of caudal vertebrae</td><td>—</td><td>5 (33.33%)</td><td>6 (40%)</td><td>10 (66.67%)</td></tr><tr><td>Absence of digit's bone of fore limb</td><td>—</td><td>3 (20%)</td><td>4 (26.67%)</td><td>9 (60%)</td></tr><tr><td>Absence of digit's bone of hind limb</td><td>—</td><td>2 (12.33%)</td><td>3 (20%)</td><td>7 (46.67%)</td></tr><tr><td>Absence of some metatarsal bone</td><td>—</td><td>3 (20%)</td><td>4 (26.67%)</td><td>6 (40%)</td></tr><tr><td>Absence of some metacarpal bone</td><td>—</td><td>2 (12.33%)</td><td>4 (26.67%)</td><td>5 (33.33%)</td></tr></table> |
cb5dc6d443444bd3d960ebd5b6c4011cd697ad7d5c4073f94f46f1c383121354.png | complex | <table><tr><td>Criteria</td><td>Total n</td><td>Normosmic</td><td>Hyposmic</td><td>Anosmic</td></tr><tr><td colspan="5">TOAST criteria</td></tr><tr><td> Large artery atherosclerosis</td><td>11</td><td>7</td><td>2</td><td>2</td></tr><tr><td> Cardioembolism</td><td>21</td><td>14</td><td>4</td><td>3</td></tr><tr><td> Small vessel occlusion</td><td>14</td><td>7</td><td>4</td><td>3</td></tr><tr><td> Stroke of other determined etiology</td><td>1</td><td>1</td><td>0</td><td>0</td></tr><tr><td> Stroke of undetermined etiology</td><td>26</td><td>11</td><td>11</td><td>4</td></tr><tr><td colspan="5">OCPS criteria</td></tr><tr><td> PACI</td><td>37</td><td>18</td><td>11</td><td>8</td></tr><tr><td> POCI</td><td>12</td><td>9</td><td>2</td><td>1</td></tr><tr><td> TACI</td><td>4</td><td>2</td><td>1</td><td>1</td></tr><tr><td> LACI</td><td>20</td><td>11</td><td>7</td><td>2</td></tr></table> |
d2d91ed4c86d63a558badf530cd792e550027991804b8716fc810a4f1c45253b.png | simple | <table><tr><td>Variable</td><td>Response</td><td>Surgeon 1</td><td>Surgeon 2</td><td><i>P</i></td></tr><tr><td>Operative time, no previous abdominal surgery</td><td>N, Mean ± SD</td><td>59, 45.6 ± 12.9</td><td>13, 73.2 ± 13.6</td><td>< 0.001</td></tr><tr><td>Operative time, previous abdominal surgery</td><td>N, Mean ± SD</td><td>43, 44.0 ± 12.6</td><td>2, 115.5 ± 2.1</td><td>0.019</td></tr></table> |
98640e52e090d892e77b5ac3f1f336a7cec1001c1afe08e72bfcf2e2b5529181.png | simple | <table><tr><td>Region</td><td>Control</td><td>Autism</td><td><i>t</i>-value</td><td><i>P</i></td></tr><tr><td>Amygdala</td><td>3.93 ± 0.64</td><td>3.69 ± 0.57</td><td>0.58</td><td>0.58</td></tr><tr><td>Caudate nucleus</td><td>4.28 ± 0.47</td><td>4.56 ± 0.62</td><td>0.67</td><td>0.52</td></tr><tr><td>Cerebellum</td><td>1.07 ± 0.10</td><td>1.25 ± 0.068</td><td>3.17</td><td><i>0.016</i></td></tr><tr><td>Cingulate</td><td>4.33 ± 0.43</td><td>4.42 ± 0.23</td><td>0.42</td><td>0.68</td></tr><tr><td>Entorhinal area</td><td>1.78 ± 0.71</td><td>2.75 ± 0.59</td><td>2.19</td><td><i>0.065</i></td></tr><tr><td>Frontal lobe</td><td>4.11 ± 0.39</td><td>4.28 ± 0.22</td><td>0.87</td><td>0.41</td></tr><tr><td>Fusiform gyrus</td><td>3.86 ± 0.49</td><td>3.69 ± 0.52</td><td>0.47</td><td>0.65</td></tr><tr><td>Globus pallidus</td><td>1.12 ± 0.14</td><td>1.28 ± 0.15</td><td>1.58</td><td>0.16</td></tr><tr><td>Hippocampus</td><td>3.74 ± 0.67</td><td>3.66 ± 0.52</td><td>0.21</td><td>0.84</td></tr><tr><td>Insula</td><td>4.58 ± 0.62</td><td>4.49 ± 0.51</td><td>0.22</td><td>0.83</td></tr><tr><td>Occipital lobe</td><td>3.22 ± 0.39</td><td>3.35 ± 0.15</td><td>0.79</td><td>0.46</td></tr><tr><td>Paracentral gyrus</td><td>2.89 ± 0.44</td><td>3.36 ± 0.32</td><td>1.83</td><td>0.11</td></tr><tr><td>Parahippocampus</td><td>3.25 ± 0.09</td><td>3.55 ± 0.40</td><td>1.22</td><td>0.26</td></tr><tr><td>Parietal lobe</td><td>3.93 ± 0.36</td><td>4.10 ± 0.14</td><td>1.08</td><td>0.32</td></tr><tr><td>Precentral gyrus</td><td>3.55 ± 0.38</td><td>3.86 ± 0.12</td><td>1.89</td><td>0.10</td></tr><tr><td>Precuneus</td><td>3.87 ± 0.24</td><td>4.19 ± 0.20</td><td>2.13</td><td><i>0.071</i></td></tr><tr><td>Postcentral gyrus</td><td>3.44 ± 0.22</td><td>3.82 ± 0.20</td><td>2.60</td><td><i>0.036</i></td></tr><tr><td>Putamen</td><td>3.90 ± 0.54</td><td>4.18 ± 0.33</td><td>0.91</td><td>0.39</td></tr><tr><td>Temporal lobe</td><td>4.23 ± 0.57</td><td>4.23 ± 0.30</td><td>0.02</td><td>1.00</td></tr><tr><td>Thalamus</td><td>2.43 ± 0.28</td><td>2.50 ± 0.29</td><td>0.37</td><td>0.72</td></tr><tr><td>Ventral striatum</td><td>4.75 ± 0.66</td><td>5.10 ± 0.50</td><td>0.89</td><td>0.40</td></tr></table> |
f8c88fa8479096b9a4fa453ed0cb63bf69075cf0b29728d3889dbd9c11efba23.png | simple | <table><tr><td></td><td>"0" + EC</td><td>"0" + NEC</td><td>p</td></tr><tr><td>Number of cycles</td><td>50</td><td>39</td><td></td></tr><tr><td>Maternal age (mean ± SD)</td><td>30.3 ± 4.0</td><td>31.6 ± 3.4</td><td>>0.5</td></tr><tr><td>Total number of embryos transferred</td><td>75</td><td>75</td><td></td></tr><tr><td>Mean ± SD embryos/cycle</td><td>1.5 ± 0.5</td><td>1.9 ± 0.5</td><td>0.000</td></tr><tr><td>Biochemical pregnancies</td><td>30</td><td>17</td><td></td></tr><tr><td>bPR (%)</td><td>60</td><td>44</td><td>>0.5</td></tr><tr><td>Clinical pregnancies</td><td>28</td><td>12</td><td></td></tr><tr><td>cPR (%)</td><td>56</td><td>31</td><td>0.020</td></tr><tr><td>Number of gestational sacs by US</td><td>32</td><td>20</td><td></td></tr><tr><td>IR (%)</td><td>43</td><td>27</td><td>0.038</td></tr></table> |
4360b4c4224ac2a0b6ba675753c82c55f70be1f82c1d4f0cd7d89813c0054533.png | complex | <table><tr><td></td><td colspan="2">Current study</td><td colspan="3">Previous studies</td></tr><tr><td>SSC<sup>a</sup></td><td>Position 1</td><td>Position 2</td><td>Position 1</td><td>Position 2</td><td>Trait</td></tr><tr><td>1</td><td>181,896,016</td><td>186,896,016</td><td>105,873,529</td><td>290,457,491</td><td>teat number [39]</td></tr><tr><td></td><td></td><td></td><td>165,580,236</td><td>257,944,209</td><td>nonfunctional nipples [41]</td></tr><tr><td></td><td></td><td></td><td>183,913,205</td><td>184,015,342</td><td>total number born [48]</td></tr><tr><td></td><td></td><td></td><td>183,913,205</td><td>184,015,342</td><td>total number born alive [48]</td></tr><tr><td></td><td></td><td></td><td>184,917,301</td><td>185,121,617</td><td>corpus luteum number [36]</td></tr><tr><td></td><td></td><td></td><td>185,717,517</td><td>185,784,945</td><td>corpus luteum number [36]</td></tr><tr><td>2</td><td>138,703,617</td><td>143,703,617</td><td>116,028,974</td><td>145,137,405</td><td>corpus luteum number [36]</td></tr><tr><td></td><td>139,963,748</td><td>140,963,748</td><td>138,002,690</td><td>142,235,710</td><td>nonfunctional nipples [41]</td></tr><tr><td></td><td>141,775,934</td><td>142,775,934</td><td>139,070,668</td><td>139,947,117</td><td>age at puberty [43]</td></tr><tr><td></td><td></td><td></td><td>139,359,663</td><td>150,135,089</td><td>nonfunctional nipples [42]</td></tr><tr><td></td><td></td><td></td><td>139,525,787</td><td>139,963,748</td><td>mummified pigs [20]</td></tr><tr><td></td><td></td><td></td><td>139,841,202</td><td>139,989,204</td><td>corpus luteum number [36]</td></tr><tr><td></td><td></td><td></td><td>140,050,554</td><td>140,262,094</td><td>total number born [20]</td></tr><tr><td></td><td></td><td></td><td>140,443,704</td><td>140,934,348</td><td>teat number [40]</td></tr><tr><td>3</td><td>5,484,217</td><td>6,484,217</td><td>1,456,046</td><td>130,209,174</td><td>teat number [39]</td></tr><tr><td></td><td>6,342,416</td><td>7,342,416</td><td>4,571,903</td><td>82,495,610</td><td>corpus luteum number [37]</td></tr><tr><td>6</td><td>154,583,417</td><td>157,083,417</td><td>19,536,155</td><td>157,765,593</td><td>teat number [39]</td></tr><tr><td>7</td><td>34,743,041</td><td>35,743,041</td><td>8,014,191</td><td>92,220,281</td><td>corpus luteum number [38]</td></tr><tr><td></td><td></td><td></td><td>10,763,543</td><td>117,929,721</td><td>teat number [39]</td></tr><tr><td></td><td></td><td></td><td>11,136,187</td><td>116,028,974</td><td>corpus luteum number [36]</td></tr><tr><td></td><td></td><td></td><td>16,365,408</td><td>42,509,154</td><td>age at puberty [7]</td></tr><tr><td></td><td></td><td></td><td>34,692,239</td><td>35,120,284</td><td>total number born [44]</td></tr><tr><td></td><td></td><td></td><td>34,692,239</td><td>35,120,284</td><td>total number born alive [44]</td></tr><tr><td></td><td></td><td></td><td>34,692,239</td><td>35,120,284</td><td>litter weight, total [44]</td></tr><tr><td>9</td><td>70,252,726</td><td>71,252,726</td><td>39,568,811</td><td>138,751,051</td><td>corpus luteum number [37]</td></tr><tr><td>13</td><td>139,777,016</td><td>142,277,016</td><td>5,836,383</td><td>188,271,972</td><td>nonfunctional nipples [41]</td></tr><tr><td></td><td>140,304,656</td><td>142,804,656</td><td>18,268,056</td><td>206,704,152</td><td>corpus luteum number [38]</td></tr><tr><td></td><td></td><td></td><td>91,625,750</td><td>145,083,047</td><td>embryo weight [45]</td></tr><tr><td></td><td></td><td></td><td>141,246,965</td><td>141,992,388</td><td>age at puberty [43]</td></tr><tr><td>14</td><td>8,423,533</td><td>13,423,533</td><td>12,814,009</td><td>12,929,926</td><td>total number born [20]</td></tr><tr><td></td><td>141,048,490</td><td>143,548,490</td><td>141,246,965</td><td>141,992,388</td><td>age at puberty [43]</td></tr></table> |
cce4ef163f54add645b48ae30d8ead05483e6c2f452fc94e8745c15aea378bdc.png | complex | <table><tr><td rowspan="3">Organs</td><td colspan="6">%ID/g</td></tr><tr><td colspan="2">4 h</td><td colspan="2">24 h</td><td colspan="2">120 h</td></tr><tr><td><sup>131</sup>I-prohy</td><td>CA4P + <sup>131</sup>I-prohy</td><td><sup>131</sup>I-prohy</td><td>CA4P + <sup>131</sup>I-prohy</td><td><sup>131</sup>I-prohy</td><td>CA4P + <sup>131</sup>I-prohy</td></tr><tr><td>Blood</td><td>4.43 ± 0.14</td><td>4.75 ± 0.65</td><td>0.66 ± 0.08</td><td>0.74 ± 0.03</td><td>0.06 ± 0.01</td><td>0.09 ± 0.02*</td></tr><tr><td>Thyroid</td><td>0.47 ± 0.03</td><td>1.14 ± 0.07**</td><td>0.08 ± 0.02</td><td>0.36 ± 0.02**</td><td>0.12 ± 0.03</td><td>0.25 ± 0.11</td></tr><tr><td>Lung</td><td>2.71 ± 0.23</td><td>2.64 ± 0.23</td><td>1.68 ± 0.16</td><td>1.27 ± 0.40</td><td>0.20 ± 0.04</td><td>0.26 ± 0.08</td></tr><tr><td>Heart</td><td>1.26 ± 0.11</td><td>1.61 ± 0.13*</td><td>0.54 ± 0.16</td><td>0.32 ± 0.02</td><td>0.24 ± 0.07</td><td>0.12 ± 0.02*</td></tr><tr><td>liver</td><td>5.60 ± 0.38</td><td>5.84 ± 0.40</td><td>2.13 ± 0.38</td><td>1.88 ± 0.24</td><td>0.70 ± 0.10</td><td>0.75 ± 0.08</td></tr><tr><td>Spleen</td><td>2.48 ± 0.06</td><td>2.98 ± 0.46</td><td>1.05 ± 0.08</td><td>0.74 ± 0.10*</td><td>0.31 ± 0.01</td><td>0.38 ± 0.05</td></tr><tr><td>Kidney</td><td>2.61 ± 0.29</td><td>2.75 ± 0.09</td><td>1.22 ± 0.13</td><td>1.24 ± 0.19</td><td>0.13 ± 0.01</td><td>0.19 ± 0.02*</td></tr><tr><td>Stomach</td><td>0.74 ± 0.14</td><td>1.14 ± 0.27</td><td>0.44 ± 0.08</td><td>0.47 ± 0.09</td><td>0.07 ± 0.01</td><td>0.14 ± 0.02*</td></tr><tr><td>Muscle</td><td>0.45 ± 0.15</td><td>0.38 ± 0.01</td><td>0.10 ± 0.02</td><td>0.15 ± 0.05</td><td>0.02 ± 0.00</td><td>0.06 ± 0.01**</td></tr><tr><td>Bone</td><td>1.57 ± 0.11</td><td>1.34 ± 0.11</td><td>0.26 ± 0.06</td><td>0.40 ± 0.14</td><td>0.10 ± 0.01</td><td>0.09 ± 0.01</td></tr><tr><td>Small intestine</td><td>2.36 ± 0.24</td><td>2.20 ± 0.40</td><td>0.28 ± 0.15</td><td>0.33 ± 0.03</td><td>0.09 ± 0.01</td><td>0.11 ± 0.03</td></tr><tr><td>Larger intestine</td><td>1.23 ± 0.09</td><td>1.70 ± 0.31</td><td>0.33 ± 0.12</td><td>0.54 ± 0.08</td><td>0.06 ± 0.01</td><td>0.15 ± 0.05*</td></tr><tr><td>Necrotic Tumor</td><td>1.99 ± 0.29</td><td>3.01 ± 0.35*</td><td>2.96 ± 0.34</td><td>3.87 ± 0.38*</td><td>1.45 ± 0.31</td><td>2.14 ± 0.19*</td></tr><tr><td>Viable Tumor</td><td>2.16 ± 0.71</td><td>3.05 ± 0.38</td><td>1.26 ± 0.31</td><td>1.48 ± 0.04</td><td>0.51 ± 0.02</td><td>0.41 ± 0.09</td></tr></table> |
20fb804cd52141adc4677d153e084051659fb73a412344cd642e8a46ee094878.png | simple | <table><tr><td>Age, sex</td><td>NOAC</td><td>Lesion</td><td>Prescription (month)</td><td>BARC</td><td>Other factors</td></tr><tr><td>Upper GI</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 92 F</td><td>D</td><td>Gastric ulcer</td><td>11</td><td>3a</td><td>PPI (-)</td></tr><tr><td> 96 F</td><td>R</td><td>Gastric ulcer</td><td>42</td><td>3a</td><td>PPI (-)</td></tr><tr><td> 63 M</td><td>R</td><td>Duodenal ulcer</td><td>29</td><td>3b</td><td>PPI (-)</td></tr><tr><td> 74 M</td><td>R</td><td>Gastric ulcer</td><td>32</td><td>3a</td><td>PPI (-)</td></tr><tr><td> 83 F</td><td>A</td><td>Gastric ulcer</td><td>16</td><td>3a</td><td>PPI (-)</td></tr><tr><td> 84 M</td><td>A</td><td>Ulcers/o</td><td>12</td><td>3a</td><td>PPI (-), steroid</td></tr><tr><td> 72 M</td><td>A</td><td>Duodenal ulcer</td><td>25</td><td>3b</td><td>PPI (-), operation</td></tr><tr><td>Lower GI</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 78 M</td><td>D</td><td>Ileal erosion</td><td>23</td><td>3a</td><td>DAPT</td></tr><tr><td> 80 M</td><td>D</td><td>Colon diverticulosis</td><td>7</td><td>3a</td><td>-</td></tr><tr><td> 72 F</td><td>R</td><td>Colon vascular ectasia</td><td>8</td><td>3a</td><td>NSAID, steroid</td></tr><tr><td> 75 M</td><td>R</td><td>Post EMR for colon polyp</td><td>24</td><td>3a</td><td>LDA</td></tr><tr><td> 85 F</td><td>A</td><td>Colon diverticulosis</td><td>3</td><td>3b</td><td>NSAID</td></tr></table> |
2ea537b487632c73364b4b66951e4168fe5531d8ffc90f7d9a64d5b5de24002f.png | simple | <table><tr><td>Parameter or measurement</td><td>July</td><td>Aug</td><td>Sept</td><td>Oct</td><td>Nov</td><td>Dec</td></tr><tr><td>OPD attendances</td><td>14,940</td><td>15,354</td><td>10,927</td><td>13,265</td><td>9,561</td><td>10,737</td></tr><tr><td>Presumed malaria</td><td>8,041</td><td>7,733</td><td>5,844</td><td>6,576</td><td>5,430</td><td>5,412</td></tr><tr><td>(%)*</td><td>(40%)</td><td>(41%)</td><td>(40%)</td><td>(37%)</td><td>(42%)</td><td>(40%)</td></tr><tr><td>Anti-malaria prescriptions</td><td>5,143</td><td>5,550</td><td>3,815</td><td>4121</td><td>3,486</td><td>3,814</td></tr><tr><td>RDT-negative treated</td><td>871</td><td>1,056</td><td>787</td><td>828</td><td>585</td><td>534</td></tr><tr><td>% RDT negatives</td><td>35.0</td><td>34.4</td><td>33.9</td><td>29.4</td><td>27.3</td><td>29.0</td></tr><tr><td>treated as malaria(CI)</td><td>(20-50)</td><td>(19-50)</td><td>(23-45)</td><td>(19-40)</td><td>(15-39)</td><td>(19-39)</td></tr><tr><td>Risk ratio^</td><td>0.71[0.53-0.96]</td><td>0.60[0.58-0.63]</td><td>0.64[0.48-0.87]</td><td>0.59[0.42-083]</td><td>0.68[0.50-0.92]</td><td>0.67[0.46-0.97]</td></tr><tr><td>p-value</td><td>0.029</td><td><0.001</td><td>0.008</td><td>0.004</td><td>0.023</td><td>0.05</td></tr></table> |
951052605b29a77e7b49bd93cbc7d7a9dcfb5ef2aae5ee27dae403fee232c2a0.png | simple | <table><tr><td>Order</td><td>Reading</td><td>Location (<i>x</i>, <i>y</i>)</td></tr><tr><td>1</td><td>1</td><td>(1.5, 3.0)</td></tr><tr><td>2</td><td>4</td><td>(3.0, 3.3)</td></tr><tr><td>3</td><td>4</td><td>(2.8, 1.9)</td></tr><tr><td>4</td><td>5</td><td>(2.3, 0.9)</td></tr><tr><td>5</td><td>3</td><td>(4.3, 0.4)</td></tr><tr><td>6</td><td>5</td><td>(5.8, 1.3)</td></tr><tr><td>7</td><td>6</td><td>(5.4, 2.9)</td></tr><tr><td>8</td><td>7</td><td>(4.3, 4.0)</td></tr><tr><td>9</td><td>3</td><td>(2.2, 4.4)</td></tr><tr><td>10</td><td>2</td><td>(3.7, 5.7)</td></tr><tr><td>11</td><td>10</td><td>(6.3, 4.7)</td></tr></table> |
6ba67dac4661284b0adefd1a2f5888f3a7695f12b333cdceb839319794957fcf.png | complex | <table><tr><td> </td><td colspan="2">CMM</td><td colspan="2">SCC</td></tr><tr><td> </td><td>Events/Pyr<sup>1</sup></td><td>OR (95% CI)</td><td>Events/Pyr</td><td>OR (95% CI)</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Female</td><td>2058/173 679</td><td>1.00 ref</td><td>1893/81 108</td><td>1.00 ref</td></tr><tr><td> Male</td><td>1938/115 144</td><td>1.51 (1.41,1.63)</td><td>3719/94 533</td><td>1.90 (1.79,2.01)</td></tr><tr><td>Age<sup>2</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> < 40 years</td><td>80/31 862</td><td>1.00 ref</td><td>19/3020</td><td>1.00 ref</td></tr><tr><td> 40-59 years</td><td>807/106 669</td><td>2.89 (2.29,3.65)</td><td>222//17 362</td><td>2.28 (1.42,3.66)</td></tr><tr><td> ≥ 60 years</td><td>3109/147 183</td><td>6.67 (5.31,8.39)</td><td>5371/155 259</td><td>4.62 (2.93,7.29)</td></tr><tr><td>Residential region<sup>3</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> North</td><td>275/23 927</td><td>1.00 ref</td><td>419/15 325</td><td>1.00 ref</td></tr><tr><td> Mid</td><td>703/54 955</td><td>1.09 (0.95,1.26)</td><td>1124/37 786</td><td>1.09 (0.98,1.23)</td></tr><tr><td> South</td><td>3018/209 941</td><td>1.20 (1.06,1.36)</td><td>4069/122 530</td><td>1.20 (1.08,1.33)</td></tr><tr><td>Calendar period<sup>2</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> < 1965</td><td>6/2959</td><td>1.00 ref</td><td>35/4411</td><td>1.00 ref</td></tr><tr><td> 1965-1974</td><td>71/13 448</td><td>3.01 (1.30,6.98)</td><td>168/10 542</td><td>2.51 (1.73,3.64)</td></tr><tr><td> 1975-1984</td><td>276/34 380</td><td>4.92 (2.15,11.24)</td><td>438/22 580</td><td>3.61 (2.50,5.20)</td></tr><tr><td> 1985-1994</td><td>913/69 763</td><td>7.80 (3.43,17.34)</td><td>1281/40 225</td><td>6.46 (4.52,9.24)</td></tr><tr><td> 1995-2004</td><td>1707/112 983</td><td>8.88 (3.91,20.17)</td><td>2364/64 765</td><td>7.76 (5.44,11.1)</td></tr><tr><td> ≥ 2004</td><td>1023/55 290</td><td>10.52 (4.63,23.9)</td><td>1326/33 118</td><td>8.73 (6.10,12.5)</td></tr><tr><td>Educational level<sup>4</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> ≤ Primary</td><td>63/5193</td><td>1.00 ref</td><td>178/6203</td><td>1.00 ref</td></tr><tr><td> Secondary</td><td>1285/85 407</td><td>0.80 (0.61,1.04)</td><td>2514/82 333</td><td>0.60 (0.50,0.71)</td></tr><tr><td> Some college</td><td>1293/85 733</td><td>0.79 (0.60,1.05)</td><td>1577/46 489</td><td>0.60 (0.50,0.72)</td></tr><tr><td> ≥ College degree</td><td>1355/112 490</td><td>0.80 (0.61,1.05)</td><td>1343/40 616</td><td>0.61 (0.51,0.74)</td></tr><tr><td>Marital status<sup>3</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Not married</td><td>1089/84 671</td><td>1.00 ref</td><td>2161/72 265</td><td>1.00 ref</td></tr><tr><td> Married</td><td>2907/204 152</td><td>1.02 (0.94,1.10)</td><td>3451/103 376</td><td>1.01 (0.95,1.08)</td></tr><tr><td>Parental status<sup>4</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> No children</td><td>881/68 530</td><td>1.00 ref</td><td>1692/56 884</td><td>1.00 ref</td></tr><tr><td> Children</td><td>3115/220 293</td><td>0.91 (0.84,0.99)</td><td>3920/118 757</td><td>0.93 (0.87,0.99)</td></tr><tr><td>Income (annual)<sup>3</sup></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> $ 0<sup>5</sup></td><td>1586/81 524</td><td>1.00 ref</td><td>3982/113 773</td><td>1.00 ref</td></tr><tr><td> $ 80–9 999</td><td>679/57 594</td><td>0.83 (0.75,0.91)</td><td>715/24 518</td><td>0.85 (0.78,0.92)</td></tr><tr><td> $ 10 000–19 999</td><td>514/50 340</td><td>0.68 (0.61,0.75)</td><td>300/12 099</td><td>0.76 (0.67,0.85)</td></tr><tr><td> $ 20 000–39 999</td><td>713/57 131</td><td>0.75 (0.68,0.82)</td><td>334/13 692</td><td>0.65 (0.58,0.74)</td></tr><tr><td> $ ≥ 40 000</td><td>504/42 234</td><td>0.65 (0.58,0.73)</td><td>281/11 559</td><td>0.59 (0.51,0.67)</td></tr></table> |
377241992d1c23fb657313e76ba94ab6e8e0786a42fd34ee475b27bdf90571c2.png | simple | <table><tr><td>New</td><td></td><td></td><td></td><td></td></tr><tr><td>Risk Factor</td><td></td><td>Adjusted Odds Ratio</td><td>95% Confidence Interval</td><td>P-value</td></tr><tr><td>Any family member suffering from hepatitis B & C</td><td>Yes</td><td>14.5</td><td>9.5-22.1</td><td>0.001</td></tr><tr><td></td><td>No</td><td>Reference</td><td></td><td></td></tr><tr><td>Dental extract/filling/scaling</td><td>Yes</td><td>1.9</td><td>1.4-2.7</td><td>0.001</td></tr><tr><td></td><td>No</td><td>Reference</td><td></td><td></td></tr><tr><td>Blood transfusion</td><td>Yes</td><td>2.9</td><td>1.2-7.3</td><td>0.017</td></tr><tr><td></td><td>No</td><td>Reference</td><td></td><td></td></tr><tr><td>History of IV/IM injection/year</td><td>None</td><td>Reference</td><td></td><td></td></tr><tr><td></td><td>< 5/year</td><td>2.1</td><td>1.3-3.4</td><td>0.003</td></tr><tr><td></td><td>≥/year</td><td>5.8</td><td>3.5-9.6</td><td>0.001</td></tr></table> |
79e4858f0b00e0499bac7b357a970266641635c5245049504c9dd6fa3e07ff1e.png | simple | <table><tr><td>Case</td><td>Age</td><td>Gender</td><td>HSCT source</td><td>Underlying disease</td><td>Interval between HSCT and CM analysis (mo)</td><td>Interval between DE onset and CM analysis (mo)</td><td>Interval between HSCT and DE onset (mo)</td><td>DE severity level</td><td>CC</td><td>Clinically affected cGVHD organs</td></tr><tr><td>1</td><td>57</td><td>Male</td><td>PBSC</td><td>ML</td><td>17</td><td>1</td><td>16</td><td>3</td><td>-</td><td>Eye, Skin</td></tr><tr><td>2</td><td>47</td><td>Male</td><td>PBSC</td><td>AML</td><td>19</td><td>6</td><td>13</td><td>4</td><td>+</td><td>Eye, Skin, Mouth, Liver</td></tr><tr><td>3</td><td>50</td><td>Male</td><td>PBSC</td><td>MM</td><td>12</td><td>1</td><td>11</td><td>4</td><td>+</td><td>Eye, Mouth</td></tr><tr><td>4</td><td>47</td><td>Female</td><td>BM</td><td>MM</td><td>43</td><td>1</td><td>42</td><td>4</td><td>+</td><td>Eye, Mouth</td></tr><tr><td>5</td><td>38</td><td>Female</td><td>BM</td><td>AML</td><td>12</td><td>0</td><td>12</td><td>2</td><td>-</td><td>Eye</td></tr><tr><td>6</td><td>57</td><td>Male</td><td>BM</td><td>MDS</td><td>14</td><td>N.A.</td><td>N.A.</td><td>3</td><td>+</td><td>Eye</td></tr><tr><td>7</td><td>51</td><td>Male</td><td>BM</td><td>CML</td><td>120</td><td>48</td><td>72</td><td>2</td><td>-</td><td>Eye</td></tr><tr><td>8</td><td>46</td><td>Female</td><td>PBSC</td><td>MM</td><td>116</td><td>108</td><td>8</td><td>2</td><td>-</td><td>Eye</td></tr><tr><td>9</td><td>55</td><td>Male</td><td>PBSC</td><td>AML</td><td>25</td><td>17</td><td>8</td><td>4</td><td>+</td><td>Eye, Skin</td></tr></table> |
51d1e0351be2b5104afca18b15c8596021e1554ee6a7267fa8cd0923c360e8b5.png | simple | <table><tr><td>SNP rsID</td><td>Marker name</td><td>Amino acid change</td><td>Chromosome</td><td>Cytoband</td><td><i>P</i>-values</td></tr><tr><td>rs4149015</td><td>SLCO1B1 c.-11187G > A</td><td>Promoter</td><td>12</td><td>p12.2</td><td>0.0001</td></tr><tr><td>rs1060253</td><td>SLC7A5 c.<sup>∗</sup>438C > G</td><td>3′UTR</td><td>16</td><td>q24.2</td><td>0.0005</td></tr><tr><td>rs4149117</td><td>SLCO1B3 c.334G > T</td><td>A112S</td><td>12</td><td>p12.2</td><td>0.0021</td></tr><tr><td>rs7311358</td><td>SLCO1B3 c.699A > G</td><td>I233M</td><td>12</td><td>p12.2</td><td>0.0021</td></tr><tr><td>rs2053098</td><td>SLCO1B3 c.1557G > A</td><td>A519A</td><td>12</td><td>p12.2</td><td>0.0021</td></tr><tr><td>rs4149056</td><td>SLCO1B1 c.521T > C</td><td>V174A</td><td>12</td><td>p12.1</td><td>0.0090</td></tr></table> |
ca415ee9abc9f6340d1d9afb67109ffcc68c1affa286b1507528239d651ff769.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Active partitions MIC values (<i>μ</i>g/ml)</td><td colspan="3">Reference antibioticsMIC values (<i>μ</i>g/ml)</td></tr><tr><td>CSBt</td><td>CSEA</td><td>Amox</td><td>Gent</td><td>Vanc</td></tr><tr><td>Gram – bacteria</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Escherichia coli</i> T20A2</td><td>NA</td><td>NA</td><td>S</td><td>R</td><td>R</td></tr><tr><td><i>Pseudomonas aeruginosa </i>T41</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>R</td></tr><tr><td><i>Pseudomonas aeruginosa </i>ATCC9027</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>R</td></tr><tr><td>Gram + bacteria</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>Dermabacter hominis </i>T47A7</td><td>312</td><td>625</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Dermabacter hominis </i>T49B5</td><td>312</td><td>625</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Corynebacterium striatum </i>T40A3</td><td>NA</td><td>NA</td><td>R</td><td>R</td><td>S</td></tr><tr><td><i>Corynebacterium striatum </i>T46C1</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Enterococcus faecalis </i>T37B1</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Enterococcus faecalis </i>T47A16</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Streptococcus agalactiae</i> T53A4</td><td>NA</td><td>NA</td><td>R</td><td>R</td><td>R</td></tr><tr><td><i>Staphylococcus aureus </i>T2510</td><td>312</td><td>625</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T281</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>8143</td><td>312</td><td>625</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>8148</td><td>312</td><td>625</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>8142</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T61</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T21</td><td>312</td><td>625</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T11</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T306</td><td>312</td><td>625</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus aureus </i>T26A4</td><td>625</td><td>625</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus epidermidis </i>T151</td><td>NA</td><td>NA</td><td>R</td><td>R</td><td>S</td></tr><tr><td><i>Staphylococcus epidermidis </i>T19A1</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>R</td></tr><tr><td><i>Staphylococcus capitis </i>T21A3</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus capitis </i>T29A2</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus pettenkoferi </i>T282</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus pettenkoferi </i>T33</td><td>NA</td><td>NA</td><td>R</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus saprophyticus 8237 </i></td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus lugdunensis </i>T36A1</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr><tr><td><i>Staphylococcus lugdunensis </i>T47B2</td><td>NA</td><td>NA</td><td>S</td><td>S</td><td>S</td></tr></table> |
3b8b63fead91e5cba52ea7ed0e1c96a19b17974c25883f8d86772e4e6836e241.png | complex | <table><tr><td rowspan="3">Credit Points(Score)</td><td rowspan="3">Class</td><td colspan="2">Premium Reduction</td><td rowspan="3">Number of LouisianaParishes</td></tr><tr><td>(SFHA)</td><td>Non-SFHA</td></tr><tr><td>4500+</td><td>1</td><td>45%</td><td>10%</td><td>0</td></tr><tr><td>4000–4499</td><td>2</td><td>40%</td><td>10%</td><td>0</td></tr><tr><td>3500–3999</td><td>3</td><td>35%</td><td>10%</td><td>0</td></tr><tr><td>3000–3499</td><td>4</td><td>30%</td><td>10%</td><td>0</td></tr><tr><td>2500–2999</td><td>5</td><td>25%</td><td>10%</td><td>0</td></tr><tr><td>2000–2499</td><td>6</td><td>20%</td><td>10%</td><td>3</td></tr><tr><td>1500–1999</td><td>7</td><td>15%</td><td>5%</td><td>2</td></tr><tr><td>1000–1499</td><td>8</td><td>10%</td><td>5%</td><td>8</td></tr><tr><td>500–999</td><td>9</td><td>5%</td><td>5%</td><td>2</td></tr><tr><td>0–499</td><td>10</td><td>0%</td><td>0%</td><td>1</td></tr></table> |
b8c9a9fd0500534e5754d5d974aa195188c564e22b37a9ee4e0abc67bcdd7ff4.png | complex | <table><tr><td></td><td colspan="2">Rest</td><td colspan="2">ΔActive standing</td><td colspan="2">ΔHandgrip</td></tr><tr><td></td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td><td>T1D</td><td>CON</td></tr><tr><td>Heart rate (bpm)</td><td>59 (12)</td><td>58 (16)</td><td>+20* (13)</td><td>+26* (16)</td><td>+22* (16)<sup>‡</sup></td><td>+27* (21)<sup>†</sup></td></tr><tr><td>Breathing frequency (Hz)</td><td>0.19 (0.12)<sup>‡</sup></td><td>0.20 (0.18)</td><td>+0.03* (0.03)<sup>‡</sup></td><td>0.00 (0.08)</td><td>+0.08* (0.08)<sup>‡</sup></td><td>+0.05*(0.11)</td></tr><tr><td>Blood pressure</td></tr><tr><td>Systolic (mmHg)</td><td>118 (18)</td><td>121 (22)</td><td>+4.4 (11)</td><td>−5.0 (24)</td><td>+40* (20)<sup>§</sup></td><td>+41* (23)</td></tr><tr><td>Diastolic (mmHg)</td><td>66 (8)</td><td>65 (7)</td><td>+11* (9)</td><td>+7.6* (12)</td><td>+26* (16)<sup>§</sup></td><td>+29* (9)</td></tr></table> |
18a1c7ca6bf0124d80b32b1f85155eb2a209e0e85651d8506d644068b51b8ddd.png | complex | <table><tr><td> </td><td colspan="4">Species</td></tr><tr><td>Habitat characteristics</td><td><i>An. arabiensis</i></td><td><i>An. chrysti</i></td><td><i>An. cinereus</i></td><td><i>An. demeilloni</i></td></tr><tr><td>Correlation</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>pH</td><td>−0.2</td><td>0.0</td><td>0.1</td><td>−0.2</td></tr><tr><td>Temperature (<sup>0</sup> C)</td><td>0.3*</td><td>−0.1</td><td>0.2</td><td>−0.3*</td></tr><tr><td>Depth (cm)</td><td>−0.6**</td><td>0.2</td><td>0.0</td><td>0.2</td></tr><tr><td>Differences of means (medians)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Substrate</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Muddy</td><td>1.9 (0.0)**</td><td>52.5(25.8)*</td><td>19.2 (2.3)</td><td>15.8 (14.3)</td></tr><tr><td>Sandy</td><td>61.5 (23.3)</td><td>17.7 (4.1)</td><td>54.1 (12.5)</td><td>16.7 (4.2)</td></tr><tr><td>Turbidity</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Low</td><td>39.5 (2.5)</td><td>31.1 (7.7)</td><td>42.2 (7.5)</td><td>15.9 (5.0)</td></tr><tr><td>Medium</td><td>1.1(1.1)</td><td>40.9(40.9)</td><td>0.0</td><td>23.9 (24.0)</td></tr><tr><td>Surface debris</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Present</td><td>38.0 (2.2)</td><td>32.4 (8.7)</td><td>42.2 (7.5)</td><td>15.0 (5.1)</td></tr><tr><td>Absent</td><td>30.3 (30.3)</td><td>17.7 (17.7)</td><td>0.0</td><td>42.1 (42.1)</td></tr><tr><td>Surface Algae</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Present</td><td>38.6 (2.2)</td><td>32.2 (8.9)</td><td>41.1 (7.4)</td><td>16.7 (7.6)</td></tr><tr><td>Absent</td><td>0.0</td><td>8.6 (8.6)</td><td>2.9 (2.9)</td><td>0.0</td></tr></table> |
dde9b79902f36c4d5dc2bd970b95ed49792142bbb4a379f30e3e627f683e3da6.png | simple | <table><tr><td>Metals</td><td>Cu</td><td>Zn</td><td>As</td><td>Hg</td><td>Pb</td><td>Cd</td><td>Cr</td></tr><tr><td>Cu</td><td>1</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Zn</td><td>–0.256</td><td>1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>As</td><td>0.194</td><td>0.467**</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>Hg</td><td>0.725**</td><td>–0.389**</td><td>0.124</td><td>1</td><td></td><td></td><td></td></tr><tr><td>Pb</td><td>0.658**</td><td>–0.032</td><td>0.306</td><td>0.648**</td><td>1</td><td></td><td></td></tr><tr><td>Cd</td><td>–0.039</td><td>0.491**</td><td>0.511**</td><td>–0.002</td><td>0.148</td><td>1</td><td></td></tr><tr><td>Cr</td><td>0.286</td><td>0.102</td><td>0.233</td><td>0.214</td><td>0.011</td><td>–0.066</td><td>1</td></tr></table> |
5a22fc09115f33cb6458106338199e24f65c6a9c2c0c9ff4c398e04344668c7e.png | complex | <table><tr><td>SNV</td><td>bp</td><td>Conserved Region<i><sup>a</sup></i></td><td><i>P</i>-Value<i><sup>b</sup></i></td><td>Alleles<i><sup>c</sup></i></td><td>MAF<i><sup>d</sup></i></td><td colspan="3">Unaffected</td><td colspan="3">Scoliosis</td><td colspan="4">Kyphoscoliosis</td></tr><tr><td>rs114080324</td><td>2947499</td><td>Yes</td><td>0.116</td><td>G/A</td><td>0.006</td><td>GG</td><td>GG</td><td>GG</td><td>—</td><td>GG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td></tr><tr><td>rs183225473</td><td>3045672</td><td>No</td><td>0.039</td><td>G/C</td><td>0.006</td><td>GG</td><td>GG</td><td>GG</td><td>CG</td><td>GG</td><td>CG</td><td>CG</td><td>CG</td><td>CG</td><td>CG</td></tr><tr><td>rs10068728</td><td>3045983</td><td>Yes</td><td>0.034</td><td>T/G</td><td>0.27</td><td>TT</td><td>TT</td><td>TT</td><td>TG</td><td>TT</td><td>—</td><td>TG</td><td>TG</td><td>TG</td><td>TG</td></tr><tr><td>rs146531224</td><td>3046004</td><td>No</td><td>0.039</td><td>G/A</td><td>0.006</td><td>GG</td><td>GG</td><td>GG</td><td>AG</td><td>GG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td></tr><tr><td>rs117273909</td><td>3182971</td><td>Yes</td><td>0.039</td><td>C/T</td><td>0.005</td><td>CC</td><td>CC</td><td>CC</td><td>CT</td><td>CC</td><td>CT</td><td>CT</td><td>CT</td><td>CT</td><td>CT</td></tr><tr><td>rs111916055</td><td>3187995</td><td>No</td><td>0.034</td><td>A/G</td><td>0.028</td><td>AA</td><td>AA</td><td>AA</td><td>AG</td><td>AA</td><td>—</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td></tr><tr><td>Novel</td><td>3188045</td><td>No</td><td>0.083</td><td>T/G</td><td>NA</td><td>TT</td><td>TT</td><td>TT</td><td>AT</td><td>TT</td><td>—</td><td>AT</td><td>AT</td><td>—</td><td>AT</td></tr><tr><td>rs16871553</td><td>3269602</td><td>No</td><td>0.029</td><td>C/T</td><td>0.109</td><td>TT</td><td>TT</td><td>TT</td><td>CT</td><td>TT</td><td>CT</td><td>CT</td><td>CT</td><td>CT</td><td>—</td></tr><tr><td>rs73733752</td><td>3278780</td><td>No</td><td>0.039</td><td>A/G</td><td>0.03</td><td>AA</td><td>AA</td><td>AA</td><td>AG</td><td>AA</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td><td>AG</td></tr></table> |
5982081deb9bcfee76d554ea6195acfbf0c29def190bcf461ece0a0d53ee3a60.png | complex | <table><tr><td>Variables</td><td colspan="2">All</td><td colspan="2">Physicians</td><td colspan="2">Nurses</td></tr><tr><td> </td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Male</td><td>29.5</td><td>156</td><td>56.6</td><td>103</td><td>15.3</td><td>53</td></tr><tr><td>Female</td><td>70.5</td><td>373</td><td>43.4</td><td>79</td><td>84.7</td><td>294</td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤30</td><td>44.1</td><td>233</td><td>26.9</td><td>49</td><td>53.2</td><td>184</td></tr><tr><td>31 to 40</td><td>31.1</td><td>164</td><td>31.9</td><td>58</td><td>30.6</td><td>106</td></tr><tr><td>>40</td><td>24.8</td><td>131</td><td>41.2</td><td>75</td><td>16.2</td><td>56</td></tr><tr><td>Skin color</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>White</td><td>63.9</td><td>338</td><td>67.6</td><td>123</td><td>62.0</td><td>215</td></tr><tr><td>Others</td><td>36.1</td><td>191</td><td>32.4</td><td>59</td><td>38.0</td><td>132</td></tr><tr><td>Specialization degree in Public or Family Health</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>10.8</td><td>57</td><td>9.3</td><td>17</td><td>11.5</td><td>40</td></tr><tr><td>No</td><td>89.2</td><td>447</td><td>90.7</td><td>165</td><td>88.5</td><td>307</td></tr><tr><td>Time since the last academic degree (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><5</td><td>68.3</td><td>359</td><td>50.8</td><td>92</td><td>77.4</td><td>267</td></tr><tr><td>5 to 10</td><td>15.4</td><td>81</td><td>14.4</td><td>26</td><td>15.9</td><td>55</td></tr><tr><td>>10</td><td>16.3</td><td>86</td><td>34.8</td><td>63</td><td>6.7</td><td>23</td></tr><tr><td>Working hours per week</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><40</td><td>30.6</td><td>161</td><td>45.6</td><td>82</td><td>22.8</td><td>79</td></tr><tr><td>≥40</td><td>69.4</td><td>365</td><td>54.4</td><td>98</td><td>77.2</td><td>267</td></tr><tr><td>Working time at the health care unit (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤1</td><td>37.9</td><td>198</td><td>49.7</td><td>90</td><td>31.7</td><td>108</td></tr><tr><td>2 to 5</td><td>43.9</td><td>229</td><td>32.0</td><td>58</td><td>50.1</td><td>171</td></tr><tr><td>>5</td><td>18.2</td><td>95</td><td>18.3</td><td>33</td><td>18.2</td><td>62</td></tr><tr><td>Patients attending per week</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤80</td><td>54.0</td><td>271</td><td>29.2</td><td>52</td><td>67.6</td><td>219</td></tr><tr><td>80 to 160</td><td>33.7</td><td>169</td><td>50.0</td><td>89</td><td>24.7</td><td>80</td></tr><tr><td>>160</td><td>12.3</td><td>62</td><td>20.8</td><td>37</td><td>7.7</td><td>25</td></tr><tr><td>Total</td><td>100</td><td>529</td><td>100</td><td>182</td><td>100</td><td>347</td></tr></table> |
bcb4197fe4425a99e9c8941d5cf83bb75a4cd88238a70f97061b5345a648fe87.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Cases 2002–2008 (<i>N</i> = 1064)</td><td colspan="5">Cases 2013–2015</td><td rowspan="2"><i>P</i></td></tr><tr><td>Total cases <i>N</i> = 990</td><td>Anterior <i>N</i> = 530</td><td>Intermediate <i>N</i> = 74</td><td>Panuveitis <i>N</i> = 226</td><td>Posterior <i>N</i> = 160</td></tr><tr><td>Median age at presentation years (IQR)</td><td>40 (26–55)</td><td>44 (29–57)*</td><td>45 (32–59)</td><td>26 (15–46)</td><td>45 (30–58)</td><td>42 (29–55)</td><td><0.001</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.300</td></tr><tr><td> Male</td><td>481 (45)</td><td>403 (41)*</td><td>204 (38)</td><td>36 (49)</td><td>93 (41)</td><td>70 (44)</td><td></td></tr><tr><td> Female</td><td>583 (55)</td><td>587 (59)</td><td>326 (62)</td><td>38 (51)</td><td>133 (59)</td><td>90 (56)</td><td></td></tr><tr><td>Site</td><td></td><td></td><td></td><td></td><td></td><td></td><td><0.001</td></tr><tr><td> Unilateral</td><td>825 (78)</td><td>499 (50)*</td><td>364 (69)</td><td>13 (18)</td><td>57 (25)</td><td>65 (41)</td><td></td></tr><tr><td> Bilateral</td><td>239 (22)</td><td>491 (50)</td><td>166 (31)</td><td>61 (82)</td><td>169 (75)</td><td>95 (59)</td><td></td></tr><tr><td>Granulomatous</td><td></td><td></td><td></td><td></td><td></td><td></td><td><0.001</td></tr><tr><td> Yes</td><td>553 (52)</td><td>545 (55)</td><td>312 (59)</td><td>13 (18)</td><td>147 (65)</td><td>73 (46)</td><td></td></tr><tr><td> No</td><td>511 (48)</td><td>445 (45)</td><td>218 (41)</td><td>61 (82)</td><td>79 (35)</td><td>87 (54)</td><td></td></tr><tr><td>Non-Italian ethnicity</td><td>31 (3)</td><td>106 (11)*</td><td>43 (8)</td><td>6 (8)</td><td>44 (19)</td><td>13 (8)</td><td><0.001</td></tr><tr><td>Has a specific diagnosis</td><td>787 (74)</td><td>759 (77)</td><td>404 (76)</td><td>45 (61)</td><td>177 (78)</td><td>133 (84)</td><td>0.002</td></tr><tr><td>Infectious etiology</td><td>257 (24)</td><td>301 (30)*</td><td>173 (43)</td><td>3 (7)</td><td>68 (38)</td><td>57 (43)</td><td><0.001</td></tr><tr><td>Systemic disease</td><td>na</td><td>259 (26)</td><td>114 (21)</td><td>12 (16)</td><td>110 (49)</td><td>23 (14)</td><td><0.001</td></tr></table> |
e82f8b54121f028ee5c98ab3089f8f86e36888b67b4f3640c9909ea7fa881092.png | simple | <table><tr><td></td><td>Total number of patients(n = 376)</td></tr><tr><td>Trials</td><td></td></tr><tr><td> Ludman [27]</td><td>40 (11%)</td></tr><tr><td> Crimi [28]</td><td>76 (20%)</td></tr><tr><td> Garcia-Dorado [30]</td><td>177 (47%)</td></tr><tr><td> White [29]</td><td>83 (22%)</td></tr><tr><td>Randomization</td><td></td></tr><tr><td> Intervention</td><td>191 (51%)</td></tr><tr><td> Placebo</td><td>185 (49%)</td></tr><tr><td>Age</td><td>59 ± 12</td></tr><tr><td>Sex — male</td><td>193 (51%)</td></tr><tr><td>Risk factors</td><td></td></tr><tr><td> Smoking</td><td>221 (59%)</td></tr><tr><td> Hypertension</td><td>166 (44%)</td></tr><tr><td> Dyslipidemia</td><td>117 (31%)</td></tr><tr><td> Diabetes Mellitus</td><td>55 (15%)</td></tr><tr><td> Family history of CAD</td><td>72 (19%)</td></tr><tr><td> Pre-infarct angina</td><td>108 (29%)</td></tr><tr><td>Onset to balloon time/min</td><td>215 ± 97</td></tr><tr><td>Artery involved</td><td></td></tr><tr><td> LAD</td><td>211 (56%)</td></tr><tr><td> RCA</td><td>71 (19%)</td></tr><tr><td> Cx</td><td>94 (25%)</td></tr><tr><td>TIMI flow pre-PPCI</td><td></td></tr><tr><td> 0</td><td>365 (97%)</td></tr><tr><td> 1</td><td>11 (3%)</td></tr><tr><td>Rentrop collateral flow</td><td></td></tr><tr><td> 0</td><td>287 (76%)</td></tr><tr><td> 1</td><td>61 (16%)</td></tr><tr><td> 2</td><td>28 (7%)</td></tr><tr><td>TIMI flow post-PPCI</td><td></td></tr><tr><td> 1</td><td>1 (1%)</td></tr><tr><td> 2</td><td>43 (11%)</td></tr><tr><td> 3</td><td>330 (88%)</td></tr><tr><td>CMR details</td><td></td></tr><tr><td> LVEDV</td><td>154 ± 36</td></tr><tr><td> LVESV</td><td>78 ± 31</td></tr><tr><td> LVEF</td><td>50 ± 11</td></tr><tr><td> MI size/%LV</td><td>22 ± 11</td></tr><tr><td> AAR/%LV</td><td>33 ± 12</td></tr><tr><td> MI size/%AAR</td><td>64 ± 21</td></tr><tr><td> MVO/%</td><td>111 (53%)</td></tr></table> |
f2d05dd2e06a7079357cfb26275ee67c9252feda1fb56f00d24dcfa042262efb.png | simple | <table><tr><td>Probe Set ID</td><td>Gene Title</td><td>Gene Symbol</td><td>FC in tumors</td><td>GO biological function</td></tr><tr><td>99104_at</td><td>adiponectin, C1Q and collagen domain containing</td><td>Adipoq</td><td>-21.75</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>99671_at</td><td>adipsin</td><td>Adn</td><td>-35.98</td><td></td></tr><tr><td>98924_at</td><td>ADP-ribosyltransferase 3</td><td>Art3</td><td>-2.55</td><td></td></tr><tr><td>92537_g_at</td><td>adrenergic receptor, beta 3</td><td>Adrb3</td><td>-2.88</td><td></td></tr><tr><td>102327_at</td><td>amine oxidase, copper containing 3</td><td>Aoc3</td><td>-3.66</td><td>Cell adhesion</td></tr><tr><td>96785_at</td><td>ankyrin repeat domain 47</td><td>Ankrd47</td><td>-2.04</td><td></td></tr><tr><td>104761_at</td><td>anthrax toxin receptor 2</td><td>Antxr2</td><td>-1.60</td><td></td></tr><tr><td>160375_at</td><td>carbonic anhydrase 3</td><td>Car3</td><td>-20.83</td><td></td></tr><tr><td>101539_f_at</td><td>carboxylesterase 3</td><td>Ces3</td><td>-4.06</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>102016_at</td><td>cell death-inducing DFFA-like effector c</td><td>Cidec</td><td>-4.79</td><td></td></tr><tr><td>95415_f_at</td><td>complement component 1, r subcomponent</td><td>C1r</td><td>-2.64</td><td></td></tr><tr><td>92224_at</td><td>C-type lectin domain family 3, member b</td><td>Clec3b</td><td>-5.87</td><td></td></tr><tr><td>96346_at</td><td>cysteine dioxygenase 1, cytosolic</td><td>Cdo1</td><td>-9.76</td><td>Organic acid metabolism</td></tr><tr><td>93996_at</td><td>cytochrome P450, family 2, subfamily e, polypeptide 1</td><td>Cyp2e1</td><td>-3.54</td><td></td></tr><tr><td>96742_at</td><td>dermatopontin</td><td>Dpt</td><td>-5.06</td><td>Cell adhesion</td></tr><tr><td>103031_g_at</td><td>dynamin 1</td><td>Dnm1</td><td>-2.21</td><td></td></tr><tr><td>92535_at</td><td>early B-cell factor 1</td><td>Ebf1</td><td>-1.81</td><td></td></tr><tr><td>100567_at</td><td>fatty acid binding protein 4, adipocyte</td><td>Fabp4</td><td>-2.31</td><td></td></tr><tr><td>92441_at</td><td>fibroblast activation protein</td><td>Fap</td><td>-2.27</td><td></td></tr><tr><td>101991_at</td><td>flavin containing monooxygenase 1</td><td>Fmo1</td><td>-3.20</td><td></td></tr><tr><td>93040_at</td><td>FXYD domain-containing ion transport regulator 1</td><td>Fxyd1</td><td>-2.69</td><td></td></tr><tr><td>93750_at</td><td>gelsolin</td><td>Gsn</td><td>-5.43</td><td></td></tr><tr><td>102373_at</td><td>glutamyl aminopeptidase</td><td>Enpep</td><td>-2.86</td><td></td></tr><tr><td>99108_s_at</td><td>growth hormone receptor</td><td>Ghr</td><td>-1.99</td><td></td></tr><tr><td>92833_at</td><td>histidine ammonia lyase</td><td>Hal</td><td>-2.25</td><td>Organic acid metabolism</td></tr><tr><td>95546_g_at</td><td>insulin-like growth factor 1</td><td>Igf1</td><td>-2.07</td><td></td></tr><tr><td>103904_at</td><td>insulin-like growth factor binding protein 6</td><td>Igfbp6</td><td>-4.34</td><td></td></tr><tr><td>92366_at</td><td>laminin, alpha 2</td><td>Lama2</td><td>-3.25</td><td>Cell adhesion</td></tr><tr><td>103083_at</td><td>lipase, hormone sensitive</td><td>Lipe</td><td>-2.46</td><td>Lipid metabolism</td></tr><tr><td>160083_at/95611_at</td><td>lipoprotein lipase</td><td>Lpl</td><td>-5.18</td><td>Lipid metabolism</td></tr><tr><td>93353_at</td><td>lumican</td><td>Lum</td><td>-9.33</td><td></td></tr><tr><td>97520_s_at</td><td>neuronatin</td><td>Nnat</td><td>-5.92</td><td></td></tr><tr><td>100120_at</td><td>nidogen 1</td><td>Nid1</td><td>-2.19</td><td>Cell adhesion</td></tr><tr><td>160481_at</td><td>phosphoenolpyruvate carboxykinase 1, cytosolic</td><td>Pck1</td><td>-2.61</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>102763_at</td><td>plasma membrane associated protein, S3-12</td><td>MGI:1929709</td><td>-8.13</td><td></td></tr><tr><td>93826_at</td><td>protein phosphatase 2, regulatory subunit B (B56), alpha isoform</td><td>Ppp2r5a</td><td>-1.43</td><td></td></tr><tr><td>102366_at</td><td>resistin</td><td>Retn</td><td>-10.89</td><td></td></tr><tr><td>97835_at</td><td>retinoic acid receptor responder (tazarotene induced) 2</td><td>Rarres2</td><td>-6.19</td><td></td></tr><tr><td>96047_at</td><td>retinol binding protein 4, plasma</td><td>Rbp4</td><td>-4.08</td><td></td></tr><tr><td>104445_at</td><td>RIKEN cDNA 4631408O11 gene</td><td>4631408O11Rik</td><td>-5.20</td><td></td></tr><tr><td>101861_at</td><td>sarcoglycan, epsilon</td><td>Sgce</td><td>-1.62</td><td></td></tr><tr><td>102707_f_at</td><td>serine (or cysteine) peptidase inhibitor, clade A, member 3C</td><td>Serpina3c</td><td>-1.94</td><td></td></tr><tr><td>97429_at</td><td>SNF related kinase</td><td>Snrk</td><td>-1.65</td><td></td></tr><tr><td>92582_at</td><td>solute carrier family 1 (neutral amino acid transporter), member 5</td><td>Slc1a5</td><td>-1.94</td><td></td></tr><tr><td>160320_at</td><td>sorbin and SH3 domain containing 1</td><td>Sorbs1</td><td>-2.74</td><td>Cell adhesion</td></tr><tr><td>94056_at/94057_g_at</td><td>stearoyl-Coenzyme A desaturase 1</td><td>Scd1</td><td>-2.76</td><td>Lipid metabolism, Organic acid metabolism</td></tr><tr><td>103087_at</td><td>sulfotransferase family 1A, phenol-preferring, member 1</td><td>Sult1a1</td><td>-1.68</td><td>Lipid metabolism</td></tr><tr><td>103568_at</td><td>sushi-repeat-containing protein</td><td>Srpx</td><td>-2.84</td><td></td></tr><tr><td>104280_at</td><td>synuclein, gamma</td><td>Sncg</td><td>-4.63</td><td></td></tr><tr><td>102916_s_at/161907_s_at</td><td>tenascin XB</td><td>Tnxb</td><td>-4.73</td><td>Cell adhesion</td></tr><tr><td>160547_s_at</td><td>thioredoxin interacting protein</td><td>Txnip</td><td>-2.83</td><td></td></tr><tr><td>99052_at</td><td>zinc finger homeobox 1a</td><td>Zfhx1a</td><td>-1.63</td><td></td></tr></table> |
b6e4c81ea6e03fc587bcb58222ac3a7261d30088eb5439719d564160e518a972.png | complex | <table><tr><td rowspan="2">Studies groups</td><td rowspan="2">No of reports</td><td rowspan="2">Relative risk (95% CI)</td><td colspan="2">Heterogeneity</td><td rowspan="2"><i>P</i> for test</td></tr><tr><td><i>P</i> value</td><td>I<sup>2</sup> (%)</td></tr><tr><td>Total</td><td>22</td><td>0.86 (0.78–0.92)</td><td>0.001</td><td>54.9%</td><td>0.002</td></tr><tr><td>Tumour subtype</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Glioma</td><td>16</td><td>0.94 (0.88–0.99)</td><td>0.003</td><td>57.0%</td><td>0.042</td></tr><tr><td>Meningioma</td><td>1</td><td>0.97 (0.64–1.47)</td><td></td><td></td><td>0.880</td></tr><tr><td>Glioblastoma</td><td>5</td><td>0.78 (0.63–0.95)</td><td>0.883</td><td>0.0%</td><td>0.014</td></tr><tr><td>Study design</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Case–control</td><td>19</td><td>0.88 (0.78–0.95)</td><td>0.000</td><td>60.3%</td><td>< 0.001</td></tr><tr><td>Cohort</td><td>3</td><td>0.93 (0.85–0.98)</td><td>0.686</td><td>0.0%</td><td>0.013</td></tr><tr><td>No of participants</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≥ 10 000</td><td>17</td><td>0.87 (0.78–0.91)</td><td>0.000</td><td>66.0%</td><td>0.003</td></tr><tr><td>< 10 000</td><td>5</td><td>0.91 (0.85–0.97)</td><td>0.155</td><td>46.3%</td><td>< 0.001</td></tr><tr><td>No of cases</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≥ 1000</td><td>11</td><td>0.83 (0.73–0.94)</td><td>0.162</td><td>24.2%</td><td>0.005</td></tr><tr><td>< 1000</td><td>11</td><td>0.90 (0.81–0.98)</td><td>0.001</td><td>65.8%</td><td>0.013</td></tr><tr><td>Study quality</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Score ≥ 7</td><td>20</td><td>0.88 (0.78–0.98)</td><td>0.002</td><td>54.6%</td><td>0.007</td></tr><tr><td>Score < 7</td><td>2</td><td>0.74 (0.67–0.82)</td><td>0.448</td><td>0.0%</td><td>< 0.001</td></tr></table> |
d3524095a414c8bf66c9861e1e4061971265f68a7942d56cdb754f678778563f.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">STX</td><td colspan="2">Okadaic Acid, DTXS</td><td colspan="2">Domoic Acid</td></tr><tr><td colspan="2">(PSP)</td><td colspan="2">(DSP)</td><td colspan="2">(ASP)</td></tr><tr><td>Sampling Date</td><td>Multi SPR</td><td>ELISA</td><td>Multi SPR</td><td>ELISA</td><td>Multi SPR</td><td>ELISA</td></tr><tr><td>24.07.2011</td><td>−</td><td>−</td><td>−</td><td>−</td><td>−</td><td>−</td></tr><tr><td>08.08.2011</td><td>−</td><td>−</td><td>−</td><td>+</td><td>−</td><td>−</td></tr><tr><td>22.08.2011</td><td>−</td><td>+</td><td>−</td><td>+</td><td>−</td><td>−</td></tr><tr><td>04.10.2011</td><td>−</td><td>+</td><td>−</td><td>+</td><td>−</td><td>+</td></tr><tr><td>20.10.2011</td><td>+</td><td>+</td><td>−</td><td>+</td><td>−</td><td>+</td></tr></table> |
c690df1c0a2de9b761fc728c24fb97a20b350de386e2ce3e2fa042a7f37bbdbd.png | simple | <table><tr><td>Vitamin D Status</td><td>IOM</td><td>Endocrine Society</td></tr><tr><td>Deficiency</td><td><12 ng/mL (30 nmol/L)</td><td><20 ng/mL (50 nmol/L)</td></tr><tr><td>Insufficiency</td><td>12–20 ng/mL (30–50 nmol/L)</td><td>21–29 ng/mL (52.5–72.5 nmol/L)</td></tr><tr><td>Sufficiency</td><td>>20 ng/mL (50 nmol/L)</td><td>>30 ng/mL (75 nmol/L)</td></tr><tr><td>Toxicity</td><td>>50 ng/mL (125 nmol/L)</td><td>>150 ng/mL (375 nmol/L)</td></tr></table> |
0005e8fe1b3ba14982336837219f285921af7c152cfc81ac88bcf52809299279.png | complex | <table><tr><td rowspan="2">Clinical characteristics</td><td colspan="3">Genotype</td><td rowspan="2">OR (95% C.I.)<sup>*</sup></td><td rowspan="2"><i>P</i></td><td colspan="2">Allele</td><td rowspan="2">OR (95% C.I.)</td><td rowspan="2"><i>P</i></td></tr><tr><td>TT</td><td>CT</td><td>CC</td><td>T</td><td>C</td></tr><tr><td>Tumor size</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <5 cm</td><td>106</td><td>83</td><td>18</td><td>1.00 (Reference)</td><td></td><td>295</td><td>119</td><td>1.00 (Reference)</td><td></td></tr><tr><td> 5-10 cm</td><td>104</td><td>79</td><td>21</td><td>0.99 (0.66-1.49)</td><td>0.963</td><td>287</td><td>121</td><td>0.96 (0.70-1.31)</td><td>0.773</td></tr><tr><td> ≥10 cm</td><td>30</td><td>21</td><td>5</td><td>1.10 (0.58-2.07)</td><td>0.753</td><td>81</td><td>31</td><td>1.05 (0.65-1.73)</td><td>0.825</td></tr><tr><td>Tumor stages</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 1a</td><td>26</td><td>32</td><td>6</td><td>1.00 (Reference)</td><td></td><td>84</td><td>44</td><td>1.00 (Reference)</td><td></td></tr><tr><td> 1b</td><td>20</td><td>14</td><td>2</td><td>1.83 (0.74-4.54)</td><td>0.150</td><td>54</td><td>18</td><td>1.57 (0.79-3.16)</td><td>0.169</td></tr><tr><td> 2a</td><td>23</td><td>14</td><td>4</td><td>1.87 (0.78-4.47)</td><td>0.121</td><td>60</td><td>22</td><td>1.43 (0.74-2.75)</td><td>0.251</td></tr><tr><td> 2b</td><td>34</td><td>33</td><td>5</td><td>1.31 (0.63-2.74)</td><td>0.439</td><td>101</td><td>43</td><td>1.23 (0.72-2.12)</td><td>0.426</td></tr><tr><td> 3a</td><td>30</td><td>19</td><td>6</td><td>1.75 (0.79-3.88)</td><td>0.129</td><td>79</td><td>31</td><td>1.33 (0.74-2.41)</td><td>0.305</td></tr><tr><td> 3b</td><td>37</td><td>24</td><td>10</td><td>1.59 (0.76-3.34)</td><td>0.182</td><td>98</td><td>44</td><td>1.17 (0.68-2.00)</td><td>0.553</td></tr><tr><td> 3c</td><td>59</td><td>41</td><td>9</td><td>1.72 (0.88-3.38)</td><td>0.086</td><td>159</td><td>59</td><td>1.41 (0.86-2.32)</td><td>0.151</td></tr><tr><td> 4</td><td>85</td><td>80</td><td>15</td><td>1.31 (0.73-2.43)</td><td>0.363</td><td>250</td><td>110</td><td>1.19 (0.76-1.87)</td><td>0.425</td></tr><tr><td>Degree of differentiation</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>215</td><td>179</td><td>39</td><td>1.00 (Reference)</td><td></td><td>609</td><td>257</td><td>1.00 (Reference)</td><td></td></tr><tr><td> Medium</td><td>94</td><td>74</td><td>17</td><td>1.05 (0.73-1.50)</td><td>0.792</td><td>262</td><td>108</td><td>1.02 (0.73-1.35)</td><td>0.863</td></tr><tr><td> High</td><td>5</td><td>4</td><td>1</td><td></td><td></td><td>14</td><td>6</td><td></td><td></td></tr><tr><td>Lymphatic metastasis</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 0</td><td>69</td><td>69</td><td>13</td><td>1.00 (Reference)</td><td></td><td>207</td><td>95</td><td>1.00 (Reference)</td><td></td></tr><tr><td> 1</td><td>55</td><td>39</td><td>9</td><td>1.36 (0.80-2.32)</td><td>0.228</td><td>149</td><td>57</td><td>1.20 (0.80-1.81)</td><td>0.360</td></tr><tr><td> 2</td><td>60</td><td>39</td><td>10</td><td>1.46 (0.86-2.46)</td><td>0.137</td><td>159</td><td>59</td><td>1.24 (0.83-1.85)</td><td>0.279</td></tr><tr><td> 3a</td><td>67</td><td>46</td><td>11</td><td>1.40 (0.80-2.42)</td><td>0.169</td><td>180</td><td>68</td><td>1.21 (0.83-1.79)</td><td>0.302</td></tr><tr><td> 3b</td><td>26</td><td>26</td><td>9</td><td>0.88 (0.46-1.68)</td><td>0.684</td><td>78</td><td>44</td><td>0.81 (0.51-1.44)</td><td>0.360</td></tr></table> |
17b1f72a0aaf3b5443238bbe6389324f00c02a04168dae224efeea18fac6c7fc.png | simple | <table><tr><td></td><td>All</td><td>Gadopentetat (Magnevist)</td><td>Gadoteracid (Dotarem)</td><td>Gadobenat (Multihance)</td><td>Gadotbutrol (Gadovist)</td><td>Gadoteridol (Prohance)</td><td>Gadodiamide (Omniscan)</td><td>Other*</td></tr><tr><td>All</td><td>45</td><td>20</td><td>5</td><td>3</td><td>9</td><td>2</td><td>3</td><td>3</td></tr><tr><td>Age (years, mean)</td><td>51.9</td><td>50.8</td><td>48.2</td><td>68.0</td><td>49.6</td><td>38.0</td><td>62.0</td><td>56.0</td></tr><tr><td>SD</td><td>16.5</td><td>18.1</td><td>19.0</td><td>4.6</td><td>16.1</td><td>14.1</td><td>4.0</td><td>13.0</td></tr><tr><td>Median</td><td>54.0</td><td>54.0</td><td>53.0</td><td>69.0</td><td>42.0</td><td>38.0</td><td>62.0</td><td>56.0</td></tr><tr><td>Range</td><td>16-77</td><td>16-74</td><td>25-69</td><td>63-72</td><td>31-77</td><td>28-48</td><td>58-66</td><td>43-69</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male (%)</td><td>62.2</td><td>75.0</td><td>60.0</td><td>33.3</td><td>44.4</td><td>50</td><td>66.7</td><td>66.7</td></tr><tr><td>Contrast dose (ml, mean)</td><td>20.6</td><td>22.5</td><td>24.8</td><td>13.7</td><td>13.2</td><td>14.3</td><td>20.0</td><td>23.0</td></tr><tr><td>SD</td><td>8.3</td><td>7.5</td><td>8.8</td><td>3.2</td><td>4.3</td><td>17.0</td><td>8.0</td><td>11.5</td></tr><tr><td>Median</td><td>20.0</td><td>22.5</td><td>28.0</td><td>15.0</td><td>14.0</td><td>28.0</td><td>20.0</td><td>27.0</td></tr><tr><td>Range</td><td>7-40</td><td>7-36</td><td>10-32</td><td>10-16</td><td>10-21</td><td>16-40</td><td>12-28</td><td>10-32</td></tr><tr><td>Category of reaction</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mild</td><td>43</td><td>18</td><td>5</td><td>3</td><td>9</td><td>2</td><td>3</td><td>3</td></tr><tr><td>Moderate</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Severe</td><td>2</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Symptoms</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Allergic shock</td><td>2</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Cardiac arrest</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Dyspnoea</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Bronchospasm</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Nausea</td><td>10</td><td>3</td><td>0</td><td>1</td><td>2</td><td>0</td><td>2</td><td>2</td></tr><tr><td>Vomiting</td><td>6</td><td>3</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>1</td></tr><tr><td>Warmth</td><td>3</td><td>2</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Headache</td><td>2</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Dizziness</td><td>5</td><td>3</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>0</td></tr><tr><td>Altered taste</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Itching</td><td>9</td><td>2</td><td>1</td><td>1</td><td>4</td><td>1</td><td>0</td><td>0</td></tr><tr><td>Flushing</td><td>10</td><td>2</td><td>1</td><td>1</td><td>6</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Chills</td><td>2</td><td>1</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Sweats</td><td>3</td><td>2</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Rash/Hives</td><td>15</td><td>4</td><td>4</td><td>2</td><td>2</td><td>2</td><td>1</td><td>0</td></tr><tr><td>Swelling of eye/face</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Anxiety</td><td>6</td><td>6</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Treatment</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Observation</td><td>30</td><td>14</td><td>3</td><td>2</td><td>5</td><td>1</td><td>2</td><td>3</td></tr><tr><td>Antihistamines</td><td>18</td><td>4</td><td>3</td><td>2</td><td>4</td><td>1</td><td>3</td><td>1</td></tr><tr><td>Steroids</td><td>14</td><td>3</td><td>1</td><td>2</td><td>3</td><td>2</td><td>3</td><td>0</td></tr><tr><td>Adrenaline</td><td>2</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></table> |
8d887243df80d5643d8019667a0786dd3949bc7cbab9983b461c8a6849c937d2.png | simple | <table><tr><td>Gene Symbol</td><td>Primary Sertoli cell signal (normalized)</td><td>hS1 cell signal (normalized)</td><td>Log<sub>2</sub> FC (hS1 vs. Control)</td></tr><tr><td><i>GDNF</i></td><td>2.7378905</td><td>4.001061</td><td>1.2631705</td></tr><tr><td><i>BMP4</i></td><td>7.070616</td><td>10.179245</td><td>3.108629</td></tr><tr><td><i>BMP6</i></td><td>2.913889</td><td>6.345799</td><td>3.43191</td></tr><tr><td><i>LIF</i></td><td>8.199608</td><td>9.237209</td><td>1.037601</td></tr><tr><td><i>FGF2</i></td><td>7.0719824</td><td>10.704937</td><td>3.6329546</td></tr><tr><td><i>SOX9</i></td><td>1.4255941</td><td>1.4340813</td><td>0.0084872</td></tr><tr><td><i>WT1</i></td><td>2.236927</td><td>2.0595062</td><td>–0.1774208</td></tr><tr><td><i>GATA4</i></td><td>10.017227</td><td>9.562365</td><td>–0.4548</td></tr><tr><td><i>GATA1</i></td><td>2.7784665</td><td>2.5375004</td><td>–0.2409661</td></tr></table> |
80c1018a35777848dcec6a97e478080b02d70e5f0deb7272d62b6fa5449364f4.png | complex | <table><tr><td><i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub>(M<sup>−1</sup> s<sup>−1</sup>)</td><td>C3</td><td>C5</td><td>C8</td><td>iso C5</td><td> </td></tr><tr><td>GEO179</td><td>0.9±0.02</td><td>100±15</td><td>1,200±130</td><td>41±1.2</td><td>Discovered</td></tr><tr><td>GEO195</td><td>2.4±0.1</td><td>200±14</td><td>1,400±160</td><td>8±0.3</td><td>Discovered</td></tr><tr><td>GEO175</td><td>0.51±0.02</td><td>48±3.7</td><td>17,000±2,700</td><td>3.3±0.2</td><td>Discovered</td></tr><tr><td>GEO175 L376T_T240S</td><td>0.27±0.02</td><td>30±7.2</td><td>1,100±160</td><td>1.6±0.1</td><td>Designed</td></tr><tr><td>1OVM</td><td>32±0.5</td><td>2,100±420</td><td>80,000±4,300</td><td>1,300±130</td><td>Native</td></tr><tr><td>2VBI</td><td>5,700±1,400</td><td>52±1.8</td><td>14±0.8</td><td>1.8±0.1</td><td>Native</td></tr><tr><td>3FZN</td><td>5.4±0.1</td><td>1,700±110</td><td>350±30</td><td>110±10</td><td>Native</td></tr><tr><td>1ZPD</td><td>8,200±545</td><td>140±5.6</td><td>19±2</td><td>0.33±0.01</td><td>Native</td></tr><tr><td>1OZF</td><td>n.d.</td><td>0.53±0.04</td><td>n.d.</td><td>17±0.9</td><td>Native</td></tr><tr><td>Native KIVD</td><td>42±0.6</td><td>9,500±470</td><td>32,000±5,500</td><td>14,000±1,100</td><td>Native</td></tr><tr><td>KIVD_VLV</td><td>0.71±0.07</td><td>1.3±0.2</td><td>2,800±860</td><td>0.24±0.02</td><td>Designed</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="6"><i>k</i><sub><i>cat</i></sub> (s<sup>−1</sup>)</td></tr><tr><td> GEO179</td><td>n.d.</td><td>0.47±0.03</td><td>0.32±0.01</td><td>0.39±0.01</td><td> </td></tr><tr><td> GEO195</td><td>n.d.</td><td>0.49±0.01</td><td>0.56±0.02</td><td>0.072±0.001</td><td> </td></tr><tr><td> GEO175</td><td>n.d.</td><td>0.97±0.04</td><td>10.1±0.6</td><td>n.d.</td><td> </td></tr><tr><td> GEO175 L376T_T240S</td><td>n.d.</td><td>0.28±0.04</td><td>3.4±0.2</td><td>n.d.</td><td> </td></tr><tr><td> 1OVM</td><td>0.2±0.01</td><td>1±0.1</td><td>1.7±0.1</td><td>7.8±0.4</td><td> </td></tr><tr><td> 2VBI</td><td>25±2.6</td><td>n.d.</td><td>0.051±0.01</td><td>0.025±0.001</td><td> </td></tr><tr><td> 3FZN</td><td>n.d.</td><td>4.7±0.1</td><td>1.3±0.1</td><td>0.52±0.02</td><td> </td></tr><tr><td> 1ZPD</td><td>46.7±1.4</td><td>0.95±0.02</td><td>0.021±0.001</td><td>n.d.</td><td> </td></tr><tr><td> 1OZF</td><td>n.d.</td><td>n.d.</td><td>n.d.</td><td>0.03±0.001</td><td> </td></tr><tr><td> Native KIVD</td><td>n.d.</td><td>14.3±0.2</td><td>7±0.3</td><td>61±2.1</td><td> </td></tr><tr><td> KIVD_VLV</td><td>n.d.</td><td>0.013±0.001</td><td>0.5±0.03</td><td>n.d.</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="6"><i>K</i><sub>M</sub> (mM)</td></tr><tr><td> GEO179</td><td>n.d.</td><td>4.6±0.6</td><td>0.27±0.03</td><td>9.4±0.2</td><td> </td></tr><tr><td> GEO195</td><td>n.d.</td><td>2.5±0.2</td><td>0.4±0.04</td><td>9.1±0.3</td><td> </td></tr><tr><td> GEO175</td><td>n.d.</td><td>20±1.3</td><td>0.58±0.09</td><td>n.d.</td><td> </td></tr><tr><td> GEO175 L376T_T240S</td><td>n.d.</td><td>10±2</td><td>3.1±0.4</td><td>n.d.</td><td> </td></tr><tr><td> 1OVM</td><td>7.5±0.1</td><td>0.5±0.1</td><td>0.021±0.001</td><td>6.1±0.6</td><td> </td></tr><tr><td> 2VBI</td><td>4.3±1.0</td><td>n.d.</td><td>3.6±0.2</td><td>14±0.5</td><td> </td></tr><tr><td> 3FZN</td><td>n.d.</td><td>2.7±0.2</td><td>3.8±0.3</td><td>4.9±0.3</td><td> </td></tr><tr><td> 1ZPD</td><td>5.7±0.3</td><td>7.1±0.3</td><td>1.2±0.1</td><td>n.d.</td><td> </td></tr><tr><td> 1OZF</td><td>n.d.</td><td>n.d.</td><td>n.d.</td><td>1.8±0.1</td><td> </td></tr><tr><td> Native KIVD</td><td>n.d.</td><td>1.5±0.1</td><td>0.21±0.04</td><td>4.5±0.3</td><td> </td></tr><tr><td> KIVD_VLV</td><td>n.d.</td><td>10±1</td><td>0.18±0.05</td><td>n.d.</td><td> </td></tr></table> |
d6dc032ecde98e1ba479e9ef8d89585ecbf6573e53fed1f76a12ca71d6c3b769.png | simple | <table><tr><td>No</td><td>Expression system</td><td>SAK Productivity [mg/L<sub>broth</sub>]</td><td>Cultivation system</td><td>Volume [L]</td><td>SAK - glycosylation [Yes/No]</td><td>Reference</td></tr><tr><td>1</td><td><i>E. coli</i></td><td>> 50</td><td>(not defined)</td><td>2.7</td><td>No</td><td>[8]</td></tr><tr><td>2</td><td><i>E. coli</i></td><td>> 175</td><td>Fermenter</td><td>10-15</td><td>No</td><td>[19]</td></tr><tr><td>3a</td><td><i>B. subtilis</i></td><td>140</td><td>Shake flask</td><td>0.25</td><td>No</td><td>[20]</td></tr><tr><td>3b</td><td><i>B. subtilis</i></td><td>337</td><td>Fermenter</td><td>2</td><td>No</td><td>[20]</td></tr><tr><td>4a</td><td><i>P.pastoris</i></td><td>110</td><td>Fermenter</td><td>< 5</td><td>Partially yes</td><td>[13]</td></tr><tr><td>4b</td><td><i>E. coli</i></td><td>300-400</td><td>Shake flask</td><td>0.1</td><td>No</td><td>[13]</td></tr><tr><td>5</td><td><i>E. coli</i></td><td>2800</td><td>Fermenter</td><td>2</td><td>No</td><td>[21]</td></tr><tr><td>6</td><td><i>P.pastoris</i></td><td>~ 1000</td><td>Shake flask (w/o -tunicamycin)</td><td>0.05</td><td>Yes</td><td>[17]</td></tr><tr><td>7</td><td><i>P.pastoris</i></td><td> </td><td>Shake flask (w - tunicamycin)</td><td>0.05</td><td>No</td><td>[17]</td></tr><tr><td>8</td><td><i>H. polymorpha</i></td><td>~ 1100</td><td>Fermenter</td><td>80</td><td>No</td><td>-</td></tr></table> |
487fd8d72e9b0d583e0681ede7dad21030730e1f945c1862fa7523e21d5a17e3.png | simple | <table><tr><td>Length of training (months)</td><td>Total hours of training</td><td>Year</td></tr><tr><td>22</td><td>2996</td><td>1989</td></tr><tr><td>23</td><td>3672</td><td>1996</td></tr><tr><td>19.5</td><td>2719</td><td>2001</td></tr><tr><td>23</td><td>3341</td><td>2007</td></tr></table> |
0ea6c21d871a1d07268885ed36dfe8fb8524491e51fb35f98d2eab05dbe77333.png | complex | <table><tr><td>Provinces</td><td colspan="5">No. of samples</td></tr><tr><td></td><td>Bovine</td><td>Ovine</td><td>Caprine</td><td>Buffalo</td><td>Camel</td></tr><tr><td>Tehran</td><td>274</td><td>100</td><td>53</td><td>165</td><td>33</td></tr><tr><td>Isfahan</td><td>188</td><td>76</td><td>148</td><td>70</td><td>81</td></tr><tr><td>Kerman</td><td>83</td><td>152</td><td>102</td><td>25</td><td>70</td></tr><tr><td>Khorasan</td><td>75</td><td>197</td><td>139</td><td>112</td><td>30</td></tr><tr><td>Total</td><td>620</td><td>525</td><td>442</td><td>372</td><td>214</td></tr></table> |
12e64697310f3a65cf9256c1f7d4a4db86941baf72334fef358bf4f15df42570.png | simple | <table><tr><td>Number of strain/strain code</td><td>Species</td><td>Biofilm</td><td>Cefoxitin resistance</td></tr><tr><td>65/ MSSE 65</td><td><i>S.epidermidis</i></td><td>black (+)</td><td>S</td></tr><tr><td>62/ MRSE 62</td><td><i>S.epidermidis</i></td><td>black (+)</td><td>R</td></tr><tr><td>93/ MSSH 93</td><td><i>S.haemolyticus</i></td><td>bordeaux (−)</td><td>S</td></tr><tr><td>89/MRSH 89</td><td><i>S.haemolyticus</i></td><td>bordeaux (−)</td><td>R</td></tr><tr><td>ATCC 12493</td><td><i>S. aureus</i></td><td>very black (+)</td><td>R</td></tr></table> |
504565b2e9f9b8aa441dd6dba7621f70efdafd06a61609cca9cf3a5722415cde.png | simple | <table><tr><td>Country</td><td>Seroprevalence of HCV in general population [1, 63] (%)</td><td>Seroprevalence<sup>a</sup> of HCV in HIV patients (%)</td></tr><tr><td>Argentina</td><td>1.9</td><td>29.9</td></tr><tr><td>Brazil</td><td>1.4</td><td>18.9</td></tr><tr><td>Chile</td><td>0.8</td><td>2.6</td></tr><tr><td>Colombia</td><td>1.0</td><td>0.8</td></tr><tr><td>Cuba</td><td>1.8</td><td>12.9</td></tr><tr><td>Mexico</td><td>1.0</td><td>12.1</td></tr><tr><td>Peru</td><td>1.0</td><td>4.3</td></tr><tr><td>Puerto Rico</td><td>6.3</td><td>5.2</td></tr><tr><td>Venezuela</td><td>0.9</td><td>0.7</td></tr></table> |
5bb678d39f5d5c3dd1d4637096d0a5902645b7b5b6580a5f2c370b50714a936c.png | simple | <table><tr><td>Variable</td><td>AQP4(−) NEBLs patients (n=16)</td><td>AQP4(+) NEBLs patients (n=37)</td><td>P values</td></tr><tr><td>Serum analysis</td><td> </td><td> </td><td> </td></tr><tr><td> CRP (mg/l)</td><td>1.81 ± 0.65</td><td>3.01 ± 1.01</td><td>0.371</td></tr><tr><td> ESR (mm/H)</td><td>17.19 ± 2.22</td><td>15.24 ± 12.24</td><td>0.57</td></tr><tr><td> C3 (g/l)</td><td>1.16 ± 0.20</td><td>1.14 ± 0.30</td><td>0.838</td></tr><tr><td> C4 (g/l)</td><td>0.29 ± 0.16</td><td>0.22 ± 0.07</td><td>0.772</td></tr><tr><td> CH50 (U/ml)</td><td>49.50 ± 10.30</td><td>44.43 ± 11.52</td><td>0.136</td></tr></table> |
50325c499138132b3cdcb62e4edd12647ee74afb576479bc35b8648d30b5e553.png | complex | <table><tr><td>Person Characteristics</td><td>SfW N = 314</td><td>Control N = 59</td><td><i>P-</i>Values</td></tr><tr><td>Female patients, n (%)</td><td>180 (57.3)</td><td>30 (50.8)</td><td><i>0.3574</i></td></tr><tr><td>Age<sup>a</sup>, yrs, (± SD)</td><td>41.2 (± 11.97)</td><td>39.9 (± 12.55)</td><td><i>0.4532</i></td></tr><tr><td>Weight<sup>a</sup>, kg, (± SD)</td><td>93.5 (± 20.88)</td><td>87.6 (± 18.53)</td><td><i>0.0437*</i></td></tr><tr><td>Height<sup>a</sup>, cm, (± SD)</td><td>171.6 (± 9.43)</td><td>171.8 (± 9.35)</td><td><i>0.8765</i></td></tr><tr><td>BMI<sup>a</sup>, kg/m<sup>2</sup>, (± SD)</td><td>31.7 (± 6.48)</td><td>29.6 (± 5.33)</td><td><i>0.0173*</i></td></tr><tr><td>Waist circumference<sup>a</sup>, cm, (± SD)</td><td>107.5(± 18.52)</td><td>105.9 (± 18.90)</td><td><i>0.5544</i></td></tr><tr><td>Waist circumference Sensitivity analysis<sup>a</sup>, cm (± SD)</td><td>106.4 (± 16.37)</td><td>103.5(± 13.89)</td><td><i>0.2115</i></td></tr><tr><td>15D total score <sup>a</sup>, (± SD)</td><td>0.814 (± 0.12)</td><td>0.857(± 0.09)</td><td><i>0.0085*</i></td></tr><tr><td>SWN total score <sup>a</sup>, (± SD)</td><td>80.5 (± 15.97</td><td>87.9 (± 18.35)</td><td><i>0.0016*</i></td></tr><tr><td colspan="4">Clinical Characteristics</td></tr><tr><td>Psychiatric Diagnosis</td><td></td><td></td><td><i>0.0627</i></td></tr><tr><td>Schizophrenia n (%)</td><td>163 (51.9)</td><td>40 (67.8)</td><td></td></tr><tr><td>Bipolar Disorder n (%)</td><td>28 (8.9)</td><td>5 (8.5)</td><td></td></tr><tr><td>Other n (%)</td><td>123 (39.2)</td><td>14 (23.7)</td><td></td></tr><tr><td>Time since diagnosis<sup>a, b</sup>, yrs, (± SD)</td><td>9.47 (9.68)</td><td>11.36 (12.27)</td><td><i>0.1911</i></td></tr><tr><td>CGI-S total score<sup>a</sup>, (± SD)</td><td>4.1 (± 0.99)</td><td>3.4 (± 1.59)</td><td><i>< 0.0001</i></td></tr><tr><td colspan="4">Psychotropic medication</td></tr><tr><td>Atypical antipsychotics n (%) <sup>c</sup></td><td>203 (64.6)</td><td>46 (78.0)</td><td></td></tr><tr><td>Antidepressants n (%)</td><td>124 (39.5)</td><td>12 (20.3)</td><td></td></tr><tr><td>Typical Antipsychotics n (%)</td><td>70 (22.3)</td><td>14 (23.7)</td><td></td></tr></table> |
62c42963ac3d31cd4d5eed53cad2a6643903139c580af982dc5f807249e891d3.png | complex | <table><tr><td></td><td colspan="2">Group</td></tr><tr><td></td><td>STZ + DMH</td><td>STZ + DMH + MET</td></tr><tr><td><i>N</i></td><td>13</td><td>15</td></tr><tr><td>Tumor-bearing rats</td><td>11</td><td>9</td></tr><tr><td>Tumor incidence (%)</td><td>84.62</td><td>60.00</td></tr><tr><td>Number of tumors</td><td>40</td><td>20</td></tr><tr><td>Average tumor number</td><td>3.1 ± 0.45</td><td>1.3 ± 0.37*</td></tr><tr><td>Average tumor number of tumor-bearing rats</td><td>3.6 ± 0.28</td><td>2.2 ± 0.36*</td></tr><tr><td>Volume of tumors (mm<sup>3</sup>)</td><td>94.8 ± 19.77</td><td>30.9 ± 8.19*</td></tr><tr><td>Inhibition of colorectal tumor (%)</td><td></td><td>29.08</td></tr></table> |
b38c61fb9c95b436f1d5b6462cc34db2b630074edc8139f5f90f0b0f445b6076.png | simple | <table><tr><td>Study design</td><td>Study</td><td>Comment</td></tr><tr><td>Survey</td><td>National TB epidemiological survey 2002<sup>17</sup></td><td>45% (121/272) of patients having interrupted or suspended treatment due to financial difficulty</td></tr><tr><td></td><td>Zhang 2007<sup>12</sup></td><td>9% of households with TB suspects (2308) or patients defaulted due to financial burden</td></tr><tr><td></td><td>Xu 2009<sup>20</sup></td><td>16% (13/82) of non-adherence patients interrupted treatment because of high medical costs of the treatment</td></tr><tr><td></td><td>Ai 2010<sup>22</sup></td><td>2% of patients who interrupted treatment (43) because of financial difficulty</td></tr><tr><td>Cohort</td><td>Jackson 2006<sup>11</sup></td><td>3% (5/159) was too poor to begin treatment</td></tr><tr><td></td><td>Sun 2007<sup>23</sup></td><td>Patients who were charged high medical cost were more likely to interrupt treatment than patients having lower medical costs</td></tr></table> |
d5f31047919c3397268b1b8677b6c1a282d8141ba6e1492c2ec2541bda4d8540.png | simple | <table><tr><td></td><td>Control</td><td>NASH</td><td>HFD</td><td>HFr</td></tr><tr><td>Liver weight (g)</td><td>18.9 ± 3.4<sup>#</sup></td><td>32.7 ± 7.9*<sup>†‡</sup></td><td>16.5 ± 2.5<sup># ‡</sup></td><td>23.1 ± 4.4<sup>#†</sup></td></tr><tr><td>Fasting plasma glucose (mM)<sup>b</sup></td><td>6.4 ± 0.2<sup>#†‡</sup></td><td>7.2 ± 0.2*</td><td>7.5 ± 0.1*</td><td>7.16 ± 0.2*</td></tr><tr><td>Fasting plasma insulin (pM)<sup>b</sup></td><td>560.6 ± 79.5</td><td>486.7 ± 93.7</td><td>603.0 ± 43.7</td><td>695.8 ± 83.7</td></tr><tr><td>Plasma β-hydroxybutyrate (μmol/L)</td><td>38.4 ± 4.2<sup>†</sup></td><td>64.0 ± 5.3<sup>†</sup></td><td>115.4 ± 16.8*<sup>#‡</sup></td><td>38.4 ± 2.8<sup>†</sup></td></tr><tr><td>Plasma leptin (ng/mL)</td><td>3283.3 ± 1035.2<sup>†</sup></td><td>3803.0 ± 1341.1<sup>†</sup></td><td>9366.6 ± 2052.8*<sup>#‡</sup></td><td>2638.0 ± 808.5<sup>†</sup></td></tr><tr><td>Plasma TG (mmol/L)</td><td>1.6 ± 0.2<sup>‡</sup></td><td>1.7 ± 0.1<sup>‡</sup></td><td>1.5 ± 0.1<sup>‡</sup></td><td>3.9 ± 0.5*<sup>#†</sup></td></tr><tr><td>Plasma FFA (mmol/L)</td><td>0.3 ± 0.1</td><td>0.4 ± 0.03</td><td>0.4 ± 0.02</td><td>0.3 ± 0.02</td></tr><tr><td>Plasma Cholesterol (mmol/L)</td><td>2.1 ± 0.1</td><td>2.5 ± 0.1</td><td>2.1 ± 0.1</td><td>2.3 ± 0.2</td></tr><tr><td>Plasma HDL-C (mmol/L)</td><td>1.3 ± 0.1</td><td>1.0 ± 0.1</td><td>1.3 ± 0.1</td><td>1.1 ± 0.1</td></tr><tr><td>Jejunal MCP-1 (ng/mL)<sup>a</sup></td><td>45.3 [36.3; 55.3]</td><td>58.1 [48.5; 69.6]</td><td>49.5 [40.1; 60.5]</td><td>56.4 [48.1; 65.5]</td></tr><tr><td>Jejunal TNF-α (ng/mL)<sup>a</sup></td><td>179.9 [129.3; 247.7]</td><td>87.6 [61.7; 125.5]</td><td>171.1 [76.1; 384.6]</td><td>213.2 [112.4; 404.3]</td></tr><tr><td>Adipose tissue MCP-1 (ng/mL)<sup>a</sup></td><td>14.8 [13.4; 16.5]</td><td>14.1 [11.9; 16.8]<sup>‡</sup></td><td>14.2 [11.3; 17.7]<sup>‡</sup></td><td>25.6 [15.2; 42.6]<sup>#†</sup></td></tr><tr><td>Adipose tissue TNF-α (ng/mL)<sup>a</sup></td><td>15.4 [14.4; 16.4]</td><td>16.1 [14.3; 18.2]</td><td>15.4 [13.6; 18.2]</td><td>16.2 [14.6; 18.0]</td></tr></table> |
1ae8376e039296ca0b09ebeefa8fa8bee8d07940507c66f7f03e5054d94fea75.png | simple | <table><tr><td>Study</td><td>Year published</td><td>n</td><td>MC/SC</td><td>Patients</td><td>EN/PN</td><td>Gln adm</td><td>Daily gln dose</td><td>Length of treatment*</td><td>Treatment benefit</td></tr><tr><td>Andrews [53]</td><td>2011</td><td>502</td><td>MC</td><td>General ICU</td><td>EN+PN</td><td>iv</td><td>10-20 g</td><td>5 (1-10)</td><td>None</td></tr><tr><td>Beale [29]</td><td>2008</td><td>55</td><td>SC</td><td>General ICU</td><td>EN</td><td>enteral</td><td>40 g</td><td><10</td><td>Morbidity</td></tr><tr><td>Conejero [46]</td><td>2002</td><td>84</td><td>MC</td><td>General ICU</td><td>EN</td><td>enteral</td><td>35 g</td><td>10 (7-25)</td><td>Morbidity</td></tr><tr><td>Garrel [47]</td><td>2003</td><td>41</td><td>SC</td><td>Burns</td><td>EN</td><td>enteral</td><td>26 g</td><td>30 ± 17</td><td>Mortality</td></tr><tr><td>Goeters [14]</td><td>2002</td><td>95</td><td>MC</td><td>General ICU</td><td>EN+PN</td><td>iv</td><td>0.2 g/kg</td><td>17 ± 11</td><td>Mortality</td></tr><tr><td>Griffiths [15]</td><td>1997</td><td>84</td><td>SC</td><td>General ICU</td><td>PN</td><td>iv</td><td>25 g</td><td>6 (2-91)</td><td>Mortality</td></tr><tr><td>Hall [48]</td><td>2003</td><td>363</td><td>SC</td><td>General ICU</td><td>EN</td><td>enteral</td><td>11-27 g</td><td>10 (6-16)</td><td>None</td></tr><tr><td>Houdijk [30]</td><td>1998</td><td>72</td><td>SC</td><td>Trauma</td><td>EN</td><td>enteral</td><td>27 g</td><td>12 ± 6</td><td>Morbidity</td></tr><tr><td>Jones [49]</td><td>1999</td><td>50</td><td>SC</td><td>General ICU</td><td>EN</td><td>enteral</td><td>18 (11-21) g</td><td>11 (3-47)</td><td>Morbidity</td></tr><tr><td>Wernerman [17]</td><td>2011</td><td>284</td><td>MC</td><td>General ICU</td><td>EN+PN</td><td>iv</td><td>0.28 g/kg</td><td>12 (4-47)</td><td>Mortality</td></tr><tr><td>Zhou [50]</td><td>2003</td><td>40</td><td>SC</td><td>Burns</td><td>EN</td><td>enteral</td><td>0.35 g/kg</td><td>12</td><td>Morbidity</td></tr></table> |
19d7a9281d88859755a67da31df6038783db4ad8ab1144623a664343f5eadfb8.png | complex | <table><tr><td></td><td colspan="4">Timing of initial post-discharge outpatient follow up</td></tr><tr><td></td><td>Casesn</td><td>≤3 daysn (%)</td><td>>3 daysn (%)</td><td>p-value</td></tr><tr><td colspan="5">Low-risk*</td></tr><tr><td> Short-stay†</td><td>34</td><td>22 (65)</td><td>12 (35)</td><td rowspan="2">0.29</td></tr><tr><td> Longer-stay</td><td>44</td><td>22 (50)</td><td>22 (50)</td></tr><tr><td colspan="5">Higher-risk</td></tr><tr><td> Short-stay</td><td>21</td><td>17 (81)</td><td>4 (19)</td><td rowspan="2">0.04</td></tr><tr><td> Longer-stay</td><td>74</td><td>39 (53)</td><td>35 (47)</td></tr></table> |
a8b95d60eb82d7ccf08b2be4b8c64e1c3eed8fda81ab5c4dae491aff5e281ac8.png | simple | <table><tr><td>Nomenclature</td><td>Amino acids</td><td>Chromosome</td><td>Intracellular localization</td></tr><tr><td>Zm2G012631_T01</td><td>699</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G112165_T01</td><td>698</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G069651_T01</td><td>699</td><td>II</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm5G833699_T01</td><td>714</td><td>V</td><td>Nucleus and mitochondrial matrix space</td></tr><tr><td>Zm2G141931_T01</td><td>804</td><td>II</td><td>Endoplasmic reticulum and vacuole</td></tr><tr><td>Zm2G141931_T03</td><td>710</td><td>II</td><td>Endoplasmic reticulum and vacuole</td></tr><tr><td>Zm2G399073_T02</td><td>1001</td><td>II</td><td>Endoplasmic reticulum</td></tr><tr><td>Zm2G399073_T03</td><td>808</td><td>II</td><td>Endoplasmic reticulum</td></tr><tr><td>Zm2G141931_T04</td><td>667</td><td>II</td><td>Endoplasmic reticulum</td></tr><tr><td>Zm2G002220_T01</td><td>793</td><td>II</td><td>Chloroplast stroma and chloroplast thylakoid membrane</td></tr><tr><td>Zm5G813217_T01</td><td>758</td><td>V</td><td>Nucleus and chloroplast stroma</td></tr><tr><td>Zm5G813217_T03</td><td>708</td><td>V</td><td>Nucleus and mitochondrial matrix space</td></tr></table> |
8154aa3fed550650fbbc16c8bf1092f584e16afada77c098ad1ef73a2896fdf4.png | complex | <table><tr><td>Clinical and laboratory parameters</td><td></td><td colspan="5">Pharmacokinetic parameters <sup>1,2</sup>(number of data points)</td></tr><tr><td></td><td><i>K</i><sub>β</sub></td><td><i>T</i><sub>1/2β</sub></td><td>MRT<sub>iv</sub></td><td>CL<sub>CEF</sub></td><td><i>V</i><sub><i>β</i></sub></td><td><i>V</i><sub>SS</sub></td></tr><tr><td>Weight</td><td>0.08</td><td>-0.05</td><td>-0.04</td><td>-0.34</td><td>-0.42**</td><td>-0.47**</td></tr><tr><td></td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td></tr><tr><td>Age</td><td>-0.65**</td><td>0.58*</td><td>0.61*</td><td>-0.75**</td><td><i>-0.50**</i></td><td>-0.34</td></tr><tr><td></td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td><i>(28)</i></td><td>(28)</td></tr><tr><td>Proteins</td><td>0.52*</td><td>-0.27</td><td>-0.28</td><td>0.24</td><td>-0.13</td><td>-0.29</td></tr><tr><td></td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td></tr><tr><td>Albumin</td><td><i>0.63*</i></td><td>-0.31</td><td>-0.32</td><td>0.21</td><td>-0.27</td><td>-0.43**</td></tr><tr><td></td><td><i>(26)</i></td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td><td>(26)</td></tr><tr><td>Hemoglobin</td><td>0.07</td><td>0.06</td><td>0.07</td><td>-0.42**</td><td><i>-0.58**</i></td><td><i>-0.59**</i></td></tr><tr><td></td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td><i>(28)</i></td><td><i>(28)</i></td></tr><tr><td>Na<sup>+</sup></td><td>-0.11</td><td>0.01</td><td>-0.01</td><td>0.17</td><td>0.38</td><td>0.38</td></tr><tr><td></td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td><td>(28)</td></tr><tr><td>Creatinine</td><td>-0.78**</td><td>0.91*</td><td>0.91*</td><td>-0.69**</td><td>-0.31</td><td>-0.19</td></tr><tr><td></td><td>(27)</td><td>(27)</td><td>(27)</td><td>(27)</td><td>(27)</td><td>(27)</td></tr><tr><td>CL<sub>Cr</sub></td><td><i>0.79*</i></td><td><i>-0.81**</i></td><td><i>-0.82**</i></td><td><i>0.88*</i></td><td>0.51*</td><td>0.35</td></tr><tr><td></td><td><i>(27)</i></td><td><i>(27)</i></td><td><i>(27)</i></td><td><i>(27)</i></td><td>(27)</td><td>(27)</td></tr><tr><td>pCO<sub>2</sub></td><td>0.28</td><td>-0.41</td><td>-0.42**</td><td>0.03</td><td>-0.14</td><td>-0.20</td></tr><tr><td></td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td></tr><tr><td>HCO<sub>3</sub></td><td>0.33</td><td>-0.42**</td><td>-0.41</td><td>-0.05</td><td>-0.27</td><td>-0.33</td></tr><tr><td></td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td><td>(23)</td></tr><tr><td>Cefepime dose (mg/kg)</td><td>0.19</td><td>-0.17</td><td>-0.17</td><td><i>0.57*</i></td><td>0.51*</td><td>0.53*</td></tr><tr><td></td><td>(28)</td><td>(28)</td><td>(28)</td><td><i>(28)</i></td><td>(28)</td><td>(28)</td></tr></table> |
ea306aada0d37430acfbce0dd525b17bdd8e2447ba9ce114721230f55d970746.png | complex | <table><tr><td rowspan="3">Age, years</td><td rowspan="3"><i>N</i></td><td colspan="7">Point prevalence of SRH</td></tr><tr><td>Fine(excellent, very good,or good)</td><td>Excellent</td><td>Very good</td><td>Good</td><td>Fair</td><td>Poor</td><td>Invalid response</td></tr><tr><td colspan="9">Men</td></tr><tr><td>20–29</td><td>51</td><td>92%</td><td>33%</td><td>12%</td><td>47%</td><td>6%</td><td>0%</td><td>2%</td></tr><tr><td>30–39</td><td>106</td><td>88%</td><td>25%</td><td>21%</td><td>42%</td><td>8%</td><td>1%</td><td>4%</td></tr><tr><td>40–49</td><td>122</td><td>89%</td><td>28%</td><td>16%</td><td>45%</td><td>9%</td><td>0%</td><td>2%</td></tr><tr><td>50–59</td><td>189</td><td>79%</td><td>14%</td><td>15%</td><td>50%</td><td>10%</td><td>2%</td><td>9%</td></tr><tr><td>60–69</td><td>354</td><td>69%</td><td>12%</td><td>15%</td><td>42%</td><td>12%</td><td>1%</td><td>18%</td></tr><tr><td>70–79</td><td>264</td><td>60%</td><td>10%</td><td>8%</td><td>42%</td><td>14%</td><td>2%</td><td>23%</td></tr><tr><td>≥80</td><td>92</td><td>59%</td><td>10%</td><td>11%</td><td>38%</td><td>13%</td><td>2%</td><td>26%</td></tr><tr><td>Total</td><td>1,178</td><td>72%</td><td>15%</td><td>14%</td><td>44%</td><td>11%</td><td>1%</td><td>15%</td></tr><tr><td colspan="9">Women</td></tr><tr><td>20–29</td><td>62</td><td>77%</td><td>24%</td><td>15%</td><td>39%</td><td>13%</td><td>3%</td><td>6%</td></tr><tr><td>30–39</td><td>224</td><td>85%</td><td>23%</td><td>24%</td><td>39%</td><td>8%</td><td>2%</td><td>5%</td></tr><tr><td>40–49</td><td>179</td><td>81%</td><td>15%</td><td>21%</td><td>45%</td><td>12%</td><td>1%</td><td>7%</td></tr><tr><td>50–59</td><td>267</td><td>79%</td><td>12%</td><td>17%</td><td>50%</td><td>10%</td><td>1%</td><td>10%</td></tr><tr><td>60–69</td><td>407</td><td>65%</td><td>11%</td><td>11%</td><td>43%</td><td>13%</td><td>2%</td><td>21%</td></tr><tr><td>70–79</td><td>315</td><td>56%</td><td>7%</td><td>11%</td><td>38%</td><td>14%</td><td>3%</td><td>26%</td></tr><tr><td>≥80</td><td>101</td><td>58%</td><td>3%</td><td>14%</td><td>42%</td><td>15%</td><td>2%</td><td>25%</td></tr><tr><td>Total</td><td>1,555</td><td>70%</td><td>12%</td><td>15%</td><td>43%</td><td>12%</td><td>2%</td><td>16%</td></tr></table> |
4e21ccfa28d26fa705d00a0a306d1969d17f05015f9011af27c5f9d4d05b7c40.png | complex | <table><tr><td>Compartment</td><td colspan="6">Local<sup>**</sup></td><td colspan="6">Distant<sup>**</sup></td></tr><tr><td></td><td>sp<sup>†</sup></td><td>sh<sup>†</sup>°</td><td>cb</td><td>ais</td><td>?</td><td>n (∑)</td><td>sp<sup>†</sup></td><td>sh<sup>†</sup>°</td><td>cb<sup>^</sup></td><td>ais</td><td>?</td><td>n (∑)</td></tr><tr><td>Abs. N°</td><td>22</td><td>47</td><td>0</td><td>0</td><td>5</td><td>74</td><td>15</td><td>56</td><td>3</td><td>0</td><td>5</td><td>79</td></tr><tr><td>%</td><td>29.7</td><td>63.5</td><td>0.0</td><td>0.0</td><td>6.8</td><td>(100)</td><td>19.0</td><td>70.9</td><td>3.8</td><td>0.0</td><td>6.3</td><td>(100)</td></tr></table> |
137472339b0bcf8d560835e52dada0873874413d04b41a1c34bf1a5caba8d888.png | simple | <table><tr><td>cDNA</td><td>No. of isolates</td><td>Characteristics</td></tr><tr><td>NIK</td><td>58</td><td>N terminal deletion</td></tr><tr><td>CD30</td><td>3</td><td>Full length</td></tr><tr><td>LT-βR</td><td>2</td><td>Cytoplasmic region</td></tr><tr><td>RIP2</td><td>1</td><td>Full length</td></tr></table> |
7d1aa2f1cf12662900dfcf304eb5657e365b2965c88cd580a13a0441e98ee509.png | complex | <table><tr><td></td><td colspan="3">Cardiac syncope vs non-cardiac syncope<i>n =</i> 142</td><td colspan="3">Cardiac syncope vs chest pain control group<i>n =</i> 147</td></tr><tr><td>Patient characteristics</td><td>Cardiac syncope<i>n = 49</i></td><td>Non-cardiacsyncope<i>n = 93</i></td><td><i>P</i>-value</td><td>Cardiac syncope<i>n = 49</i></td><td>Chest paincontrol group<i>n = 98</i></td><td><i>P</i>-value</td></tr><tr><td>Age, <i>years</i></td><td>60 ± 13</td><td>54 ± 12</td><td>0.002</td><td>60 ± 13</td><td>60 ± 12</td><td>0.810</td></tr><tr><td>Male gender</td><td>32 (65)</td><td>57 (61)</td><td>0.716</td><td>32 (65)</td><td>64 (65)</td><td>>0.999</td></tr><tr><td>BMI, <i>kg/m</i><sup>2</sup></td><td>26 ± 3</td><td>26 ± 4</td><td>0.365</td><td>26 ± 3</td><td>27 ± 4</td><td>0.116</td></tr><tr><td>Systolic Blood Pressure, <i>mm Hg</i></td><td>143 ± 20</td><td>140 ± 21</td><td>0.349</td><td>143 ± 20</td><td>144 ± 16</td><td>0.990</td></tr><tr><td>Diastolic Blood Pressure, <i>mm Hg</i></td><td>81 ± 13</td><td>83 ± 13</td><td>0.396</td><td>81 ± 13</td><td>78 ± 9</td><td>0.140</td></tr><tr><td>Active smoking</td><td>19 (39)</td><td>27 (29)</td><td>0.256</td><td>19 (39)</td><td>38 (39)</td><td>>0.999</td></tr><tr><td>Diabetes mellitus II</td><td>3 (6)</td><td>4 (4)</td><td>0.693</td><td>3 (6)</td><td>5 (5)</td><td>>0.999</td></tr><tr><td>Family history of CAD</td><td>16 (33)</td><td>43 (46)</td><td>0.152</td><td>16 (33)</td><td>27 (28)</td><td>0.566</td></tr><tr><td>PROCAM risk score</td><td>9 (4–21)<sup>a</sup></td><td>7 (2–16)<sup>b</sup></td><td>0.131</td><td>9 (4–21)<sup>a</sup></td><td>8 (3–16)</td><td>0.280</td></tr></table> |
bf2f11c3fe8a0aaa0082fa482305f537d13f90574faf8f4e13c4870afba8d816.png | simple | <table><tr><td>Sample</td><td>pH</td><td>Temp (°C)</td><td>Conductivity (μS cm<sup>−1</sup>)</td><td>dO<sub>2</sub> (%)</td><td>TSS (mg L<sup>−1</sup>)</td><td>PO<sub>4</sub> (μM)</td><td>NH<sub>4</sub> (μM)</td><td>NO<sub>2</sub> + NO<sub>3</sub> (μM)</td><td>Partic P (μM)</td><td>Rainfall (mm)</td><td>V rich</td></tr><tr><td>6-3_0830</td><td>7.19</td><td>21.4</td><td>479.2</td><td>23.5</td><td>125.1</td><td>0.29</td><td>13.58</td><td><i>BDL</i></td><td>0.40</td><td>0</td><td>12</td></tr><tr><td>6-3_1330</td><td>6.60</td><td>26.2</td><td>122.4</td><td>58.0</td><td>88.4</td><td>1.05</td><td>5.43</td><td>11.2</td><td>3.39</td><td>28.4</td><td>6</td></tr><tr><td>6-4_0930</td><td>6.76</td><td>21.8</td><td>127.3</td><td>45.0</td><td>55.0</td><td>1.57</td><td>5.62</td><td>10.5</td><td>2.26</td><td>5.6</td><td>4</td></tr><tr><td>6-4_1700</td><td>6.50</td><td>23.5</td><td>136.7</td><td>30.1</td><td>45.5</td><td>1.86</td><td>6.13</td><td>5.48</td><td>2.11</td><td>0</td><td>6</td></tr><tr><td>6-5_0930</td><td>6.65</td><td>20.9</td><td>143.9</td><td>26.6</td><td>44.0</td><td>1.86</td><td>7.12</td><td>6.65</td><td>1.93</td><td>0</td><td>7</td></tr><tr><td>6-5_1800</td><td>6.70</td><td>21.9</td><td>154.1</td><td>19.2</td><td>43.3</td><td>2.05</td><td>7.19</td><td>7.76</td><td>1.95</td><td>0</td><td>7</td></tr><tr><td>6-6_0940</td><td>6.74</td><td>20.9</td><td>168.1</td><td>33.1</td><td>29.1</td><td>1.52</td><td>6.39</td><td>4.76</td><td>1.73</td><td>0</td><td>13</td></tr><tr><td>6-6_1500</td><td>6.40</td><td>22.7</td><td>173.9</td><td>33.7</td><td>30.4</td><td>1.52</td><td>5.73</td><td>4.32</td><td>1.90</td><td>0</td><td>14</td></tr><tr><td>6-7_0930</td><td>6.10</td><td>21.9</td><td>109.8</td><td>77.0</td><td>23.6</td><td>9.04</td><td>3.71</td><td>5.60</td><td>1.83</td><td>36.6</td><td>15</td></tr><tr><td>6-7_1500</td><td>6.24</td><td>20.9</td><td>87.9</td><td>83.2</td><td>144.4</td><td>3.86</td><td>5.03</td><td>19.0</td><td>3.58</td><td>34.5</td><td>6</td></tr><tr><td>6-8_1300</td><td>6.40</td><td>24.0</td><td>105.7</td><td>48.2</td><td>213.1</td><td>7.38</td><td>3.67</td><td>8.31</td><td>6.96</td><td>61.2</td><td>7</td></tr><tr><td>6-9_1500</td><td>6.27</td><td>27.1</td><td>96.7</td><td>31.4</td><td>86.5</td><td>4.90</td><td>1.80</td><td>6.20</td><td>2.77</td><td>0</td><td>6</td></tr><tr><td>6-10_0930</td><td>6.53</td><td>23.5</td><td>101.5</td><td>25.0</td><td>198.9</td><td>5.00</td><td>4.29</td><td>4.27</td><td>7.13</td><td>0</td><td>11</td></tr><tr><td>6-11_0920</td><td>6.04</td><td>22.9</td><td>124.1</td><td>23.0</td><td>70.8</td><td>4.62</td><td>1.91</td><td>5.98</td><td>2.82</td><td>40.4</td><td>6</td></tr><tr><td>6-11_1500</td><td>5.98</td><td>27.5</td><td>130.3</td><td>28.0</td><td>90.3</td><td>4.90</td><td>2.20</td><td>2.49</td><td>3.67</td><td>0</td><td>6</td></tr><tr><td>6-12_0930</td><td>6.10</td><td>21.8</td><td>132.0</td><td>17.8</td><td>92.7</td><td>3.71</td><td>1.84</td><td>2.88</td><td>3.29</td><td>0</td><td>6</td></tr><tr><td>6-12_1430</td><td>6.54</td><td>26.2</td><td>136.2</td><td>33.4</td><td>73.3</td><td>3.52</td><td>BDL</td><td>2.27</td><td>3.98</td><td>0</td><td>8</td></tr><tr><td>6-13_0930</td><td>6.47</td><td>22.4</td><td>142.1</td><td>28.6</td><td>166.0</td><td>2.81</td><td>3.89</td><td>1.77</td><td>6.38</td><td>0</td><td>8</td></tr><tr><td>6-13_1520</td><td>6.50</td><td>34.0</td><td>152.9</td><td>38.0</td><td>124.5</td><td>1.38</td><td>BDL</td><td>0.06</td><td>7.00</td><td>0</td><td>10</td></tr><tr><td>6-14_0920</td><td>6.82</td><td>18.2</td><td>177.1</td><td>28.0</td><td>86.2</td><td>2.62</td><td>2.42</td><td>0.06</td><td>3.98</td><td>11.4</td><td>7</td></tr><tr><td>6-14_1500</td><td>6.72</td><td>21.0</td><td>178.9</td><td>32.1</td><td>64.8</td><td>3.33</td><td>2.31</td><td>1.11</td><td>3.26</td><td>0</td><td>ND</td></tr><tr><td>7-16_1010</td><td>6.17</td><td>24.4</td><td>127.2</td><td>28.6</td><td>63.7</td><td>3.5</td><td>2.5</td><td>5.5</td><td>2.60</td><td>0</td><td>ND</td></tr><tr><td>7-16_1330</td><td>6.08</td><td>26.4</td><td>127.5</td><td>31.2</td><td>58.6</td><td>2.9</td><td>2.8</td><td>5.0</td><td>2.70</td><td>0</td><td>ND</td></tr><tr><td>7-17_1010</td><td>6.09</td><td>24.6</td><td>162.6</td><td>34.2</td><td>43.3</td><td>3.7</td><td>1.1</td><td>3.7</td><td>4.29</td><td>0</td><td>ND</td></tr><tr><td>7-17_1330</td><td>6.02</td><td>28.7</td><td>156.2</td><td>52.4</td><td>68.0</td><td>2.5</td><td>2.1</td><td>3.1</td><td>4.15</td><td>0</td><td>ND</td></tr><tr><td>7-18_1010</td><td>6.61</td><td>24.5</td><td>211</td><td>48.0</td><td>68.0</td><td>6.2</td><td>5.1</td><td>2.5</td><td>7.08</td><td>0</td><td>7</td></tr><tr><td>7-18_1330</td><td>5.33</td><td>26.8</td><td>198.6</td><td>48.0</td><td>41.4</td><td>2.0</td><td>0.7</td><td>2.2</td><td>3.43</td><td>0</td><td>7</td></tr><tr><td>7-19_1010</td><td>5.80</td><td>23.1</td><td>302.3</td><td>32.0</td><td>52.0</td><td>2.1</td><td>2.0</td><td>1.2</td><td>6.07</td><td>0</td><td>8</td></tr><tr><td>7-19_1330</td><td>5.08</td><td>24.9</td><td>294.2</td><td>ND</td><td>53.4</td><td>1.2</td><td>1.5</td><td>1.7</td><td>3.52</td><td>0</td><td>6</td></tr></table> |
c29f8f2d0b4975bc2e587d1c2f1367f1ca658e1f5391c45d9cd80a6f0f104b68.png | complex | <table><tr><td>Main mindfulness instruction</td><td>General guidance points</td><td>Contemplative movement</td><td>Mindful movement</td></tr><tr><td>Awareness of sensations</td><td>Bodily sensations as objects for the attention (sensations related to autonomic response, skeletal and muscular aspects, pressure, tactile and visceral, proprioception, kinematics)</td><td>√</td><td>√</td></tr><tr><td rowspan="2">Awareness of the present moment (PM)</td><td>PM attributes of body, movement sensations, and breath</td><td>Implicit</td><td rowspan="2">√</td></tr><tr><td>PM attribute of mental experience, e.g., emphasis on staying with the present moment (not getting lost in past or future thinking)</td><td>Not usually</td></tr><tr><td>Awareness of attention</td><td>Deliberate awareness of the ways in which to move, shift, narrow, and widen the focus of attention to aspects of body and movement. Commentary on the quality of the attention (vivid, dull, agitated, stable, striving)</td><td>Not usually</td><td>√</td></tr><tr><td>Awareness of mind-wandering</td><td>Acknowledgment and suggested management of mind-wandering</td><td>Not usually</td><td>√</td></tr><tr><td>Awareness of intention (on purpose)</td><td>Purposeful, deliberate engagement with the intention to move the body, pay attention, be present, mindful</td><td>Can be (e.g., Tai Chi, Feldenkrais, continuum movement)</td><td>√</td></tr><tr><td>Awareness of non-judgment</td><td>A deliberate attitude of acceptance and gentleness to mental and physical phenomena. For example, psychological responses to learning new movements (frustration, elation, irritation, pride)</td><td>Implicit and in relation to the physical body rather than the mind</td><td>√</td></tr></table> |
8daaa9901c5060289bcf1f6bff7996da46e946d2b0c480e13bb5e98a491b220f.png | complex | <table><tr><td>Markers</td><td colspan="3">Markers in the DG</td><td colspan="2">Markers in the SVZ</td></tr><tr><td></td><td>Ki67</td><td>DCX</td><td>Prox1</td><td>SOX2</td><td>Dlx2</td></tr><tr><td rowspan="2">BrdU</td><td>-</td><td><i>F</i><sub>(1,5)</sub> = 11.2, <i>r</i> = 0.83 <i>p</i> = 0.020 (AIE, P57)</td><td>-</td><td>-</td><td><i>F</i><sub>(1,5)</sub> = 9.9, <i>r</i> = 0.82 <i>p</i> = 0.025 (Control, P95)</td></tr><tr><td></td><td>-</td><td><i>F</i><sub>(1,6)</sub> = 10.0, <i>r</i> = 0.79</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td></td><td><i>p</i> = 0.020 (AIE, P95)</td><td></td><td></td><td></td></tr><tr><td>SOX2</td><td><i>F</i><sub>(1,5)</sub> = 13.3, <i>r</i> = 0.85 <i>p</i> = 0.015 (AIE, P57)</td><td>-</td><td>-</td><td>N/A</td><td>-</td></tr><tr><td>DCX</td><td>-</td><td>N/A</td><td>-</td><td>-</td><td><i>F</i><sub>(1,6)</sub> = 6.9, <i>r</i> = 0.73 <i>p</i> = 0.04 (AIE, P95)</td></tr><tr><td rowspan="2">Activated caspase-3</td><td><i>F</i><sub>(1,5)</sub> = 11.5, <i>r</i> = 0.83, <i>p</i> = 0.020 (AIE, P57)</td><td>-</td><td>-</td><td><i>F</i><sub>(1,6)</sub> = 14.9, <i>r</i> = 0.85 <i>p</i> = 0.008 (AIE, P95)</td><td>-</td></tr><tr><td></td><td>-</td><td><i>F</i><sub>(1,6)</sub> = 8.3, <i>r</i> = 0.76 <i>p</i> = 0.028 (AIE, P95)</td><td><i>F</i><sub>(1,6)</sub> = 7.5, <i>r</i> = 0.75 <i>p</i> = 0.034 (AIE, P95)</td><td>-</td><td>-</td></tr></table> |
01b79b27aad9485b9b4adcc71c7eaae0caa45cd15bf550004ed86ac544ee95ac.png | simple | <table><tr><td> Compounds of hydrocarbon</td><td>Mean</td><td>SD</td></tr><tr><td>Pars 1 dispersant</td><td>0.126</td><td>0.082</td></tr><tr><td> Pars 2 dispersant</td><td>0.055</td><td>0.049</td></tr><tr><td> Gamlen dispersant</td><td>0.011</td><td>0.004</td></tr><tr><td> Crude oil</td><td>0.072</td><td> 0.046</td></tr><tr><td>Pars 1 dispersant + petroleum</td><td> 0.156</td><td> 0.098</td></tr><tr><td>Pars 2 dispersant + petroleum</td><td> 0.104</td><td> 0.087</td></tr><tr><td>Gamlen dispersant + petroleum</td><td> 0.115</td><td> 0.067</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.